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Abstract
In the search for new treatments for cancer, advances in biology have provided
targets for the destruction of cancer cells. One such structure the microtubule, a protein
required for cell division, has been the target of many successful anticancer agents
including the multi-million dollar earning Taxol@ (paclitaxel) and the epothilones,
currently in late-stage clinical trials. More recently it has been shown that peloruside A L,
a secondary metabolite isolated from the New Zealand marine sponge Mycale hentscheli,
prevents cell division by stabilising microtubules, and thus offers promise as a novel
anticancer agent. However, due to its limited natural abundance, significant quantities of
peloruside A can only be obtained through chemical synthesis.
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A retrosynthetic analysis of peloruside A divided the molecule into four key fragments:
a) the commercially available c-l to c-2benzyloxy acetic acid fragment;
b) the C-3 to C-7 fragmenr;
c) the C-8 ro C-I1 fragment and
d) the remainingc-lz to c-24 portion of the macrocycle and side chain.
The C-3 to C-7 and C-8 to C-l I fragments combine to form a key intermediate pyranose
ring. This thesis however, addresses the synthesis of two of these key fragments, namely
the C-8 to C-l I and C-12 to C-24 fragments.
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An effieient synthesis of the C-8 to C-11 fragment of peloruside A, starring from
comrr.rerciall! available pantolaetone, has been de-velopod, This synthesis proceeds in
good ov,ctall yield, and has been successfully reBlodueed on the, multigram scale. The
signif,oant portion of this thesie, however, is dedicated to the synthesis of the C=12 to C-
24 fragment, After our initial strat€gy proved unv,iablE, a short, facile rnethod for the
synthesis of the C'I2 to C-24 fragment, involving Ere f,ormation of a Dls-silyl ether, was
developed. The protocol for its desired coqpling, via a boron_mediated, rcrnote l,S_anti,-
industion aldsl reaction has also been established. These and subsequent studies provided
valuable ir,rsigit into the origin of L,S-anti induction in borcin-mediated aldol reactions.
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Preface
Cancer is a group of diseases characterised by the uncontrolled growth and
spread of abnormal cells that invade and disrupt other tissues and spread to other areas
of the body' If the spread is not controlled, it can result in death. Cancer is a growing
public health problem whose estimated worldwide new incidences are over six million
cases per year.r In New Zealand,in 1999, approximately 16,700 people were diagnosed
with cancer, and about 7,600 died as a result of this invasive disease. This makes cancer
the leading cause of death in New Zealand,, accounting for over 27Vo of deaths from all
causes.2
This thesis represents part of a collaborative effort towards the total synthesis of the
novel anti-cancer agent, peloruside A, with the overall view to providing a practical and
efficient synthesis of this compound. Studies towards the determination of the absolute
stereochemistry of peloruside A will also be discussed. However, as with many
scientific journeys, results can lead in unexpected directions. During the synthesis of a
key fragment of peloruside A, the opportunity arose to investigate the origin of the
selectivity in boron mediated I,S-anti aldol reactions. These results are reported
accordingly.
-l-
Introduction
1.1: Tubulin stabilising antimitotic compounds 
- 
an overview
In the search for anticancer drugs, compounds from natural sources, such as
pacf itaxel, extracted in 197 | from the bark of the Pacific Yew tree3 and bryostatin,
isolated from a marine bryozan,a have displayed useful anticancer activity and proven
successful in clinical trials. In fact, paclitaxel, known clinically as Taxol, is one of the
most successful cancer drugs ever produced. Since 1992 ithas added months to the lives
of over 800,000 patients with cancers of the breast, ovary or lung - in the process
accumulating over $1.5 billion a year in revenue for Bristol-Myers Squibb. Eight years
after the initial discovery of paclitaxel, it was determined that its unique anti-cancer
activity can be attributed to its tubulin-binding mechanism of action.s Taxol functions
by crippling a cell's ability to divide, or undergo mitosis. The drug binds to and
stabilises the rod-like structures inside the cell called microtubules that, like moving
train tracks, help chromosomes arrange and split in two during cell division.
However, Taxol and its late-stage semisynthetic derivative Docetaxel (taxotere) are not
miracle drugs. Clinical trials with Taxol on metastasising renal6 and colonT carcinomas
have been disappointing. Furthermore, some cancers mutate and become resistant to
Taxol'8'e Thus even when a tumour is all but eliminated by Taxol, a few cells possessing
mutant phenotypes may remain, growing into more deadly tumours. Additionally, the
therapeutic index of Taxol is narrow due to mechanism-based side effects of
neutropenia, peripheral neuropathy, alopecia and hypersensitivity reactions.r0 Taxol is
also highly hydrophobic, necessitating delivery in Cremophor, which in itself can
induce cardiac anhythmi as and extensi ve hypersensi tivity reactions. r r
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Nevertheless, the phenomenal clinical success of Taxol promoted the search for new
drugs with similar mechanisms of action. once again, mother nature offered a solution
in the form of the epothilones A and B, whose isolation in the late 1980's from culture
extracts of the cellulose-degrading mycobactei,um Sorangium cellulo.szm (first found in
soil collected from the banks of the Zambesi River)r2 provided an additional class of
tubulin stabilising anti-cancer drugs. The epothilones exhibit superiority over paclitaxel
as a killer of tumour cells, particularly with cell lines exhibiting multiple drug resistance
(MDp;.':''o In some of the cytotoxicity experiments, epothilone B demonstrated a 2000-
5000 fold higher potency than paclitaxel, a striking enough observation to awaken and
stimulate the interest of many in both the academic community and the pharmaceutical
industry. Consequently, the epothilones and analogues thereof, are currently undergoing
advanced clinical trials.
Even though paclitaxel and the epothilones are the most well known tubulin-stabilising
antimitotic drugs, a small number of other tubulin-stabilising compounds exist. Of
particular interest to us is the discovery that peloruside A (pel A) (l), a novel secondary
metabolite isolated from a New Zealand marine sponge, Mycale hentscheli,Ls exhibits
potent paclitaxel-like microtubule-stabilising activity. r6,r7
14"
Pel A belongs to one of three classes of tubulin-stabilising compounds 
- 
namely the
macrolide class which includes the epothilones (to which peloruside is structurally
related) and the laulimalides,rs isorated from the marine sponge cacospongia
mycofijiensjs. other classes are a) the terpenoids, including the taxanes,
'",oMe
OH
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eleutherobin/sarcodictyinte (isolated from marine corals), and the bacterial metabolite
WS9885B;4 and b) the polyhydroxylated alkatetraene lactones, including
discodermolide, isolated from a Carribean sponge.tr'' Reported ICro values for the
cytotoxicity of these drugs are generally in the low nM range.
Although it is possible that pel A may not introduce anything substantially new ro the
antimitotic group of drugs, it is anticipated that its unique structure, and hence differing
bioactivity, will offer distinct advantages when compared to the other known
microtubule-stabilizing compounds. Furthermore, therapeutic anti-cancer drug cocktails
comprise a mixture of drugs having unique and complementary properties,u'- to which
pel A may be a valuable constituent. Multi-drug treatment regimes applied either as a
single cocktail or in a rotating sequence, may help to prevent the development of
resistant subclones that arise in long-term chemotherapy.
As is the case with many natural products, obtaining a sufficient quantity of the desired
compound from its natural source can be a serious limitation in drug development.
Although Mycale hentscheli is endemic to New Zealand, occurring in scattered
populations in calm coastal water around both the North and South Islands, pel A levels
in these populations are not large, with less than one third of the individuals in a
population containing detectable levels of the metabolite.s It has been estimated that to
obtain 30 mg of peloruside, 30 kg of sponge will have to be collected. To date, the
scarcity of pel A has prevented in-depth biological studies from being conducted.
However, before an overview of our strategy for the synthesis of pel A is discussed, it
will be instructive to first examine further the molecular and cellular biology of tubulin
binding agents, and how pel A relates to them.
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1..2: Tubulin, microtubules and the cytoskeleton
Tubulin is a heterodimeric protein primarily composed of a- and p-tubulin
subunits and represents the monomeric buitding blocks of microtubules. Microtubules,
in turn, are one of the fundamental structural components of the cytoskeleton in all
eukaryotic cells. Operating either alone, or in conjunction with other proteins to form
more complex structures, microtubules serye as structural beams and conveyer belts
within cells. They rigidify the cell and translocate vesicles, granules, organelles and
chromosomes. Although these filamentous protein networks are usually transparent and
hence often neglected in cell drawings, this "nanolevel web" plays a crucial role in the
dynamic organization of the interior of living cells and its existence should not be over
looked.
Structually, microtubules are regular internetworked linear polymers (protofilaments) of
highly dynamic assemblies of heterodimers of cr- and B-tubulin. When thirteen of these
protofilaments are arranged parallel to a cylindrical axis they self-assemble to form
microtububes of approximately 24 nmin diameter and up to several pm in length. The
cr,B heterodimer is itself very compact but can be divided into three functional domains:
the amino-terminal domain containing the nucleotide-binding region, the intermediate
domain containing the paclitaxel-binding site, and the carboxy-terminal domain, which
probably constitutes the binding surface for motor proteins.b
Formation of microtubules proceeds by a nucleation-elongation mechanism and occurs
within an area of the cell called the "aster".27 Nucleation is the initial phase of the
process in which preformed heterodimers of s- and p-tubulin assemble in the presence
of Mgz*, guanosine 5'-triphosphate (GTP) and microtubule-associated proteins (MAps).
This process is relatively slow until a short microtubule is formed, triggering the much
faster elongation process. The elongation phase involves the extension of the
microtubule nucleus at both ends by a reversible, non-covalent addition of tubulin
heterodimers to form growing oligomers that become linear rows of tubulin beads.
Although both ends can either grow or dissociare, the (+)-end, which is kinetically more
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dynamicr. usually qrows fasterthan the (_r_encl. (rvhich is less dynamic). Conversely. net
shortening takes place at the (-)-end. l'igure l. "Treaclmillin-e" or "flux" occurs when
both of'these dvnamic processes occur lt once. r'esulting in a net flow of subunits from
the plus ro the minus encl
rvithout a significant change
in microtubule length.:'
Figure 2 depicts rhe
assembly of tubulin inro
microtubules and the
influence that paclitaxel and
the epothilones nave on
tubulin polymerisarion.
Figure l: Polymerisarion o1.
tubulin to microtubulesr
Figure 2: Dynamic equilibria of tubulin-nticrorLrbuler
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Bound GTP molecules regulate the growth and dissolution of microtubules. Each
tubulin dimer camies two GTP molecules, one on the cr-subunit or N site and one in the
B-subunit' However only the exchangable B subunit appears to function as a GTpase.z8
During polymerisation, the GTP molecule hydrolyses ro guanosine diphosphate (GDp)
and orthophosphate (Pi). GTp, GDp, and p, form a ,,cap" on the ends of the
microtubules that facilitates further grorvth clue to their high affinity for additional
tubulin subunits.re Conversely, hydrolysis of the GTP subunit on the end of the
microtubule causes shortening of the microtubule.3o While the half-life of tubulin at
37 "C is nearly a full day, that of a given microtubule may be only about l0 minutes.
Accordingly, microtubules are in a constant state of flux responcling to the needs of the
cell. This state of stochastic switching between shortening and growing phases at the
ends of the individual microtubule is called "dynamic instability" and is controlled by
regulatory processes within the cell.?e.ir
Tubulin is a major component of the cellular apparatus known as the mitotic spindle,
and hence plays a crucial role throughout mitosis 
- 
the process during cell replication in
which the duplicated genetic material, in the form of chromaticls, is partitioned equally
between the two daughter cells. Mitotic spindle microtubules are especially dynamic,
and exchange their tubulin with tubulin in rhe cytoplasmic pool with half-lives of less
than a minute.r2 A cell enters mitosis after transcending through the Gap t (Gl),
chromosome replication (S phase) and Gap 2 (G2) phases of the cell cycle (collectively
known as interphase), figure 3. During prophase, the first division of mitosis, the
homologous sister chromatids contract and pair within the nucleus. Outside the nucleus,
two dipolar spindle-shaped arrays of microtubules are formed outward from organising
centres known as centrioles.' The centrioles, or microtubule-organising centres
(MTOC)' act as the major site of mjcrotubule nucleation by lowering the critical
concentration of tubulin required for polymerisation and anchoring the (-)-ends of the
resulting microtubules.33 Near the end of prophase the nuclear envelope breaks down,
allowing the spindle microtubules to enter the nuclear area. Kinetochores (mirotubule
I centrioles consist of a ring of nine groups of three fused microtubures
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binding proteins) then form on either face of the centromereu and become attached to
special microtubules called kinetochore microtubules. These microtubules radiate in
opposite directions from each side of every chromosome and interact with the (+)-end
of the spindle microtubules. Once the spindle microtubule/kinetochore/chromosome
complex is formed, metaphase commences.
Figure 3: Schematic diagram of the cell cycle'
At metaphase, the sister chromatids are assembled to an equatorial position on the
mitotic spindle by the dynamic action of the microtubules and associated motor
enzymes. This eventual congression at the cellular equator is the net result of both P-
motion (towards the pole) and AP-motion (away from the pole) and can be thought of as
a gentle jostling motion to align the chromatids along the equator. The P movement is
driven by a t)-end directed motor protein in the kinetochore, while the AP movement is
driven by a (+)-end motor protein. The kinetochores also contain motor enzymes that
destabilise the microtubules, leading to a loss of tubulin heterodimers from the (+) end,
u The centromere is the region on the chromomsome where the individual sister chromatids meet
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or net microtubule shrinkage.tt''o Movement of the microtubules is also dependent upon
t he i nherent microtubul e dvnami cs. -10.3r.-1-1.r.ta
The next stage of cell division is anaphase cluring which the microtubule dynamics
change and the chromatids partition and move to the new spindle poles on the dynamic
microtubules, where new cells are being formed. Anaphase microtubule dynamics are
particularly rapid, with motor proteins at the poles effectively reeling in the
chromosomes by shortening the microtubules.rt ln this process, duplicate chromosomes
are provided to each of the two daughter cells.
1.3: Tubulin binding agents and cell death
1.3.1: The two divisions of antimitotic compounds
Interruption of microtubule dynamics has proven to be an effective target for
cancer chemotherapy. These rapid clynamics are extremely sensitive to tubulin-
interactive agents that exert their antimitotic action at the metaphase to anaphase
transition, possibly by mimicking the actions of naturally occurring regulatory
proteins,ss figure 4. Ultimately, this results in arrest at the GZ:M transition.Many
antimitotic compounds, including the well established chemotherapeutic agents
colchicine, the Vinca alkaloids,
(including vincristine and
vinblastine) and podophylotoxin,
operate by interfering with the
formation and growth of
microtubules during mitosis.r6 At
appropriate concentrations, these
drugs inhibit the formation of
spindle microtubules or
Figure 4: Blocking of mitotic spindle division
by antimitotic compounds I
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depolymerise existing ones. Tubulin is instead diverted into other types of aggregares.
This class of antimitotic compounds further includes combretastatin,3T maytansine,38
rhizoxin,3s phomopsin,3s the dolastatins,-18'-1e"Io cryptonphycins,ar benzimidazoles (such as
nocadazol),2e'3rr'42 the curacinsas and the baceterial metabolite RpRl r237g.zo selected
natural products promoting the depolymerisation of tubulin are shown in figure 5.
vhbhsthe rhizoxin
9H
OMe
P-4f>a,I\-V \C(\o
rueolAorvre
OMe
podophy,llotoxin
1a ,\aoue
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'tfH
RPRl 12378colchicine
Figure 5: selected natural products promoring tubulin depolymerisation
Paclitaxel however, has a mechanism of action unlike any of the tubulin-targeting
agents that preceded it to the clinic. In contrast to the antimitotic drugs described above,
paclitaxel promotes tubulin-polymerisation, stabilises microtubules and thereby alters
normal microtubule dynamics. This results in the formation of abnormal mitotic
spindles, mitotic arrest, and the initiation of apoptosis (programmed cell death).*.as At
concentrations that are stoichiometric or near-stoichiometric with respect to the
AcHN
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concentration of tubulin present in solution, paclitaxel causes thick microtubule bundles
to form in cultured cells, even in the absence of GTP or MAPs. Once formed, the
microtubules are resistant to cold or calcium inducecl depolymerisation.s Data supports
the hypothesis that binding of a molecule ol' paclitaxel to a tubulin subunit in
microtubules induces a conformational change in that subunit that strongly reduces its
ability to dissociate when the subunit becomes exposed at the microtubule end.s
For morc than l5 years paclitaxel, and the structurally related taxanes, were the only
compounds known to have this mechanism of action. However, over time, additional
drug classes have been shown to act by a similar mechanism. In particular the recently
discovered epothilones, identifiecl after screening tens of thousands of compounds for
their ability to polymerise tubutin, have been shown to incluce tubulin polymerisation in
a manner similar to that of pacliltaxel.ra'tt' In fact, when compared to paclitaxel, both
epothilones A and B have reported higher potencies as tubulin polymerisation agents,
although in vivo studies identified epothilone B as being too toxic for use as an
anticancer drug. The lactam analogue of epothilone B however, referred to as aza-
epothilone B, has shown considerable potential in oncology, and has recently entered
phase [I clinical trials.+8
A computer-assisted search for novel compouncls with structural analogy to colchicine
site inhibitors, also identified the marine natural product (+)-discodermolide, isolated
from the sponge Discotlennia clissolure, as an antimitotic agent.zt,te Indeed,
discodermolide-treated breast carcinoma cells displayed spectacular rearrangement of
the microtubule cytoskeleton, including extensive microtubule bundling at
concentrations one tenth of those required by paclitaxel.sr The enhanced bundling
observed with both discodermolide and the epothilones when compared with paclitaxel
is readily understood in terms of the appatent increased affinity of these compounds for
tubulin relative to paclitaxel.
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However, paclitaxel, the epothilones and discodermolide are not the only antimitotic
agents that stimulate tubulin polymerisation. Gradually other natural products have been
added to this class of compounds. These inclucle laulimalide,rs eleutherobin.s0
sarcodictyin and more, recently pelorusicle A, figure 6.
,nA*, o
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NU
sarcodictyin A
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taxol Bzo
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discodermolide
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epothiloneB(B=Me) laulimallde
.,rrOMg
eleutherobin peloruside A
Figure 6: Selected natural products with tubulin polymerisation and microtubule
stabi I i sation properties.
1.3.22 Mode of action of the antimitotic agents
It had long been thought that the mechanisms of action of the two classes of
compounds were fundamentatly different due to the easily recogSrisable visible effects
of either microtuble polymerisation or depolymerisation. However, this concepr was
OH
CO2Me
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recently revisited because at low concentrations both classes of compounds appear to
inhibit cell proliferation by kinetically stabilising the dynamics of spindle microtubules
and not by changing the mass of polymerisecJ material.sr This is best illustrated by
paclitaxel, which is perhaps the most widely studied antimitotic agent. Numerous
studies have shown that in addition to stimulating microtubule polymerisation,
paclitaxel also inhibits tubulin exchange at microtubule ends and treadmiiling at
polymer mass steady state.5r'sr Such observations however, depend greatly upon the
stoichiometry of binding of paclitaxel to the microtubule.ut' Comparisons between
paclitaxel and vinblastine yieldecl similar results and lead to the hypothesis that
differences in the actions of antimitotic drugs may result from the relationship between
the stoichiometry of binding of the drug to the microtubules and the degree to which the
specific dynamic parameters, such as the extent of growing or shortening, are
suppressed.
ln the case of paclitaxel, induction of apoptosis has generally been directly associated
with G2lM arrest and occurs as a direct consequence of centrosomal impairment,
induction of abnormal spindles and suppression of microtubule dynamics.-5t However, in
some instances, the cell may pass through the M phase of the cell cycle yet arrest at the
Gl stage' 5s Significant debate exists conceming the mechanism by which paclitaxel
induces a stable late-Gl block. one scenar-io involves a critical element of Gl control
being sequestered on microtubules, and that the activation of the element requires its
release' The release and activation of this element can occur either in a dynamic
microtubule system or can be triggerecl in the absence of microtubules, but would not
occur when microtubules are stabilised by paclitaxel. Alternatively, by inducing hyper-
assembly of microtubules, paclitaxel might impose a checkpoint control upon the cells.
Checkpoint controls, which normally function to assure the integrity of the genome,
arrest the cell cycle at a discrete point until all prerequisite events have been
completed'so However, the triggering of apoptosis by aberrant mitosis or by subsequent
multinucleated Gl-like state rclated to mitotic slippage, largely depends on cell type and
drug schedule.s* other antimitotic agents. rnclucling the epothilones, have also been
reported to arrest cells at the Gl phase of the cell cycle.
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Although numerous studies and their insights have identified a myriad of cellular and
molecular effects of antimitotic agents that may offer promise in cancer therapy, these
results have often generated contradictory observations.sT What is known though is that
the cytotoxicity of these antimitotic compouncls involves signalling distinct from DNA
damaging drugs but common to all microtubule-active drugs with the specific hallmark
of Bcl-2 hyperphosphorylation.'8'5n Bcl-2 is a receptor found on the mitochondrial
membrane that plays a regulatory role in apoptosis. The serine/threonine kinase(s)
responsible for Bcl-2 phosphorylation. horvever, have not been conclusively identified.
The controversial role of p53r'r in paclitaxel-incluced apoptosis is still uncler debate.
Although it was initially thought that paclitaxel-induced apoprosis is p53-
independentm'.ragain, this depends on cell type and drug concentration. At
concentrations too low to inhibit mitotic progression (3 
- 
6 nM) paclitaxel can
completely inhibit cell proliferation in cells proclucing higher rhan normal amounts of
p53' Hence, paclitaxel has been shown to compliment the effects of p53 sufficiently to
cause arrest at Gl and G2.62
I.4: Biochemistry of peloruside A
1.4.1: Cell cycle arrest and effects on the cytoskeleton
Like its famous predecessor paclitaxel, peloruside A also causes cells to
accumulate at the G2/M phase of the cell cycle, as evidenced by an increase in the
number of cells in metaphase during flow cytometry studies.r? Such observations
support the hypothesis that pel A is interacting with the cytoskeleton of cells, in
particular, with the microtubules involved in the formation of the spindle. In a manner
analogous to the other microtubule stabilisers, pel A causes the formation of
microtubules in the absence of microtubule-associated proteins (MAps) and GTp. Once
t" p53 is a tumour suppressor gene that often plays a crucial role in apoptosis
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formed, the microtubules are resistant to cold or calcium
induced depolymerisation.tT Figure 7 is a Transmission
Electron Micrograph of pel A induced polymerised
microtubules, (in vivo preparation). I 7
Although studies comparing pet A with paclitaxel indicated
that the arest in G2lI4 was more complete for paclitaxel,
western blot results indicate that pel A appears to be more
potent than paclitaxel in inducing microtubule
polymerisation.rT A simple cellular assay was used in which
the shift in tubulin from depolymerised (soluble) to
polymerised (particulate) forms was followed by
electrophoresis and western blotting of centrifuged soluble
(S) and polymerised (P) fractions, figure g. At 100 nM
concentrations, complete tubulin polymerisation was observed for both pel A and
paclitaxel. Colchicine, on the other hand, drove the process toward the depolymerised
form as expected, figure 8A. The shift in tubulin dynamics was rapid for both pel A and
paclitaxel, being complete for 100 nM pel A at or before '0 min' (about 30 min after
addition of compund to intact cells) and complete for 100 nM paclitaxel at .5 min' (35
min after compound addition), figure gB.
A 0 lOnM l00nM I rM/'---^-\SPSPSPSP
pactitaxel *Arn> !} (I
Figure 7: TEM of
PelA induced
polymerised tubulin
B Qont 0 min 5 min l0 min 20 min/--^-\/--\- /-X:i--SPSPSPSPSP
Paclitaxel
Peloruside
Peloruside
Colchicine
Figure 8: Western blotting showing the effects of paclitaxel, peloruside A and
colchicine on tubulin polymerisation
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Upon the treatment of human lung carcinoma (H441) cells with pel A, abnormal
cytoskeletal rod-like fibres were also observed. Figure 9 shows cells treated for 48 hours
with 100 nM peloruside (B) or 100 nM paclitaxel (C). Control cells (A) were left
untreated. The fibres did not stain with anti-tubulin or anti-actinrv antibodies, and thus
appear not to be microtubular bundles or actin fibres. Other abnormal cytoskeletal
elements, including multiple asters were also observed.'t These observations are
consistent with studies of this nature on other known tubulin-binders including
discodermolide and the epothilones A and B.
Figure9: H44l Human lung carcinoma cells showing cytoskeletal bundles. A:
Control. B Treated for 48 hours with 100 nM peloruside A. C: Treated for 48
hours with 100 nM paclitaxel
L.4.22 cytotoxicity and the identification of apoptotic pathways
The cytotoxic activity of pel A has been determined in a number of cell lines
including the human myeloid leukaemic cell line HL-60, the nontransformed murine
myeloid cell line 32D, the human lung adenocarcinoma cell line HMI and 32D cells
transformed with ras and bcr/abl oncogenes. IC', values for pel A ranged from 4 nM to
15 nM in the different cell lines.rt These values are comparable to those of other
antimitotic drugs.
rv Actin is a filamentateous protein found in muscle tissue and in the cytoskeleton of cells
t'
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However. considerable work is still required to determine the exact mode of action of
pel A' Although the microtubule is presumably the major site of action of pel A, it is not
necessarily this particular interaction that kills the cells. A proteomics approach has
been used to decipher some of the downstream changes due to the action of pel A, with
tryptic digest finger printing identifying a 37 kDa protein altered by both pel A and
pacitaxel, as an isoform of g-tubulin.63 Further proteomics analysis has revealed points
of difference between paclitaxel and pel A, however this work is on-going and awaits
further confirmation' Prelimin ary in vitro sr.udies examining the effects of paclitaxel and
pel A on neutrophil superoxide procluction also revealed differences in the
immunosuppressive action of both compounds.tu Neutrophils are cells involvecl with the
immune system's response that. among other functions, destroy foreign bodies by
producing superoxide radicals. Again, these observations point to differences in the
secondary targets of paclitaxel and pel A.
What is perhaps more striking tlrough, are the differing effects of paclitaxel and
pel A on the metabolic activity of cells as measured by WST-I (water soluble
tetrazolium) dye reduction. Only metabolically active cells achieve reduction as this
requires functional mitochondrial dehydrogenases. Pel A (180 pM) stimulatecl WST-l
dye reduction by 2o+12o7n' rather than inhibiting it, as might be expected for a porenr
cytotoxic agent. By contrast, Taxol inhibited WST-t reduction by 70 + ZVo at 120 pM
but has little effect at l5-30 pM.u'Such results point to key differ.ences in the initial
cellular responses to the two compounds and suggest unique mechanisms of action,
depending on concentration and time of exposurc.
lt is also interesting to note that the soclium
borohydride reduction product of pel A, 2,65 does
not stabilise microtubules, figure 10,r7 yet is only
3O-fold less cytotoxic than pel A, figure ll.16 The
observation that 2 causes cell death at nanomolar
concentrations without polymerising microtubules
HO
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further illustrates
polymerisation.
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Figure 10: Western blot of pel A and
the reduction product 2
1.5: Tubulin binding sites
The diverse, seemingly unrelated structures of antimitotic anticancer agents raises
the question of whether they bind to the same or different sites on tubulin. Primarily, two
very distinct binding sites have been identified, conesponding to the primary mode of
action of the antimitotic agent. The first site, found only on unpolymerised tubulin dimer
but not the intact microtubule, is the colchicine site.6 Many other natural products such
as cornigerine, podophyllotoxin, and combretastatin A also bind to the colchicine site,
thus preventing tubulin polymeristation. It is also believed that the recently discovered
antimitotic agent, RPRI12378 binds to, or near, the colchicine-binding site.r0 The other
predominant binding site is the paclitaxel-binding site.28'67
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Each a/B-tubulin heterodimer contains one paclitaxel-binding site located between the
protofilaments formed from cr and B tubulin association. Paclitaxel does not bind to free
tubulin.0s The epothilones,rs discodermoliderr'6e and eleutherobin all inhibit the binding of
[]Hl paclitaxel to tubulin polymers, while laulimalide has been shown to bind to a unique
site on B-tubulin.70 To date, it is not knorvn if pel A binds directly to microtubules, and if
so, whether it binds to the same site as paclitaxel.
1.6: Multiple Drug Resistance
Resistance to paclitaxel has generally been associated with either over-expression
of the P-glycoprotein efflux pump,t' decreased intracellular levels of polymerised
tubulin,Tr or as a result of a mutation of the paclitaxel-binding site on tubulin.?z
Phosphoglycoprotein is a membrane glycoprotein that functions as a drug eftlux pump,
thereby reducing the effective intracellular concentration of anticancer drugs.
Overexpression of P-gp leads to the multiple drug resistant (MDR) phenotype, wherein
tumour cells become simultaneously resistant to a multitude of drugs.'t't'Eleutherobin
shows similar MDR sensitivity to paclitaxel, however, epothilones, discodermolide,2:
sarcodictyins and laulimalide look promising in this regard, being only transported to a
limited extent by P-gp.'' Studies comparing the cytotoxicity of pel A with paclitaxel in
cell lines that either overcxpress or do not express P-gp are under investigation.
Mutations in the B-tubulin structural gene results in the resistance of some cell lines to
both paclitaxel and the epothilones.ou'"t'Such cell lines include the ovarian carcinoma
lA9/A8 and lA9/Bl0 cell lines. with mutations at amino acids 8274'thr+rreun4 8282A'8-Grn.
respectively. Othel selected mutations in similar cell lines affecting paclitaxel
cytotoxicity but not discodermolide toxicity have also been reported.Tr Laulimalide was
also active in epothilone-t'" and paclitaxel-resistantTab cell lines bearing paclitaxel site
mutations in the M40 B-tubulin gene.To These studies suggest that even those tubulin-
binding drugs that compete with radiolabeled paclitaxel fbr what appears to be the same
binding site, display subtle differences in their interaction with the specific amino acid
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residues of the p-tubulin bincling site. Hence each antimitotic drug offers distinctive
advantages over one another with respect to resistant cell lines. It is thus anticipated that
pel A will exhibit its own unique cytotoxity with respect to various resistant cancer cell
lines.
1.7: The development of peroruside A as a viable drug candidate
Although the strategy of using tubulin ils a target for cancer chemotherapy has
been well established,tt clifferent microtubule inhibitors vary in their ability to selectively
destroy tumour cells in a clinical setting. While the chemotherapeutic effect of
microtubule inhibitors would seem in some way linked to the most eviclent effect of the
drugs, mitotic arrest, there is no direct evidence in support of this assumption - the
difference in chemotherapeutic efficacy may lie in more subtle effects. For example both
paclitaxel and nocodazole impose mitotic arrest on mammalian cells,55 yet paclitaxel has
shown promise in chemotherapy, particularly in the treatment of ovarian and breast
cancers, while nocadazole has not.
Fortunately though, recent in t'ivo tests have shown pel A to be efficacious in tumour
rcgression'7. A sample of pel A (5mg) was tested on mice bearing the colon 38 tumour
using a single intraperitoneal dose of 4Omg/kg. At this dose, pel A was fbund to be toxic
in four of the five mice, however the remaining mouse showed no toxicity and survived
for the duration of the experiment with no evidence of tumour. A further sample of drug
(3 mg) was then tested on mice bearing the colon 38 tumour using a lower single
intraperitoneal dose of 25 mg/kg. It was again toxic in four of the five mice. The
surviving mouse however, showed complete tumour regression with further tumour
regression being observecl in all the deacl mice. Although further studies are required in
order to determine the effective dosage in vivo, these rcsults are particularly encouraging
because they involved a single bolus dose of pel A, yet anti-cancer treatments normally
require multiple doses or intravenous infusion to be effective.
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Whpther pel A will e.qual the utility of Taxol in treating canoer however,, can gnly be
answered a'fter,sigrnificant investment ,in the drug developmenr and clinieal trial p.rocess,
which ultimately requires an abundant sup-ply of pell A. D-uc ts its scarce naturat
abundance, it is anticipated that significant quantitios o.f pel A can only be obtained
thiough ehernical synthes{s. However, at the time of comrnercing thi,s project, the
absolute s,tereoehen:i.s'try of pel A was unknown. Ideally, it would be desirable to know
the Erbsol'ute stereoohenistry of pel A at the beginning" if not during the early stages of
lhe synthesis, to avoid any ,possibre repetition of work. Thris, methods for dete.rrnining the
absolute stereoehemistry of pol A wil[ be discussed befsre an overview of qur synthetic
slrategies for the synthesis of pel A is provided.
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1.8: Determination of the absolute stereochemistry of peloruside A
Possible methods of determining the absolure stereochemistry of pel A include: a)
the synthesis of one enantiomer of pel A fbllowecl by comparison of the optical rotation
of this enantiomer with that of natural pel A; b) ring opening the macrolide under mild,
aqueous conditions, followed by esterification of the resulting carboxylic acid moiety
with a chiral reagent and comparison of the absolute stereochemistry at C-Z by ,H NMR
specttoscopy in a manner similar to Mosher's method;77,7s and c) comparing a synthesised
fragment of pel A of known stereochemistry with a similar fragment cleaved from the
natural product.
The la.st strategy initially appeared to be the most viable, with the details of this chosen
fragmentation given in scheme l. This approach involves selectively protecting the
primary hydroxyl group of pel A with the rerr-butyldimethylsilyl (TBS) moiety, followed
by ozonolysis and work-up to produce the side chain fragment 3. The synthesis of an
identical fragment of known chirality at C-18 has been reported.Te Chiral gas
chromatography would then be used to comparc the retention times of the cleaved side
chain 3 and both the synthetically derived racemic, and enantiomerically pure, versions of
3' The attraction of this strategy is that it not only enables the absolute stereochemistry of
C-18 to be determined, and hence the absolute stereochemistry of the entire molecule, but
also results in the fonnation of the macrolicle se-qment 4 which may have its own unique
biological properties.
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Scheme 1: Methodology for the determination of the absolute stereochemistry of pel A
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L.9i synthetic strategies towards the synthesis of,peloruside a
1.9.1: Retrosynthetic Analysis
Although the structure of pel A is considerably less eompl,ex than that sf
paclitaxel, it nevertheless poses some considerable synthetic challeng.es, particularly in
the formation of the pyranose ring and eontrol of the I0 stereogenic eEntres. Mo.roover,
pel A provides rnan'y op.porffnities for the discovery and developrnent of new synthetic
teehnologies and strategies. Scheme 2 illustrates the fragmentation of the syr4hetic target
to three ma'in ,building blocks: the pyranose ring 5, commercially available
benzyloxyacetic acid 6', and tfie remaining side chain and macrocycle fr,agrnent 7. The
two bond disconnestions depicted on pyranose ring 5 facilitate the synthes.i,s of this corc.
aklol
reaction
.,l
hemhcetal
cycfizafon
Seheme 2: Retrosynthetic analysis of peloruside A
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Formation of pyranose 5a, a
with a diastereoselective aldol
aldehyde 9 to give B-hydroxy
(TES) moiety under mildly
envisioned to afford 5a.
synthon for the C-3 to C-11 fragment, would commence
reaction between the enolate of genr-dimethyl ketone I and
ketone 10, scheme 3. In situ deprotection of the rriethylsilyl
acidic conditions, with subsequent cyclisation,8O was
BnO OTBDPS
oz*4orBDps
9
Scheme 3: Formation of pyranose 5a
Although the total synthesis of pel A is outlined in this thesis, rhe research
contains in this thesis involvedd developing a plausible strategy for the synthesis of the
C-8 to C-24 carbon backbone of pel A. Accorclingly, this required synthesising rhe two
key retrosynthetic fragments, the C-12 ta C-24 fragment 7 and the gent-dimethyl ketone
liagment 8. Progress towards the incorporation of ketone 8 into pyranose 5a is outside the
scope of this thesis, however for completeness, strategies for the synthesis and assembly
of all the key fragments of pel A will be outlined in the subsequent pages of this chapter.
1.9.22 synthesis of the c-3 to c-ll fragment of peloruside A
Controlling the stereochemical outcome cluring the formation of the pyranose ring
of pel A will be one of the more challenging aspects of the synthesis. First, the desired
axial orientation of the C-8 benzyloxy substituent in 5a requires formation of the E
enolate of gern-dimethyl ketone 8. Although the close proximity of the genr-dimethyl
substituents to the carbonyl group will favour formation of the Z enolate, it is anticipated
that the use of lithium tetramethylpipericlide (LTMP), a sterically hindered base, will give
the desired E geometry,8r scheme 4.
8
+
OTES
5a
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Controlling the facial selectivity of the subsequent aldol reaction necessitates a transition
state involving chelation control of the B-hydroxy substituent. Lithiumv has been reported
to display useful levels of chelation control,sr as depicted in scheme 4. Here lithium
chelates to the enolate anion and to both the alctehyde carbonyl oxygen and the B-alkoxy
oxygen of the approaching aldehyde. Chelation of the lithium enotate to the approaching
aldehyde moiety occurs via a six-membered twist-boat Zimmerman-Traxler transition
state,83 with coordination of lithium to the OTES substituent resulting in the chair
conformation of the aldehyde pafiner. Chelation occurs with both the gent-dimethyl side
chain and the alkyl chain of the B-hyclroxy aldehyde adopting an equatorial orientation.
Thus, the anticipated net outcome of this reaction is the desire d anti- relationship between
the C-5 and C-7 and C-7 and C-g substituenrs.
OTBDPS
OTBDPS
10
-]
"rr"ra ]
Scheme 4: Proposed control of the stercochemistry of the pyranose ring by B-alkoxy
lithium chelation
v Magnesium has also been shown to have sirnilar levels of chelation control
OTES:3
57
Bn
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If a stereoselective aldol reaction proved unviable, an alternative, although slightly more
involved approach for the formation of the pyranose ring has been proposed. An
unselective aldol reaction between the enolate of ketone 8 and aldehyde 9 would give,
after in situ deprotection of the TES substituent, pyranose 11 as a mixture of
diastereomers with the two alkyl chains adopting the equatorial orientation, scheme 5.
Upon methylation, hydrogenation and oxidation, cyclic intermediate 12 would be formed.
The C-7 methoxy could then be epimerised to the equatorial position to give 13 by
treatment of 12 in a basic medium.84 At a later stage in the synthesis, the cyclic ketone
could be asymmetrically reduced with NaBHa, or other suitable reducing agent, to give
the axial conformation of the C-8 ring hydroxyl.
TBDPSO-Y
o
6Ys rOMeTBDPSA-*--a-14o7-\{-l ,
1) Methylation
2) H2, Pd
3)Oxidation
12
I
11
NaOMe
MeOH
TBDPSo-^--cphoMeo7{
.---J ',O
o"lz \
13
Scheme 5: Alternative strategy for the synthesis of the pyranose ring
Two strategies have been proposed for the synthesis of ketone 8. The first of these
commences with an aldol reaction between glyoxal and isobutyraldehyde, forming the
intermediate acetal 14, scheme 6. The base catalysed thermal rearrangement of 14 gives
hydroxy furanone 15, which is subsequently reduced to diol 16, then benzylated to afford
E. Although it is conceivable that difficulties may be encountered in preventing self-
condensation during the first aldol reaction, a patented procedure for this synthesis has
been reported.ss
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Scheme 6: Synthesis of ketone 38 starting with glyoxal ancl isobutyraldehyde
Alternatively, reduction of commercially available pantolactone 17, followed by selective
benzylation of the primary hydroxy groups and oxidation of the remaining secondary
alcohol yields ketone 8, scheme 7. Although this three-step synthesis appears to be ideal,
difficulties could be encountered in selectively benzylating the primary hydroxyl groups
in the presence of the secondary alcohol. Thus the alternative five-step srraregy
commencing with the protection of pantolactone to give l7a may be required, scheme 7.
The subsequent reduction of l7a, followed by benzylation, deprotection and oxidation
yields ketone 8. Even though the primary hydroxyls coulcl be selectively protected with
alternative protecting groups, such as silylanes,s6 due to literature precedent for the
folmation of benzloxy enolatess7 and its overall fit within the synthetic strategy, synthesis
of the ketone derivative in its benzylated form was pref'erred.
eno^&o'n
( 17 R=H\ 17a R = Protecting groLrp
scheme 7: synthesis of ketone 8 starting with pantolacrone
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It was proposed that the synthesis of the final fragment of the pyranose ring, aldehyde 9,
would commence r.vith the mono silylation of commercially available propane-1,3-diol.
Oxidation, followed by asymmetric allyl boration using ally diisopinocampheyl-borane,sB
yields the intermediate alcohol 19, which is further silylated and ozonolysed, to give
aldehyde 9,80 scheme 8.
o
HO-\-^OH + HUOTaopS _
18
Scheme 8: Synthesis of aldehyde 9
9TES
:
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aldol reaction
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of the C-12 to C-24 fragment
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1.9.3: Sythesis of the C'12 to C-24 fragment of peloruside A
Two strategies were considered for the synthesis of the C-12 to C-24 fragment of
pel A. The key intermediate in the first of these strategies is the keto-lactone 20, which
when reduced, gives the C-I2 to C-24 fragment 7, scheme 9. Lactone 20 results from the
ring closing metathesis (RCM) of ester 21. itself formed from an esterification and aldol
condensation reaction, as depicted. For clarity, it should be noted that a regio- and
stereoselective aldol reaction between keto-lactone 20 and the pyranose fragment of pel
A would first be conducted before lactone 20 is reductively opened.
estsrificationp
.--------_-- V,,.\ 
-
I
Scheme 9: Initial retrosynthetic analysis for the formation
20
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Amongst the strategies considered for the synrhesis of the C-12 to C-24 fragment, the
aldol reaction with keto-lactone 20 was perhaps the most intriguing. Despite a multitude
of precedent for the formation of kinetic verses thermodynamic enolates, as the cr -
lactone proton in 20 is also susceptible to deprotonation, this may result in double bond
isomerization and in difficulties with controlling the regiochemistry of the aldot reaction.
However, as it was believed that the synthesis of 20 would be relatively straightforward,
this strategy warranted investigation.
In the eventuality of encountering clifficulties in controlling the regiochemistry of the
aforementioned aldol reaction, the altemative synthesis of the Dis-alkoxysilyl ether 22
was considered for the formation of the C-12to C-24 fragment, scheme 10. Bis-alkoxy
ether 22 is essentially the "tethered" analogue ol'7. Initial concerns about the synthesis of
this eight membered bfs-alkoxysilyl ether by the RCM of the corresponding acyclic
precursor 23 were subsequently alleviated by recent publications reporting the synthesis
of similar molecules by RCM.89'* Diene 23 could in turn be synthesised by the sitylation
of B-hydroxyketone 24 and(s)-3-hydroxymethyrpenr- l-ene 25.
p ;{-.f
ro--
\
25
Scheme 10: Alternarive retrosynthesis of the C_12 to C_24
1.9.4: The assembly of peloruside A
To accommodate for the variability in the synthesis of the key fragments of pel A,
different methodologies for the assembly of these fragments have been developed. In
particular, two key strategies have been proposecl reflecting the inclusion of the diff-erent
C-12 to C-24 fragments into the total synthesis. The first of these strategies involves the
incorporation of lactone 20 into the overall synthetic plan, as outlined in scheme I l.
ooHilt
I
24
fragment
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Scheme 11: Synthesis of peloruside A: Strategy I
To facilitate the coupling of fragment 20a (the TMS enol ether of 20), pyranose 5a would
be first methylated to give 5b, selectively debenzylated, using triphenylmethyltetra-
fluoroborate,er the ensuing hydroxyl oxidised to an aldehyde under Swem conditions,e2
and an asymmetric aldol reaction with 20a conducted. It was envisioned that a Lewis acid
catalysed Mukaiyama aldol reaction would be used to control the stereochemistry of this
reaction.er A Evans-Tischenko reductione? when then be employed to give the desired C-
I t to C-13 anti relarioship and the resulting hydroxyl methylated to give 26, (where R =
EtCOJ. The lactone would then be reductively opened using ZnBHo, which would also
result in the deprotection of the propanyl ester. Thus, thrs overall transformation would
result in three hydroxyl moieties, a primary, allylic and secondary which can be
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selectively protected, before the primary terl-butyldiphenylsilyl protecting group is
deprotectedet and the resulting hydroxyl oxidised to give aldehyde 27. An asymmetric
aldol reaction between 27 and the enolate of the benzyloxy acid derivative 6a, followed
by methylation of the resulting alcohol will follow to yield 21. It is proposed that a chiral
auxiliary (X), such as Evans' oxazolidinonee5 will exert the necessary n-facial selectivity
required for this aldol reaction. Finally, hydrolysis of the auxiliary, followed by
deprotection of the allylic hydroxy substituent, Yamaguchi macrolactonisation,eo and
deprotection of the remaining protecting groups, including the methoxy acetal, gives
peloruside A.
Alternatively, if the C-12 to C-2? bis-alkoxysilyl ether fragment22 is incorporated into
the synthesis, the order of assembly of the key fragments varies slightly, as depicted in
scheme l2 overleaf. First, the tert-butyldiphenylsilyl group on pyranose 5b will be
removed and the resulting hydroxyl oxidised to the aldehyde. An aldol reaction with the
benzyloxy derivative 6a, followed by methylation of the newly formed hydroxyl, then
gives intermediate 29. Selective clevage of the primary benzyl ether, followed by Swern
oxidation, and an asymmetric aldol reaction with bis-alkoxysilyl ether 22 would then give
the complete carbon skeleton 30. An Evans-Tishchenko reduction of 30 with samarium
iodide and propanal, then establishes the correct stereochemistry for the 1,3,5-triol
sequence and protects the C-11 hydroxyl as the propanoyl ester.eT Methylation of the
resulting hydroxyl, fbllowed by desilylation of the bis-silyl ether gives intermediate 31.
Following the hydrolysis of the chiral auxiliary, and propanoyl ester (R), a Yamaguchi
macrolactonisation will then be attempted directly with 3l to give peloruside A. If a
mixture containing the 16, 2l or the I I membered lactones is formed, a series of
protection and deprotection strategies will be required to selectively protect the C-11 and
C-24 hydroxyl groups before the macrolactonisation.
-31-
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Scherne 1?: Synthesis of peloruside A: Straegy 2
Although not without its, own unique challenges, the above synthesis appears
flexibJe and convergent enough to enable modifications to be,made as required, and at a
laler date, to facilitate the s.yrrthesis of analogues of peloruside A. More reoently, several
paper$ concerning the synthesis or partial synthesis or peloruside d, have appemed in the
literature. These publications are rcviewd in the appendix (page 178)"
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Chanter Two
-
Determination of the absolute stereochemistry of peloruside A
2.1: Review
As previously discussed, determination of the absolute stereochemistry of pel A
was to be achieved by determining the stereochemistry at C-18 of the side chain, scheme
13. One possible approach to this requires silylation of the primary hydroxyl of pel A,
followed by ozonolysis to produce 2-((rert-butyldimethyl)-siloxymethyl)butanal 3. After
synthesising both the racemic and enantiomerically pure versions of 3, chiral gas
chromatography would first be used to compare the retention times of these derivatives,
thus enabling the order of elution of the (R)- ancl (S)- enantiomers to be determined. By
co-injecting a synthetic racemic mixture of 3 with the cleaved fragment of pel A, the
relative retention time of the cleaved fragment, and hence the chirality at C-lg, could then
be deduced. Due to the limited abundance of pel A, investigations into this strategy began
with the synthesis of the racemic alkyl side chain. This would provide valuable insight
into any potential problems that may arise r,vith handling a substrate such as 3, and enable
the optimum conditions for the separation of the two enantiomers by chiral gas
chromatography to be determined.
MeO
1
Scheme 13: Strategy
o
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2,22 Strategy One
The availability of propan-1,3-diol l8 provided a convenient starting point for the
synthesis of the racemic alkyl fragment. Monosilylation of diol l8,e8 followed by a Dess-
Martin oxidationee resulted in the formation of 3-(tert-butyldimethyl-siloxy)propanal 32,
scheme 14. However, due to its apparent volatility, propensity to decompose, and
difficulties in finding an adequate stain for thin layer chromatography (t.l.c) analysis,
purification of aldehyde 33 proved to be somewhat troublesome. Nevertheless, eventually
gram quantities of 33 were produced in an overall modest vield.
Ho-^*oH
1)NaH,1.5eq
THF 1h
2)TBSC|, t h,94o/o
18
Hol\/-orBS Dess-Martin
cH2cl' ,50%
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1) KH (1.1eq)0 "C, 2) Efl;or
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Scheme 15: Attempted cx-alkylation reactions
,.,LO"'
Scheme 1 4 : Formati on of t e rt -butyldi methy l si lox ypropanal
To complete the racemic synthesis of the side chain, an cr-alkylation reaction of 33 with
ethyl iodide was required. Although the alkylltion of aldehydes is problematic, with
dialkylation and self-condensation frequently being observed, during the attempted
alkylation of 33 it was nonetheless disappointing to observe none of the desired alkylated
adduct 3b' A variety of conditions were investigated, as detailed in scheme 15, however
in all instances, the starting material simply decomposed.
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In an endeavour to synthesise a substrate more amenable to a-alkylation, attempts were
made to convert 33 into the potentially more robust N-cyclohexyl-3-(tert-
butyldimethylsiloxy)imine 34, scheme 16. Although 'H NMR specrroscopic analysis
indicated that imine 34 had indeed been synthesised, on the sub-gram scale, attempts at
separating the excess cyclohexylamine frorn the desired immine proved futile.
Consequently, this procedure was abancloned.
o
tlH^4ores
33
c6H6,4A MS
u'cY
H'll-6orBS
34
CyNH2
Scheme l6: Attempted synthesis of N-cyclohexyl-3-( tert-butyldimethylsiloxy)imine
In view of these findings an alternative, and indeed more elegant, strategy for the
synthesis of 3 b was devisecl, scheme 17. This involved the reduction of
diethylethylmalonate,rm monosilylation of the ensuing diol and a Dess-Martin oxidation to
form the racemic fragment 3b. Fortunately, these transformations proceeded relatively
smoothly. Although literature precedent called for the reduction of the malonate in
diethylether at room temperatrure, to ensure complete conversion of the starting substrate
to the requisite diol, the reaction mixture was heated at reflux. yields were comparable to
those previously reported.r00 Unfortunately, yields for the oxidation were once again
modest as difficulties were encountered in encouraging this reaction to go to completion
whilst preventing the decomposition of starting material. Similar difficulties were
encountered with the attempted oxidation of 36 using pyridium chlorochromate (pCC) as
the oxidant.
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Scheme 17: Altemative strategy for the racemic synthesis of fragment 3b
Having synthesised racemic 3b, investigations into determining the optimum conditions
required for the separation of the enantiomers using a 30m x 0.25mm Cyclodex-BrM
chiral gas chromatography column were conducted. As the retention times for the
enantiomers were very similar, some problems were encountered when attempting to
separate the enantiomers. The apparent instability of aldehyde 3b, which rapidly oxidises
to the corresponding acid within a few days (even with storage under argon at <4"C), also
provided an additional hurdle. Numerous changes to the run conditions were required
before distinguishable, yet overlapping peaks, for the enantiomers were obserued.
Thus with a suitable synthetic strategy for the racemic synthesis of the alkyl side
chain in place. work began on the synthesis of the enantiomerically pure alkyl side-chain.
Literature precedentTe for the synthesis of (-)-(2S)-2 ^((tert-butyldimethyl-
siloxy)methyl)butan-1-ol initially involved an enantioselective alkylation reaction using
Evan's chiral oxazolidinone 37, titanium(IV) chloride, triethylamine, and trioxane,
scheme 18. Subsequent in sittt protection of the hydroxyl group using tert-
butyldimethylsilylchloride gives 38. The enantiomeric excess of the alkylation reaction
was reported to be greater than 99Vo, yet the reported overall yield for the two
transformations was a mere 487o.
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Scheme 18: Literature precedent for the synthesis of C)-(2S)-2-((rert-butyldimethyl-
siloxy)merhyl) butan- l-ol 39
Reproduction of the literature methodology for the titanium tetrachloride mediated cr-
alkylation reaction gave astonishingly poor yields. Grams of substrate 37 would yield
only milligram quantities of the requisite product. In toral, only l0 mg of 38 was ever
isolated.
Thus with only a l0 mg sarnple of 38, the auxiliary was apprehensively cleaved using a
solution of LiBHo in wet TFIF. Fortunately this proceeded smoothly. Due to rhe small
sample of the desired alcohol 39, purification of the crude material by flash
chromatography was particularly chailenging. Nevertheless, 5 mg of pure (-)-(2s)-2-
((rert-butyldimethyl si loxy)methyl)butan- I -o I 39 rvas isol ated.
once again, the Dess-Martin oxidation protocol was followed for the oxidation of 39.
This protocol is particularly facile for the oxidation of milligram quantities of substrate.
After a simple filtration of the crude reaction mixture through a pasteur pipette sized silica
gel plug, a sufficient quantity of the enantiomerically pure aldehyde 3c was obtained for
analysis by gas chromatography; scheme lg. Thus, with great anticipation,
enantiomerically pure 3c and a freshly prepared sample of the racemic aldehyde 3b were
co-injected into the gas chromatogram.
*^eorBS
39
scheme l9: Final oxiclation of the enantiomer.ically pure alcohol
Dess-Martin
cH2cl2
-Jt-
Althor,lgh separation of the enantiomers by gas chrornatography was nol ideal, it was
nevertheless possible to conclude that the (,S)--enantiomer was the first enantiomer etruted,
as evid,enoed by an increase in the peak height of the first of the two eluted peaks.Thus all
that remained in this $trategy was to silylate pel A with the rumrbutyldr'rnethylsilyl group
thea cleavo the olefinie bond, via ozonolysis, to fo,nn the coresponding aldehyde.
Unfortuntat€ly this was where considerable difficulties arose. Due to the I mg sample size
of pel A ,that was available, silylation proved unviab,le, scheme 20. Presumably, this was
due to the dilution at which the reaction was conducted 
- 
effective sllylation requires:
concenhafed conditions"ror Although we acknowledged ttrat small+cale reaetions are
often troubleso.r'ne and present their own unique practioal diffjculties, this was
never.theless an exceptionally disappointing regult. An alternative a:pproech was roquired.
TBDSCI T
___jF_
ry
Scheme 20: Thc attempted si,lylation of poloruside A
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2.32 Strategy Two
Two factors were of utmost concelrr when redefining the target molecule. First, a
protecting group had to be chosen that had a much greater likelihood of being
incorporated onto a natural product on such a small scale, and second, there had to be a
facile synthesis for the corresponding enantiomerically pure side chain. Although one
could contemplate simply performing ozonlysis on unprotected pel A, there were some
concerns with this strategy. While an Oppenauer-type oxidation of diol 35 using CptZrH,
could be conducted, scheme 2l,r0r formation of the required enantiomer would be difficult
and would ultimately require the manipulation of (-)-(2S)-2-((tert-butyldimethylsiloxy)-
methyl)butan-l-ol 39, or similarly protected alcohol. Given the difficulties in synthesising
the siloxy alcohol, further chemical manipulations on this segment were unpractical. It
was also conceivable that 41 would be a difficult molecule to work with due to its low
molecular mass and highly polar naturc. Consequently, this strategy was discarded.
Ho^I]oH
35
Cp2ZrHp
Cyclohexanone
Scheme 21: Possible Oppenauer-type oxidation of 35
Literature precedent for the acetylation of rnany natural productsr03 prompted us to
believe that the primary hydroxyl group of the side chain of pel A would also be amenable
to acetylation. However unlike the previous silylation strategy, in which only the primary
hydroxyl terminus was expected to be protected, acetylation of pel A would ultimately
rcsult in the acetylation of many, if not all, of the free hydroxyls in pel A. Although it was
initially desirable to retain the remaining portion of pel A in its unprotected form after
oxidative cleavage (for potential biological testing), this was not of fundamental
importance to the strategy. Thus, a review of the literature was conducted to determine if
there was synthetic methodology for the synthesis of the enantiomerically pure acetylated
-39-
alkyl side chain. Fortuitously, such methodology had been reported,rm as outlined in
scheme 22. Here the lipase, extracted from the microorganism Pseudotnonas cepacia,
kinetically deacetylates, and hence resolves, the diacetylated precursor, 42. Alcohol 43 is
subsequently oxidised under Swern conditions to give enantiomerically pure 44.
ncol]onc
42
Lipase PS, H20 Swern oxidation BHlionc
:
44
HolYoAc
\
43
pH7.2
Scheme 222 Altemative strategy for the synthesis of an enantiomerically pure side
chain 44
Thus with a plausible strategy for the synthesis of the enantiomerically pure acetylated
side chain in place, all that remained was a methodology for the synthesis of the racemic
acetylated side chain. Needing both the monoacetylated alcohol 43b, (for the racemic
synthesis) and the diacety.lated alcohol 42 (for the enzymatic resolution), a solution of diol
35 was acetylated under standard conditions but with only 1.2 equivalents of acetyl
chloride, scheme 23' This produced an easily separable mixture of the monoacetylated
and diacetylated alcohols,43b and42 respectively, in a l:l ratio. Although there was
literature precedent for the oxidation of 43b under Swern conditions, the Dess-Martin
oxidation protocol had been effectively adapted to meet our requirements for small-scale
sample sizes and therefore this later oxidation protocol was followed. However like its
silylated counterpart, 44b was also prone to decomposition and was difficult to detect via
t'l'c' Numerous stains were screened'* before a combination of reagents, saturated o-
dianisidine in glacial acetic acid, was founcl to be suitable.
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scheme 23: Formation of the acetylated racemic fragment 44b
Thus with the racemic aldehycle in hand, attempts were then made at separating the two
acetylated enantiomers using the 30m x 0.25mm Cyclodex-BrNt column. Although
numerous changes were made to the operating conditions during the GC studies,
regrettably, these enantiomers were practically inseparable with this particular column.
After some consideration, a decision was macle to invest in a 60 m x 0.25 mm Cyclodex-
Bl'M column as it was anticipated that the increased length of the column would result in a
greater separation of the two peaks for the eluted enantiomers. Thankfully this assumption
came to fruition' The acetylated enantiomers could indeed be separated when using the 60
m x 0.25 mm Cyclodex-Brltt column, albeit after an extended two hour run time! The
optimum run conditions were as follows: Inlet: Split 275"C;Detector: FID 320'C; Carrier
gas: hydrogen;Flow: 35.8 cmrs-r: Temperarure programme: Isothermal at 60oc.
Having established the conditions required for the adequate separation of the two
acetylated enantiomers, our focus then shifted towards the enzymatic resolution of the
diacetylated prccursor 42. As surmised in the literature,rm diacetate 42 readily undergoes
hydrolysis into the racemic monoacetate in the absence of lipase pS, (thus 42 must be
added to an aqueous solution of lipase P.S buffered at pH 7.2). Although the literature
reported enantiomeric excesses of greater than 887o at 697o hydrolysis, the cost of the
4243b
-4t-
enzyme meant that this reaction could only be conducted at 5Vo of the scale reported.
Consequently, it was a little more difticult to monitor the hydrolysis rate and the ee
value,ur using only 100 mg of the lipase, was only 72Vo. This result however, was still
adequate.
Thus with only 40 mg of enantiomer 43 available, and with the knowledge that the
corresponding aldehyde 44 has limited stability, a small (8 mg) sample of purified 43 was
subjected to a Dess-Martin oxidation. Once again, this methodology proved to be
successful with milligram quantities of aldehyde 44 being produced after purification
though a small (pasteur pipette sized) silica gel plug, scheme 24.
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Scheme 24: Synthesis of the acetylated, enantiomerically enriched side chain.
Concumently, racemic 2-(acetoxymethyl)butanal was synthesised and the racemic and
enantiomerically pure fragments co-injected into the gas chromotograph. As anticipated,
the two samples co-eluted. The (R) enantiomer elutes first from the column with a
retention time of 116.5 minutes, while the (S)-enantiomer has a longer retention time of
I19.5 minutes. The gas chromatograph trace of racemic aldehyde 44b coinjected with the
(S) enantiomer 44 is given in figure 12.
vr The enantiomeric excess was determined by g.c irnalysis of the corresponding aldehyde
.ta
Figure 12: G_as chromatograph trace of the racemic aldehyde 44b co-injected with the(.S)-enantiomer 44
Once again, the point in the strategy had now been reached where pel A had to be
manipulated. But this time only 0.5 mg of pel A was available. However, even before any
attempts at acetylating pel A were made, two important questions needed to be answered.
First at this scale, would the final enantiomer even be cletectable by the gas
chromatograph, and second, how l'easible were small-scale ozonolysis reactions?
To determine the sensitivity of the gas chromatograph, some approximate concentration
studies were conducted. Due to the instability of 40b and the 2 hourrun times required for
good peak resolution, pinene was instead chosen as a standard. Fortunately, 3 pL aliquots
taken at dilutions as low as 0.01 mg of pinene per I mL of dichloromethane could be
detected by the GC. This equated to 2.2 x l0'r0 moles of substrate and indicated that, when
starting with a 0.5 mg sample of pel A (9.11 x l0'Tmoles). the cleaved acetylated side
chain should be detected, even if the acetylation and ozonolysis reactions went to only
l07o completion.
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The easily prepared model compounds 45 and 46, figure 13, were then synthesised in
order to investigate small-scale ozonolysis reactions. What became apparent in these
studies was that the length of time that the substrate was exposed to ozone was crucial -
between two and three seconds was ideal for samples sizes of less than I mg.
Furthermore, triphenylphosphine, as comparecl to dimethylsulphide, appeared to be a
better reagent by which to reductively work-up the reaction. Nevertheless, these were
difficult reactions. Undesired side proclucts were always formed, and there was a fine
balance between the complete conversion of the alkenes to the corresponding aldehydes
with additional side products, or incomplete reactions and fewer side products. Isoprene
was added to the reaction mixture in an attempt to "mop-up" the excess ozone, although
this proved futite. All the same, as much experimenting as was practical had been
conducted and the acetylation of pel A was attempted.
y'\/\..Orc
45 46
Loe.
Figure 13: Model substrates fbr small-scale ozonolysis rcactions
A 0'5 mg sample of pel A was thus dissolved in I ml of a l:l mixture of acetic
anhydride:pyridine, then left to stir for l8 hours at room temperature in the dark, scheme
25. The solution was then passed through a small glass column packed with Hp-20S
(polystyrene divinylbenzene) beads and the eluenr combined with 3 mL of distilled water
and passed through the same column. The resulting eluent was diluted with a further 3 mL
of water and passed through the column. The column was then washed with
approximately 25 mL of water to remove most of the remaining pyridine and acetic
anhydride, then l0 mL of 20: I water:acetone, ancl 2.5 mL of l: I water:acetone to remove
any unacetylated pel A. The reaction procluct was then elutecl with 6 mL of acetone and
the solvent removed under reduced pressure. Silica gel t.l,c analysis of the crude material
revealed the presence of two major spots with R,. values of approximately 0.50 to 0.55 in
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57o MeOH:CHrCl,. It was believed that these two products were the tetra and penta
acetylated adducts. The crude material was then purified further by silica gel
chromatography using a solvent gradient from pure CHrCl2 to l07o MeOH:CHtClr. Due
to the exceptionally small sample size, the trvo major products were collected as one
fraction.
Ac2O:py; 'l:1
rt. 18 h
Scheme 25: Acetylation of peloruside A
Spectral analysis of the combined products by 'H NMR revealed the presence of two
major acetyl methyl peaks 
^t 
E 2.24 and 6 2.07, three peaks of slightly lower intensity at 6
2.19, 6 2.14 and 6 2.22, and several other minor acetyl peaks in the same region of the
spectrum. Charactedstic peaks of pel A, such as the methoxy peaks between 6 3.3 and 6
3.5 ppm were also present in spectrum. This suggested that although we had not cleanly
acetylated every free hydroxyl of pel A, we speculated that the least sterically encumbered
primary hydroxyl was definitely acetlyated. Due to the small sample size, we were unable
to obtain any other conclusive evidence that we had acetylated pelA, however
chromatographic analysis most definitely suggested that pel A had been acetylated. For
example, native pel A elutes from HP-20S beads with a 3.3:1 solution of acetone:water.65
Our sample however, was washed with a l: I solution of acetone:water, which would most
certainly remove any unacetylated pel A. The less polar acetylated adduct however, would
remain on the column. Furthermore, pel A cannot be eluted from a silica gel column when
using a solvent gradient fiom pure CHrClr to IO%, MeOH.
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0.25 mg of the purified acetylated pelA was then subjected to ozonolysis, scheme 26, with
a sample from the crude reaction mixture being subsequently injected into the gas
chromatograph. The initial GC trace looked encouraging 
- 
an exceptionally small peak
with a retention time of approximately I l6 min was observed. Although this differed
slightly from the retention times of I16.5 and 119.5 minutes previously reported, we
postulated that this was within experimental en'or and subjected a second sample, spiked
with a freshly prepared sample of the racemic aldehyde, to GC analysis. Unfortunately, in
this and subsequent runs, three peaks were observed. Unbelievably, an impurity present
had a retention time within 20 seconds of the desired enantiomers.
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Scheme 26: Attempted ozonolysis of acetylated peloruside A
To say the least, these results were tremendously disappointing. In an attempt to
determine why the desired compound was not detected, a small sample of the racemic
aldehyde was subjected to our ozonolysis conditions. Although in theory it is the
intetmediate ozonolide, and not the subsequent aldehyde, that will be exposed to ozone, it
was important to determine how stable the resulting aldehyde is in the presence of excess
ozone. Indeed, the 'H NMR of our crude procluct told an interesting story - there was no
sign of the aldehyde substrate. Obviously, on such a small scale, even the smallest trace of
excess ozone would destroy our desired compound. It became apparent that on this scale,
and with our patticular substrate, this was not a plausible strategy.
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Although this strategy was beginning to look particulcrly dubious, after investing
so much time into this project it seemed careless to not to at least consider one last option
- namely that of a dihydroxylation of the olefinic double bond using osmium tetroxide
followed by a periodate oxidative cleavage.to-t As I was unwilling to take any uncalculated
dsks, model studies on a trisubstitued alkene closing resembling that of the side chain of
pel A first needed to be conducted. Indeed, such a substrate could be synthesised by
performing a Wittig'6 reaction on aldehyde 44b using triphenylphosphoranylidene
isopropane. However, to add to the frustration, this meant returning to the starting point of
the synthesis as all of the precursors had been consumed.
Thus aldehyde 44b was synthesised in a manner similar to that previously discussed,
although, due to the larger scale, the Swern oxidation procedure was used, scheme 27.
Although there was literature precedent for this synthesis,rm it was found that a slight
modification of the literature procedure was required to give yields similar to those
previously reported. It is interesting to note that the yields for both the Dess-Martin and
Swern oxidations of alcohol 43b are comparable.
Ho^I]onc 1) (COC|)2 . DMSO, -78 "CCHzCl2,30 min
2) Et3N,-78'C t h
0 "C, 5 min, 63%
43b
Scheme 27: Swern oxidation of alcohol 39b
Isopropyltriphenylphosphonium bromide, synthesised according to literature procedure,l07
was then used as the precursor for the in slrr formation of triphenyl-phosphoranylidene
isopropane, scheme 28 overleaf. Aldehyde 44b was subsequently added to the ylide, with
the model alkene 47 being synthesised in modest yield.
44b
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Scheme 28: Synthesise sf the rnodel alkene substrate 47
Alkene 47 wae then subj,ected to oxidative cleavage using 10 mol 9o OsOn and sodium
periodate, gcheme 29. Fortunately, on the 15 mg scale, the roquired aldehyde 44b was
igolated and characterised. This reaction was then scaled down to the 0,5 tng scale. and
analy,sed viagas chrornatography. Again results looked promising, with two peaks eluting
with the same retention timeg as those for the racemic aldehyde.
1) OsO4 ,THFIH2O fl.el)
10min
t),NalOa, rt, 90 min
Scheme 29: Model studies tor the oxidative cleavage of pel A
After preparing o second sample of acetylated pol A" all that rcma,ined was the
oxidative c.leavage of tfre doub,le bondl of pel A. Thus, a 0,5 rng, sample of acetylated pel A
was subjected to the dihydroxylation conditions previou$ly devised for the model studies,
scheme 30. The erude sanrple was subsequently injected into the gas chromatognaph.
Upon o;bserving a single peak near those of our desired enantiomers, a seoond sample,
spiked with the racemic aldehyde was injected.
k.^"
-4&
1) OsO4 
,
THF/HzO (1.8:i )
10 min
--a-
"'OMe 2) NaJO4, rt, 90 min
a
rH
oJ jl.ry
+
M
AcO a.
441a
Scheme 30: Attempted osmium/periodate olefinic cleavage of peloruside A
Disappointingly, the peaks did not co-elute. There was no evidence of the desired cleaved
side chain fi'agment from pel A, only an impurity that again had a retention time within 20
seconds of the desired enantiomers. The source of this impurity remained a mystery. It
was not observed in the previous model studies.
We could only speculate as to why this strategy failed. Perhaps the reaction conditions
weren't specific enough for the cleavage of the olefinic bond in pel A and alternative
reactions' that ultimately destroyed the desired tragment, occurred. [n any case, with a
limited natural abundance of pel A, it was not feasible to repeat these experiments. From
the observed results it appeared that a larger sample size of pel A was required if this
strategy was to succeed. consequently, the project was discontinuecl.vrr
utt- The total synthesis, and hence determination of the absolute stereochemistry, of pel A was
subsequently published by Xibin Liao, yusheng wu and Jef K. De Braband..i16 A,rgrrrrrnt,
Chemie, Int. Ed. Engt. 2003.42, 1648. The absolute configuration of pel A was reportid to be
opposite to the one shown throughout this thesis
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Chapter Th.ree
synthesis of the c-8 to c-ll fragment of peloruside A
3.1: Strategy One
Amongst the strategies considered for the synthesis of the gem-dimethyl ketone 8,
the aldol reaction between glyoxal and isobutyraldehyde appeared to offer the most
potential as the starting point in our synthesis, scheme 31. Although this strategy has the
advantage in that it does not require the regioselective protection of primary alcohols in
the presence of a secondary alcohol, it was quickly established that the formation of 14
was more difficult than originally envisioned. The large-scale patent proceduress that was
followed for the formation of 14 appeared to be unsuitable on the multigram scale. Rather
than cleanly producing 14, a menagerie of aldol condensation ancl self-condensation was
observed. The methodology required for the successful implementation of this protocol
appeared to requirc very precise conditions. Determining these exact conditions would be
a particularly laborious process ancl hence, an avenue we were not prepared to explore at
this stage.
Pp
r\n * n\-ol ,."*3HK2CO3
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scheme 31: Synthesis of the ge,r-dimethylketone g: strategy one
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3.22 Strategy Two
Consequently, we focussed our attention on the formation of gem-dimethylketone
8 from pantolactone 17, scheme 32. Literature precedent indicated that the reductive ring
opening of 17 could be achieved using a solution of lithium aluminium hydride (LiAIHr)
in TFIF.r08 However in our hands, the yields for this procedure were disappointingly low
even though several attempts were made at this strategy. Consequently attempts were
made at reducing the lactone using a solution oi NaBH, in ethanol, but again, the yield of
the desired triol was exceptionally low.
olleHo
foH LiAlH4 - no,1AroH 1)Protection- eno+oh
1',,' i\ 2)Oxidalion j\
178
scheme 32: Proposed route for formation of gerr-dimethyl ketone g
Our limited success in reducing unpror.ected pantolactone 17 prompted us to
investigate the reductive ring opening of a suitably protected species, scheme 33. We felt
that the highly polar nature of the triol and the workup conditions, which requires
filtration through a small silica gel plug. may have lowered the yields. Although the
protection of pantolactone would add additional steps to the synthesis, the protected diol
48 has the advantage in that regioselective protection strategies are no longer required
when protecting the primary alcohols.
o
q\o'
a,
17
OP
1) Protection HotVoH eno$oBn1) Protection
2) Reduction 2) Deprotection
(secondary alcohol)
3)Oxidation48
Scheme 33: Modified strategy for the formation ot genr-dimethylketone g
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The ability to perform a one-pot desilylation-oxidation'oo of aliphatic tert-
butyldimethylsilyl ethers using catalytic quantities of PdClr(MeCN), prompted us to first
investigate the protection, and subsequent reduction of the silyl protected lactone 17a,
scheme 34. Although protection of lactone 17 as the silyl ether proceeded smoothly,
initial investigations within our laboratory into the reduction of this lactone were
disappointing. Upon reduction of the lactone the silyl group preferentially migrated to the
primary terminus.rro In many respects this was not an entirely unexpected observation as
the ability of a silyl group to migrate from one hydroxyl to another is not uncommon and
frequently causes problems in organic synthesis.rrrln fact, the TBS group is particularly
rcnowned for its migratory ability.'13 Thus, an alternative protecting group was sought.
Accordingly, it was proposed that a tosyl group would suffice as a protecting group. Even
though one may question the wisdom of reducing the lactone in the presence of the tosyl
functionality, literature precedent existed for the tosylation of pentalactone 17, followed
by reductive ring opening using diisobutylaluminium hydride (DIBAL-H).'rr Thus this
strategy warranted investigation, scheme 34. Although synthesis of protected lactone 17b
proceeded smoothly in yields comparable to those reported in the literature, in our hands,
the subsequent reductive ring opening using DIBAL-H was unsuccessful. Diol 48b was
only ever formed in abysmal yields, even :rfter the addition of excess DIBAL-H and the
implementation of longer reaction times.
48a: n=TBS
4g!; P = Ts
Consequently, alternative reduction protocols were investigated. The portion-wise
addition of NaBH* to a solution of the tosyl protected lactone l7b in THF at 0 "C
produced a myriad of undesired side products, with no trace of the desired diol 48b. 'H
1)TBSCI, py, DMAP
OH 85%
or
17 2)rs42);DMAP, pv ln; l: Il,
Scheme 34: Protection of pantolactone 17 und attempted reduction
<.)
NMR of the crude product suggested that the lactone had not undergone ring opening.
Similar results were observed when lithium borohydride (LiBHo) was added in portions at
0 "C to a solution of l7b in THF. Although a solurion of lactone l7b and LiAlHo in
refluxing THF primarily resultecl in the decomposition of the lactone, there was some
evidence by 'H NMR that the lactone had undergone reductive ring opening.
Even though these results were less than clesiriible, they suggested that if a more stable
protecting group was used, the lactone might be successively reduced using a solution of
LiAlHl in refluxing THF. Being rather chemically inert, it was therefore postulated that
an ether-protecting group would be suitable. In particular, an allyl ether was chosen for
this purpose as there was some evidence for dual deprotection/oxidation at a later stage in
the synthesis.'ra
A standard Williamsons ether synthesis protocol,rr5 using allyl bromicle as the alkyl
halide' was followed to synthesise the allyl protected lactone. The use of the more polar
DMF, rather than THF, as a solvent produced optimal results. However, due to an
untimely quench of the NMR magnet, we were unable to conclusively prove that the
desired allyl protected lactone had been synthesised. Conclusive mass spectral data on the
compound was also unattainable. Nevertheless, due to the interests of time. and from IR
and t'l.c analysis, it was concluded that the hyclroxyl functionality had been protected
with an allyl group, and we decided to continue on with the synthesis.
Thus, the next step in this strategy was the rcduction of the allyl protected lactone. Based
on our previous observations, LiAIH.r was initially chosen as a reclucing agent.
Fortunately, after a little experimentation with the reaction conditions, the lactone was
successfully reduced in a modest 577o yielcl. The workup procedure in this synthesis was
important, requiring the quenching of the reaction with hydrated sodium sulfate followed
by filtration though a small silica gel plug for oprimum yields.
Having successively reduced the lactone. the next functional
involved the protection of the rwo primary hydroxyl groups.
group transformation
As there is literature
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precedent for the fbrmation of p-benzyloxy enolates,sT and the commercially available
benzyloxyacetic acid is also a key fragment in our retrosynthetic analysis, it was decided
that the protection of the hydroxyl groups as benzyl ethers was mosr appropriate. This
would allow for a global deprotection of the benzyl groups upon the completion of our
synthesis. Consequently our proposed diol was benzylated, again following Williamson's
ether synthesis protoc ol, in 77Vo yield.
Thus at this stage of the synthesis, strategies for the deprotection of the allyl group were
investigated. Ideally, removal of the allyl group can be effected by metal catalysed
isomerization of the allyl ether to the coresponding propenyl ether, with subsequent H+
or Hgr* hydrolysis'ro or oxidative cleavage."t Appropriate metal catalysts include
paf ladium on carbon,"8 palladium tetrukis-triphenytphosphine,ile and t r i s -
triphenylphosphine rhodium(I) chloricle (Wilkinson's catalyst). 
'ro The aforementioned
strategies were thus attempted on our allyl-protected substrate, but with little success.
Consequently alternative strategies, including rhe use of sodium borohydride and iodine
(it is believed that NaBH*/I, in TFIF is a source of diborane which initially coordinates to
the ethereal oxygen),'I oxidative cleavage using selenium dioxide and acetic acidrz. or
titanium trichloride and magnesium,rlr'vttt were investigated. Allyl transfer reactions,
involving palladium chloride and acetic acidra or palladium chloride, copper chloride and
o''35 were also attempted. unfortunately, none of lhese were successful.
Not surprisingly, these results were panicularly puzzling. However just as frustration set
in, we obtained access to another NMR instrument and were able to fully analyse the
synthetic precursors. This provided us with some valuable information. Both ,H and '3C
NMR analysis revealed that even though we had protected the hydroxyl group of the
starting lactone 17, the initial allyl protected lactone underwent a subsequent c-
substitution reaction, forming the di-substituted species 50, scheme 35. Thus, our
previous reduction and benzylation strategies, as discussed above, had actually been
vrrr Although TiCt3 and Mg is also known Lo cleave berrzyl ethers, the cleavage of auyl ethers is
more facile as the 113-allyl complexes formed in the reaction are more stable than the
conesponding q3-benzyl complexes; see rel'erence 123
-54-
conducted on the disubstituted species 50. Suddenly the discrepancies in our data and the
potential problems with our methodology became glaringly obvious.
17
1) NaH, 4eq, DMF, O 'C, B0 min
4 4/Br 3eq,rt,14h
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Scheme 35: Formation of the dialkylated species
In an attempt to prevent disubstitution from occurring, for every mole of lactone
used the number of moles of NaH anil allyl bromide were limited to l.l and 1.05,
respectively. Previously four moles of NaH and three moles of allyl bromide had been
used. For the most part, these conditions prevented disubstitution from occurring,
however they also resulted in incomplete reactions. These problems were circumvented
by the use of I equivalent of potassium-rerl-butoxide in a l:l solution of TFIF/DMF,
followed by the addition of l.l equivalents of allyt bromide. The desired allyl protected
lactone 17c was cleanly produced in 82Vo yield, scheme 36. Inirially we proposed that the
steric bulk of the base may favour mono-substitution, although it was later found that an
excess of the base would also result in the disubstituted adduct.126 Thus, simply the ability
to accurately measure one equivalent of potassium-lerr-butoxide, when compared to
NaH. resulted in the clean formation of the desired mono alkylated adduct l7c.
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Fortunately the techniques developed for the reduction of the lactone 50 were also
applicable for the reduction of the allyl protected lactone 17c. In fact, when compared to
the reduction of 50, the yield for the reduction of 17c improved dramatically with the
desired diol 53 being synthesised in a respecrable 77Vo yield. Subsequent benzylation of
53 again proceeded smoothly with the dibenzylated species 54 being synthesised in 90Vo
yield, scheme 36.
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Scheme 36: Synthesis of the benzyl protected allyl ether 54
With the allyl ether 54 successfurlly synthesised, the next major challenge was
removing the allyl group. As alluded to earlier, it was proposed that a two-step, one pot,
dual deprotection/oxidation of the allyl ether 54 was plausible. Although such
methodology is sparse, there is literature precedent indicating that the combination of
rert-butyl hydroperoxide (TBHP) and CrO., initially deprotects an allyl group, then
oxidises the resulting alcohol.r'o One can infer from the literature that this deprotection
arises from the allylic hydroxylation of the allyl substituent to from a hemiacetal, which
decomposes to an unsaturated aldehyde and an alcohol. Upon the addition of a second
equivalent of TBHP (to reoxidise the chromium catalyst), the resultant alcohol is then
oxidised to the ketone.r2T However when these conditions were applied to allyl ether 54,
starting material was predominately isolated, scheme 37. tH NMR analysis of the crude
Tl Vo
il
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material however, indicated
suggesting that these reagents
the presence of trace amounts of an aldehyde moiety,
preferentially deprotected and oxidised the benzyl groups.
tBuOOH, Cro3 (cat) ?H#ano*oh
CH2C|2, rt,12h I',,
scheme 37: Attempted dual deprotection/oxidation of allyl ether 54
Allyl groups can also be oxidatively deprotected with chromia-pilliared montmorillonite
clay and rert-butyl hydroperoxide.rzT'r?8 However due to mechanistic similarities between
this system and the previous example, and the observation by Choudary et. al. that such
systems can be extended successfully to oxidative debenzylation reactions, we opted
against exploring this strategy and focussed on simply deprotecting the allyl group. Even
though a dual deprotection/oxidation strategy may still be applicable for our system, this
would involve a significant investment of time, and was not of utmost importance to our
synthesis.
Ideally, a catalytic methodology was sought for the deprotection of the allyl group
so the previous experimental conditions, using palladium on carbon to isomerise the
double bond'rt8 were repeated on the correct substrate. Although this methodology looked
somewhat promising, the reaction would not go to completion with extended reaction
times resulting in the decomposition of the starring substrate. Consequently, the pdcl,,
CuCl, O. system was investigatecl. Again initial results looked promising, but
unfortunately similar difficulties to those observed with the pd/C svstem were
encountered.
5554
Although only a small proportion
groups'to had been surveyed, an
of the thirty or so methods for the deprotection of allyl
intuitive hunch prompted us to investigate the milder
-57-
reaction conditions of palladium chloride, acetic acid, sodium acetate and water.r?*
Gratifyingly, the allyl ether was cleanly deprotected, forming the corresponding
secondary alcohol 55 in a respectable 83Vo yield, scheme 38.
PdCl2, AcOH
NaOAc, H20
18 h, rl, 839/o
54
Scheme 38: Deprotection of the allyl group
This deprotection strategy however, is not without its pitfalls. Stoichiometdc amounts of
palladium chloride are required, which dLle to its expense, does not facilitate a
particularly economic synthesis upon scale-up. Nevertheless, we decided to continue on
with our strategy and experiment further with allyl deprotection methodologies at a later
stage. Thus the final obstacle to overcome in this synthesis was the oxidation of the
secondarv alcohol.
Ideally, a fairly benign oxidation procedure was desirable, so investigations into
the oxidation of alcohol 55 using an aqueous solution of sodium hypochlorite and acetic
acid'30 were conducted. Unfortunately, these conditions were not particularly effective for
our system, with the desired ketone being formed in a mere llVo yield. The starting
material predominantly decomposed, presumably as a consequence of over oxidation.
Next, a TEMPO oxidation was investigated. This is also a fairly benign oxidation
procedurc, requiring only catalytic amounts of 4-methoxy-2,2,6,6,-tetramethylpiperidine-
l-oxyl with continuous generation of the oxoammonium salt by NaOCI under aqueous
organic two-phase conditions.r" However, in contrast to the previous oxidation strategy,
starting material was only ever isolated using this protocol.
Although not an ideal choice of reagent, we nevertheless turned towards the use of
chromium derivatives as oxidising agents. Initially a solution of chromium trioxide in
.,,
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acetic acid looked promising,r3r though the ketone was only ever obtained in a mere 30Vo
yield. A solution of PCC and CaCO, in dichloromethane, however, held more potential.
Although the desired ketone 8 was synthesised in approximately 50Vo yield, the reaction
would not go to completion, even if excess PCC and longer reaction times were used.
Substitution of CaCO, for NaOAc ns the base offered some improvement, enabling
ketone 8 to be synthesised in a 60To yield. Nevertheless, we were still plagued by
incomplete reactions, with approximately l07o of the preceding alcohol still remaining.
A subsequent review of the literature however, indicated that such practical difficulties
were frequently encountered. Unduly long reaction times and the requirement of a large
excess of pyridinium chromate oxidising agents, leading to unsatisfactory yields, are
common problems.'r3 Czernecki et altiru however, determined that the use of anhydrous
acetic acid and freshly activated molecular sieve powder in combination with pyridinum
dichromate (PDC) were the decisive factors for achieving reproducible and successful
oxidations. Such adaptations enabled the amount of toxic PDC to be limited to 1.5 mole
equivalents. Fortunately this methodology was also applicable for alcohol 55, with
complete oxidation to the desired ketone I occurring in a respectable 84Vo yield, scheme
39.
PDC, AcOH (anhydrous)
OBnBnO BnO
Molecular sieve powder
CHzCl2, 30 min,84%
Scheme 39: Svnthesis of ketone 8
The rH NMR spectrum of ketone 8 is shown in figure 14 overleaf. The C-l and C-4
protons, previously reported as doublet of doublets at 6 3.64 and 3.49, and as doublets at
6 3.38 and3.27 ppm, respectively, in alcohol55 are now rcduced to two singlets at 6 4.38
and 6 3.44 ppm in ketone 8. Similarly, the previously diastereotopic methyl substituents
at 6 0.97 and 0.96 ppm in alcohol 55, are now homotopic with a chemical shift of l.17
ppm in ketone 8.
55 I
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Figure 14: rH NMR of genr-climethyl ketone g
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Although it is highly plausible that another oxiclation strategy may improve the yield or
eliminate the need for a chromium reagent during the oxidation of 55, we were
nevertheless satisfied with our methodology ancl the knowledge that the synthesis of the
final gent-dimethyl ketone is plausible. All that remained was to reinvestigate alternative
methods for the deprotection of the allyl group.
unfortunately studies into the use of the NaBHl, systemnr and the Seo,
systemrl for the cleprotection of allyl ether 54 were disappointing. Both resultecl in the
decomposition of the starting substrate. The use of Wilkinson's catalyst and DABCO
(1,4-diazabicyclo[2'2.2]octane) in l0%,aq ethanol initially looked more promising.tso
Surprisingly though, analysis of the crude substrare by 'H NMR indicated that there was a
small amount of the debenzylated adduct along with the requisite deprotected allyl ether.
This was unexpected as literature prececlent indicated that benzyl groups are stable to
these reaction conditions but the unwantecl reaction may have occuned as a result of
unduly long reaction times.x An additional problem with this rhodium catalysed
deprotection was the cleavage of the intermecliate isomerised ether. We wished to avoid
the Hgr* promotecl cleavage of the propenyl ether, and opted insteacl for an acidic work-
up, but this resulted in the incomplete cleavage of the isomerised ether. Although it
appeared highly likely that these difficulties might be surpassed by careful manipulation
of the reaction conditions, a fortuitous sequence of events prompted us to disregard this
strategy.
A further review of the literature drew our attention to work published by
Nagakura et. al- in 1997, whereby allyl ethers could be cleaved using p-toluenesulfinic
acid as both an allyl acceptor and proton source in combination with catalytic amounts of
Pd(0) in CHrCl,.rrt As the sulfinic acid was not readily available, this methodology was
not initially attempted. Simultaneously, a guest lecturer revealed that they harl been
ft Significantly longer times than those repofied in the Iiterature were used as GC analysis
indicated that the reaction was not complete
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having similar difficulties with the deprotecrion of allyl groups and found that with a
slight modification of Nagakura's procedures, they were able to reproducibly deprotect
allyl groups in good yields. A communication by Kunz and Opatzr'5 thus indicated that
the choice of solvent played a critical role in this reaction with the use of 1,2-
dimethoxyethane or dioxane, as compared to dichloromethane, produced more
reproducible results.
Thus the precedent of Kunz and Opatz was followed and attempts were made at
deprotecting allyl ether 54 in dioxane with p-toluenesulfinic acid and caralytic (6 mol7o)
Pd(PPh.)*; a slightly lower loading than that reported. Gratityingly, a clean conversion of
allyl ether 54 to alcohol 55 was observed. This initial result prompted further
experimentations with catalytic loadings and solvents. Although additional reductions in
the catalytic loading rcsulted in incomplete reactions, dioxane could be successfully
substituted with the more environmentally benign and less hazardous TIIF, scheme 40.
Thus allyl ether 54 could be rcproducibly cleprotected with TFIF as rhe solvent.
Pd(PPh3)4 (6 md%)
p-TolSO2H
THF, rt, 7 h,83o/o
scheme 40: catalytic deprotection of rhe allyl erher 54 with pd(pph,)o
The catalytic deprotection of the allyl ether 54 thus represents the last synthetic
challenge in the synthesis of gem-dimethylketone 8. For clarity, the overall synrhetic
scheme is shown in scheme 4l overleaf, with the overall yield for this synthesis being a
respectable 35Vo ovet the five steps. Furthermore, additional work in our laboratory has
demonstrated that this strategy can be perfbrmecl on the multi-gram scale.r-16
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Scheme 4l: O,verall qynth@sis of g.em.dimethyl ketone g
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synthesis of the c-tz to c-24 fragment of peloruside A:
Strategy I
4:1: The lactone appnoach
The first strategy inv.estigated for the synthesis of the C-12 to C-22 fragment of
p-el ,-{ involved formation of laotone 20, scheme 42. Lactane 20 is reductively opened,
following a regio-and stereos€lecfive aldol reaction with the pJranos€ fragment of pel A
(depicted in rred) to give the carbon skeleton below.
Je
.#ru: -"'#-A
20,
Scheme 421 Retrosynthetio analysis for the synthes-is of the C-12 to C-24 fragment
To initially test the viability of this strategy, a racemie svnthes's of the target lactone was
investigated, with the ethyl substituentfrom the side chain also being omitted, scheme 43.
Mod-ified lactonE 56 results from the RCM of diene S?, itself formed ftonr the
esterification reactisn of vinyl aeetlc acid 58 with the aldol addu et 24. With a vlew to
investigating the bioactiviry of analogues of pel A, oynthesis of the non-methylated 61 =
FD analogue of pel A was also explored
-5+
o
tl
'---------- #on +
24
Scheme 43: Retrosynthetic analysis for the synthesis of the model C-12 to C-24 fragment
The starting point in this synthesis involved formation of the p-hydroxyketones,
24a and 24b, using standard, low temperature aldol reactions, scheme 44. Literature
prccedent was followed for the synthesis of (+)-4-hydroxy-5-hexene-2-o ne 24a, whereby
the lithium enolate of acetone was captured by acrolein.r'tt A slight adaptation of this
protocol, with methacrolein being substituted fbr acrolein, enabled us to synthesise the
methyf ated derivative 24b, in 84Vo. The successful reproduction of these results however
depended grcatly upon the purity and dryness of the solvents and reagents, particularly
that of the TFIF. Inadequately dry THF often resulted in lower yields and a propensity of
the resulting p-hydroxy ketone to unclergo elimination, forming the highly unsaturated
dienone 59.
l+l'
J
Fo
B
R59-78 "C, 1O min R
24aR = H (807.)
24bR=Me(84%)
Scheme 44: Formation of B-hydroxyketones Z4a and24b
The p-hydroxyketone was then coupled to vinyl acetic acid following a standard
dicyclohexylcarbodiimide (DCC), dimethylaminopyridine (DMAp) esterification
protocol. Although this reaction successfully produced the corresponding esters, 57a and
57b, scheme 45' purification proved to be somewhar tedious. Flash chromarography
would not adequately remove all of the dicyclohexyl urea by-product formed during this
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reaction without severely jeopardising the yield, yet bulb-to-bulb distillation alone would
not separate the small portion of the c,p unsaturated dienone 59 also formed during the
reaction. Consequently the most successful purification strategy involved a combination
of flash chromatography, followed by bulb-to-bulb distillation. Although this was not
ideal methodology, yields of 80Vo or greater werc nevertheless obtained for the svnthesis
of esters 57a and 57b.
fl2*on
24aR=H
24bR=Me
DCC. DMAP,
0"c-RT,14h R
57a R = H,84o/o
57b R = Me,807o
Scheme 45: Synthesis of esrers 57a and S7b
Due to these difficulties, altemative coupling reagents were investigated. Although the
use of l-[3-(Dimethylamino)propyl]-3-ethylcarbodiimicle hydrochloride (EDCI) resulted
in the formation of the desired ester, a significant portion of the conjugated enone 59
resulted. even after formation of a pre-mixed solution of vinyl acetic acid and EDCI at
0 "C. The altemative choice of carbonyldiimidazole (CDI) as a coupling reagent resulted
in an uncharacterisable mixture of products.
Nevertheless, with the esters 57a and 57b in hand, the next stage in the strategy
involved the synthesis of the corresponding lactones via RCM. Some of the more
common alkylidene-metal complexes widely used for RCM include the alkoxy-imido
molybdenum complex (the Schrocl</Hoyveda catalyst) 60,r38 the benzylidene ruthenium
complex (Grubbs' Catalyst) 6lr3e and the modified benzylidene ruthenium complexes
coordinated to 1,3-dimesitylimidazol-2-ylidene ligands (Grubbs' second generation
catalyst)r{ 62, figure 15. The crucial factors we considered when choosing the
appropriate catalyst for our substrate were reactivity, stability and availability/cost.
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(CFs)2MeCO,,.
60
?'il1?)*v' Pcys
61
-?x}tr
v' Pcyt
62
Figure 15: Examples of common metal-alkylidene metathesis catalysts
Compared to Grubbs' catalyst 61, the molybdenum complex 60 exhibits high reactivity
towards a broad range of substrates containing numerous steric and electronic
variations.raO Unfortunately though, it also suffers from extreme sensitivity to air and
moisture as well as decomposition upon storage. Grubbs' second-generation catalyst 62
however, exhibits activity similar to that of the molybdenum complex 60 yet has also
retained remarkable air and moisrure stability characteristic of the parent benzylidene
ruthenium complex 61.'o' The enhanced reactivity of Grubb's second-generation
ruthenium catalyst over its first generation counterpart is believed to arise as a result of
the greater basicity of the imidazole ligands, when compared to their unsaturated
analogues, which in turn translates into increased activity.'" This enhanced basicity is
due to the lack of carbene stabilisation provided by the absence of rr-interactions.
Although one would thus expect the second-generation ruthenium catalyst 62 to be the
catalyst of choice, due to its expense (or the additional steps required for its synthesis)ta'
we opted to first explore the viability of the commercially available Grubbs' first
generation ruthenium catalyst 61. This catalyst generally exhibits excellent activity for
ring closing metathesis resulting in the formation of five or six-membered rings, although
its activity drops dramatically for the synthesis of larger cyclic compounds.rl0 Difficulties
in the RCM of substituted olefins using Grubbs' first generation catalyst have also been
rcported.t*o'rrl
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As the synthesis of lactone 56a required RCM involving an unsubstitued olefin, we were
fairly confident that Grubbs' first generation catalyst would be adequate for this purpose.
Accordingly, we were justly rewarded when lactone 56a was synthesised in a 90Vo yield,
scheme 46. One disadvantage of this strategy however, was that 5 mol percent of the
catalyst was required for complete cyclisation. Several attempts were made at decreasing
the catalytic loading, but without success. As a consequence, purification of the lactone
proved to be somewhat difficult and tedious.x Separation of the residual ruthenium from
the desired product by flash chromatography was problematic, and bulb-to-bulb
distillation simply resulted in decomposition of lactone.
61 (s molz)
CH2Clz , reflux 16 h
$u/o
56a
Scheme 46: Synthesis of lactone 56a
An interesting observation however was made upon the attempted cyclisation of ester
57b, scheme 47. The 'H NMR of the procluct, after a solution of ester 57b was refluxed
rvith five mol Vo of 61 in CH.,CI, for ?4 hours, revealed some anomalous peaks,
particularly in the olefinic region of the spectrum. Two singlets were observed at 6 4.98
and 6 4,90 ppm, integrating fbr two protons each, along with two multiplets at 6 5.76 and
6 5.68 ppm. Additionally, the rrC NMR of this sample revealed thirteen r3C resonances,
four more than that of the anticipated lactone 56b.
l?Tt-A
tla
fr4-;f'g O 61 (s mor%) 3n Pffi
57b 56b
Figure 47: Attempted RCM of ester 57b using Grubbs' catalyst 61
x 5 mof o/o of the catalyst equates to approxim ately 25 wt%t
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After consideration of these facts, it was apparent that ester 57b had undergone an
intermolecular dimerisation to form the E and Z isomers 63, scheme 48. High rcsolution
electrospray ionisation mass spectroscopy (HRESIMS) gave an ion with mass of 365.20
corresponding to that of the proposed dimer in protonated form (M+H.). With this
additional information it now became apparent that the two singlets observed in the 'H
NMR at 6 4.98 and 6 4.90 ppm corresponded to the terminal olefinic methine protons of
the dimerised product 63. The two multiplets at 6 5.76 and 6 5.68 were the rH resonances
of the internal olefinic methine protons for the dimerised E and Z isomers. Unfortunately
I was unable to distinguish between the two isomers by 'H coupling constants.
61 (5 mol%)
CH2Cl2 , reflux 24 h
Scheme 48: Metathesis reactions of ester 57b using first generation Grubbs' catalyst
The anomalous peaks in the r3C spectra are now also readily explained. Although the
dimerised products are symmetrical, the ester carbonyl carbon, the methylene carbon q to
the ester, and the internal olefinicmethine have different chemical shifts tor the E andZ
isomers. These chemical shifts are observed ar 6 170.2 and 6 169.9,6 37.8 and 6 33.1,
and 6 126.0 and 6 124.4 ppm, respectively. The other ''C resonances for the E and Z
isomers are overlapping. Comparison of the 'rC chemical shifts of the E and Z olefinic
methines of dimethyl fumarate (6 133.5 ppm) and dimethyl maleate (6 129.9 ppm) to 63,
enabled us to tentatively distinguish between the E and Z isomers of dimer 63 and
conclude that the E:Zratio is approximately 2:1.
Thus, the next major challenge was preventing this unwanted dimerisation. In an
attempt to avoid the competing intermolecular metathesis reaction, the concentration of
57b was lowered from 0.1 Molar to 0.01 Molar. Unfortunately though, the dimerised
57b
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produet still prevailed. Ctrearly the methyl. sub.srituent on the olefin was hindering
inff araol ecul ir eyolization.
G'iven this sbserv ion, it was eoncluded that a more active mEtathresis catalyst was
required for the RCM of the methylated subsrale. Due ro the availability,of materials,
studi,e-s into the applicability of the ruthenium vinylidene metathesis catalya gelrerated
tn s'ita '(scher'ne 49),tor were init'ially explored. Although reaction ratss:are slightly slower
for this vinylidene catalyst, ite geneml reactivity profilo towards a variety of substrates is
sirnilar to the analogous, highly active, second generatio,n ruthenium alky,lidene
compoun{s,
f*"p--*],
+ NsObu
- NaCl
- HotBu
[((p *ym er,r e)n u0l a ]*J
NaOrBu
<--=-
NaGi
+4nrur"rffiruro
l..cl
"lo64
sehorne 49; Proposed pathways for catallrst generation and decomrpositionra3
F
--1R tBu
rrn"rrflr,rna.u
lpl )1
cy'*F{,r,
-JQi-
As depicted in scheme 49, the formation of the ruthenium vinylidene catalyst requires the
use of one equivalent of sodium lert-butoxide. Unfortunately the presence of this base
during the attempted RCM of 57 resulted in alkene isomerization. The analogous c,p
unsaturated ester was the only product isolated. lnitially it was proposed that an increase
in the length of time between the addition of sodium rerr-butoxide and diene 57 may
ensure complete deprotonation of the imidazolinylidene ligand, and hence, prevent the
excess NaO'Bu from causing the unwanted isomerization. However, during these studies
we were able to obtain Crubbs' second-generation ruthenium benzylidene catalyst 62.
Thus we opted to investigate the potential of 62 in the RCM of diene 57b and
discontinued the studies involving the irr sitr ftrrmation of the vinylidene catalyst.
Fortunately the greater reactivity of second-generation ruthenium benzylidene catalyst 62
enabled the desired lactone 56b to be synthesised in an 85Va yield, scheme 50. The t3C
NMR spectrum of lactone 56b is shown in figure 16 overleaf; with the signals for the C-8
and C-9 methyl carbons at 6 30.2 and 6 18.8 ppm, signals for the C-2 and C-6 methylene
carbons at 6 46.8 and 6 31.3 ppm, the signal lol the C-5 methine carbon at 6 78.9 ppm,
the signal for the C-3 olefinic methylene carbon at 6 117.6 ppm, with the remaining
quarternary olefinic, ester and ketone carbons signals at 6 131.9, 6 169.0 and 6 204.8
ppm, respectively. Moreover, the RCM of diene 57b was conducted with only a l.5Vo
catalytic loading. Given these positive results, the ruthenium benzylidene catalyst 62 was
used for the RCM of the unsubstituted diene 57a. The lower catalytic loading would
alleviate some of the problems with the purification of the resulting lactone. Indeed,
Iactone 56a was once again synthesised in a90Vo yield, but this time only a l7o catalytic
loading was required.
62 (1 - 1.5 mol%)
CH2C|2 , reflux 16 h
90plo. R = H
857", R = Me
3
*?3
F
R R
56aR=H
56hR=Me
57aR=H
57bR=Me
-7 t-
Scheme 50: RCM using second-geleration Grubbs' c,atalyst 62
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Figure 16r IrC NMR of lactone 56b
Wjth the key intermedjate lactones synthesised, all that remained in this strategy
was a regioselective aldol reaction between the lactone and the p,yranose rin,g of
peloruside. Even though there is a multitude of precedent for the seleetive formation of
kinedc vef,ses thermodynamis enolates, our system presented additional difficulties with
the poss,ibility of both double bond isornerization and a second aldol reaction occurring cr
or T to the lactsne carbonyl. Thus, to investigate this system, aldol reactions were
conducted with butyraldehyde or benzaldehyde being used as model substrates for the
pyranose ring, scheme 51.
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1) LDA or LTMP, - 78'C
2) B2CHO
56aR=H
56bR=Me
Scheme 5l: Model aldol studies with lactones 56a and 56b
R
R= H, Me
R2 = Ph, C,sHz
Initial studies involved enolate formation at 
-78 oC using LDA as the base.
Unfortunately, these reactions were ploblematic. The desired aldol product was formed
along with a multitude of other products; as indicated by rH NMR and HRESIMS
analysis. Furthermore there was evidence for an aldol reaction occurring o to the lactone.
Consequently it was postulated that a morc sterically hindered base, such as LTMP,
would favour the formation of the kinetic enolate at 
-78 oC. Again, numerous aldol
reaction studies were conducted with LTMP as the base, but once again, mixtures of
products resulted. Although disappointing, these results were not entirely unexpected.
The pKa values of ester and ketone cx, protons are approximately 25 and 20, respectively.
Thus one would expect the more acidic ketone o-proton (C-8) of 56 to deprotonate
preferentially. Incorporation of the adjacent olefin moiety in lactone 56 however, would
result in a decrease in the pKa value of the lactone cr,-proton (C-2) in 56. At the time of
commencing the synthesis, we were unsut'e about the influence that the olefinic moiety
would have on the pKa of the lactone o-proton. However from the above experimental
results, the pKa atC-2 appears to be equivalent to, or perhaps even lower, than that at C-
8, as a mixture of aldol products were obtained.
Subsequently, a pKa prediction server called SPARCX' was used to predict the pKa
values of the cx protons at the methylene C-2 and methyl C-8 positions of 56.
Remarkably, a pKa of ll.5 was reported for the C-2 position, with a value of 17.3 being
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given for C-8. The dramatic decrease in the pKa of the lactone ct-proton was somewhat
unexpected.
Potentially the problems in controlling the regiochemisty of the aldol reactions could be
circumvented by protecting the ketone under neutral conditions using 1,2-di(trimethyl-
silyoxy)ethane, scheme 52. Reduction of the lactone, followed by protection of the
resulting diol, would then enable a regioselective, kintetically controlled, aldol reaction to
be preformed at the desired a-methyl position. However, this modification adds several
steps to our synthesis and is, for the most part. undesirable.
TMSO OTMS
1) uAH4 ttY\r^ p
T16** etolpteA-'\TMSOTf
56aR=H
56bR=Me
Scheme 52: Alternative strategy for the synthesis of the C-12 to C-24 fragment of
peloruside A
Alternatively, one may speculate that the combination of the ethyl substituent, where R2 =
Et, and a sterically hindered base such as LTMP, may prevent the lactone cl-proton from
being deprotonated. Although a plausible suggestion, we believed that enough time had
been spent on this strategy and an altemative, less problematic, methodology should be
investigated. Consequently we discontinued these studies and turned our attention
towards the synthesis of the C-12 to C-24 fragment using the cyclic iris silyl ether tether.
x' See, http://ibmlc2.chem.uga.edu/sparc/index.cfm
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Chapter Five
synthesis of the c-12 to c-24 fragment of peroruside A:
Strategy Two
5.1: Initial aldol studies with the cycric Dis-silyt ethers
As the previously described strategy for the synthesis of the C-LZ to C-24
fragment of pel A was problematic, an altemative strategy involving the synthesis of the
bis-alkoxysilyl ether 22 was investigated, scheme 53. It was anticipated that RCM of the
appropriate acyclic precursor 23 would form the desired brs-silyl ether 22. Diene 23
could in turn, be synthesised by the addition of p-hydroxyketone 24 and(S/-2-ethyl-but-
3-ene-l-ol 25 to the appropriate dichlorosilane. In this way, the silane acts as both a tether
for the RCM and a protecting group for both alcohols.
Ho-*
\
25
Scheme 53: Retrosynthetic stragety (II) for synrhesis of the C-12 to C-24 fragment of
peloruside A
There were many factors that needed to be considered when choosing the appropriate
dichlorodialkylsilyl substrate as a tether for this reacrion. First, rhe Dis-sityl ether 22
needed to be robust enough to withstand the aldol reaction and subsequent chemical
transformations' Second, the intermediate acyclic silyl tethered ether 23 needed to be
amenable to RCM and finally, the impact of the silyl substiruents (R) in the subsequent
asymmetnc aldol reactions needed to be addressed. Although it was anticipated that the
23 24
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larger phenyl substituents would l'orm a more robust cyclic ether and may offer
advantages in controlling the subsequent asymmetric aldol reaction (see chapter 6), many
of the reported RCM studies fbrming similar silyl tethered ethers had been conducted
with the smaller methyl substituents.se'etr'rr'r Even though many disubstituted isopropyl and
phenyl derivatives had been synthesised for other purposes,r*s it was unknown if the
stedc, or electronic constraints of these larger substituents would impede the RCM
reaction of our substrate.16 In view of these considerations, all three alkyl groups were
initially investigated in order to find the combination of reagents that would best suit our
purposes.
The above retrosynthetic strategy was further modified in that although both (R)- and (S/-
2-ethylbut-3-en-l-ol are available in one step using aZr-catalysed ethylmagnesation of
2,5-dihydrofuran,rat for simplicity but-3-en-l-ol was coupled to the appropriate silyl
derivative, scheme 54. Our emphasis was initially on establishing a racemic synthesis for
the C-12 to C-24 fragment of pel A. once a plausible racemic strategy had been devised,
this would then be adapted for the asymmetric synthesis of peloruside A.
+ HO-^*
24aR2 =H
24b R2 = Me
Scheme 54: Simplified retrosynthetic analysis fbr synthesis of the C-12 to C-24 tiagment
Thus. the first step in this strategy was the formation of the mono silyl ethers 68,
scheme 55. During these syntheses, problems were encountered in preventing
disubstitution fiom occurring. Even though numerous changes were made to the reaction
conditions in an attempt to improve the ratio of mono- to disubstitution adducts, the
controlling factor tn determining whether mono- or disubstitution occurred appeared to be
the size of the substttuents on the silyl tether. Disubstitution predominates with small
. f-
R\ F' r-
p O'Si--"g
.Y
A2
66
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substituents when the solution of but-3-en-l-ol in dichloromethane was slowly added, at
0 "C, to a solution of the dichlorosilane in dichloromethane. For example, with
dimethyldichlorosilane as a starting substrare, the desired monosilyl ether, but-3-en-l-
oxydimethylsilyl chloride 68c, was formed in a mere LTVo yield. The undesired diether
was formed in 50Vo yietd. These results progressively improved as the size of the alkyl
group increased, with isopropyl 68b giving the desired monosilyl erher in 50Vo yield, and
the diphenyl substrate 68a giving the analogous diphenyl monosilyl ether in
approximatelyKl 7SVo yield. No improvement could be made with these yields, even
when the temperature of the initial reaction mixture was lowered to -40 "C. Additionally.
the reaction would not go to completion unless the solution was refluxed.
R\^rct
R-.\cl
67a Rl=Ph
67b R1= Fr
67c R1=Me
a\ n-r--/
R-S\CI
68a R1=Pl't, ca.75lo
68b Rr= Fr, ffiT"
58c R1=Me, 177o
Et3N, CH2Clz HO._/\y'
0'C-rt6h
Reflu 3648 h
scheme 55: synthesis of the bur-3-en-l-oxydialkylsilyl chlorides
The B-hydroxy ketone 24 was then coupled to the silyl tethers 68 to form the
cotresponding bi.s-silyl ether adducts 66, scheme 56. As but-3-en-l-oxydiphenylsilyl
chloride 68a could not be isolated by fractional distillation due to its high boiling point,
this substrate was made in sittt and the comesponding B-hyclroxy ketone added to the
reaction vessel. Yields for the synihesis of the but-3-en-l-oxydialkylsilyl chloride
derivatives are summarised in Table l.
xrrBut-3-en-l-oxydiphenylsilylchloride 
could not be purified by fractional disrillation. The
percentage of mono-to di- substituted adduct was based upon 'H NMR analysis of the crude
substrate.
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a\ ,o-Z--/
R-s\cl
EbN, CH2Ct2
68 66
Scheme 56: Synthesis of the but-3-en-l-oxydialkylsityl chloride derivatives 66
Table 1. Yields for the formation of the but-3-en-l-oxydialkylsilyl chloride derivatives
Entry Compound Substituents Isolated vield
I
2
aJ
4
5
66a
66b
66c
66d
66e
Rr=Ph,R2=Me 6lVoo
65VonRr= Ph, Rl = H
Rl =iPr, R2 = Me 86vob
R' =iPr, Rl = H 82%ob
R'=Me,Rr=H 77Vo
"Overall yield from Ph2SiCl2;
Although formation of these silyl aclducts occurred relatively smoothly and in good
yields, it was interesting to note that formation of the butenoxydiisopropylsilyl chloride
derivatives, 66c and 66d, required the addition of catalytic amounts of DMAp. DMAp
displaces the chloride ion, forming the silyl pyridinium ion, which is more amenable to
nucleophilic displacement by the approachrng alcohol.t"s DMAP however, is not required
for the analogous but-3-en-l-oxydimethylsilyl chloride derivative 66e. Because of the
smaller size of the methyl substituents, the approaching alcohol can more readily
approach the silicon atom and hence displace the chloride ion in the dimethyl tethered
adducts. Even though the diphenyl substituents of the analogous but-3-en-l-
oxydiphenylsilyl chloride derivatives, 66a and 66b, are similar in size to the isopropyl
substituents' presumably the electron clonating properties of the phenyl substituents
favour the displacement of the chtonde ion, making it act as a better leaving group. Thus,
this facilitates the nucleophilic displacement by the approaching alcohol.
-18-
In an attempt improve the initial selectivity of the first mono etherification
reaction the order of addition of the two alcohols was reversed. By adding the more
sterically encumbered p-hydroxyketone 24 first we anticipated that this would limit the
amount of the disubstituted adduct lbrmed, scheme 57. However, changing the order of
addition simply resulted in elimination of a hydroxide ion from the B-hydroxyketone to
form the unsaturated ketone 59. Presumably this elimination occurs via an El.o
mechanism involving deprotonation of 24 to form the thermodynamically stable, highly
conjugated enone 59. The electron withclrawing chlorides on the dichlorosilane
derivatives 67 undoubtedly make these substrates less amenable to alkoxy substitution
reactions with the competing E1.o elinrination being favoured. A variety of conditions
were trialed, however in all instances, the unsaturated ketone 59 predominated.
n\ 
,cr
nf\cr
Rr = Me, lPr
67
??H
'< 24#
Et3N, CH2C|20t-rt
R\ F'
3 l*'/Y
R2
69
Scheme 57: Attempted reversal of the order of addition of the hydroxy substrates
Nevertheless, with the required bis silyl ethers 66a-e in hand, investigations into
the comesponding RCM reactions were conducted, scheme 58. As Boiteau et. ul.,t,s had
used Grubbs' second generation ruthenium catalyst 62 in refluxing benzene for the RCM
of similar silyl tethered substrates, these conditions were initally used for the RCM of
66e. Although the desired cyclic ether was formed, an unknown, and inseparable by-
product was also formed in almost equivalent yield. The solvent was then changed to
dichloromethane and the solution was heated to rcllux with five mole percent of 62. T.l.c
analysis of the reaction solution after 30 minures however, indicated that at least three
compounds were now present. Clearly an irnpurity was forming at a rate similar to that of
the desired cyclic ether. The reaction was then conducted in CH?CI" at room temperature,
again with 5 mol Vo of the catalyst. Although the side product was once again formed.
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this time it was far less prevalent. Horvever 5 mol 7o of 62 was evidently not sufficient
for this reaction as the starting acyclic silyl ether was still present.
R1=Me, Fr, Ph
R2=H,Me
Scheme 58: Desired RCM of the but-3-en-1-oxydialkylsilyl chloride derivatives
The instability of the dimethyl silyl tether was porenrially the cause of the impurity,
therefore the RCM of the diphenyl tethered substrate 66b, was attempted. It was also
unknown if this diphenyl tethered substrate would even be amenable to RCM. Seven
mole Vo of catalyst 62 was thus added to a solution of 66b in CHrCl, and the reaction
stirred at room temperature for l0 hours. Fonunately, the desired cyclic adduct was
formed' but again a small amount of an impurity was present. These results however did
indicate that the RCM of the Dis-silyl ether is a finely tunecl process depending on both
the reaction temperature and catalytic loading and not on the alkyl or aryl substituents on
the silyl tethers. Thus, by carefully deducing the optimum amount of catalyst required for
each system, one should be able to preferentially form the clesired cyclic adcluct and
control undesirable competing reactions.
This assumption was investigated by repeating the RCM of 66b in CHTCI. ar room
temperature with a l07o catalytic loading of 62. Fortunately, rhe desiredcyclic silyl ether
was formed almost exclusively. The optimum conditions for the RCM of the isopropyl
tethered silyl ether 66d, where R2 = H, also required the additjon of at least l0 mole
percent of 62, with the desired 4.8-O-diphenylsilanediyloct-5-en-2-one being formed in a
respectable 817o. Due to the very poor yielcl (17%) when forming the initial dimethytsilyl
chloride adduct' it was decicled that the dimethylsilyl tether was an inappropriare reagent
to use synthetically and the synthesis 4,8-di-O-dimethylsilanediyl-5-ocren-2-one was
never optimised.
62
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The RCM of the acyclic ethers where R3 = Me however, proved to be a little more
problematic. Due to the increased steric requirement of the methyl substituented olefin,
and hence slower reaction rates. a minimum of l2 mole percent of the catalyst was
requircd for these RCM reactions. Yields for these cyclisations were also slightly lower at
54Vo fot the phenyl derivative and 609o for the isopropyl derivative. A summary of the
RCM of the &is-silyl ether precursors is given in table 2.
Table 2. Synthesis of bH-silyl cyclic ethers 65 by RCM
Entry Compound Substituents Isolated yield
6
7
8
9
l0
65a
65b
65c
65d
65e
Rt=Ph,Rr=Me
Rl=Ph,R3=H
Rr = iPr, Rr = Me
Rr = iPr, Rr= H
Rl =Me,R2=H
547o
Sl%o
60Vo
74Vo
42Vo"
"Duetotlrelowyieldsoftheproceeding*ono
The 'H NMR spectrum of 4,8-O-diphenylsilanediyl-5-methylocr-S-en-2-one 65a is given
in figure 17 overleaf. The three dimensional representation of 65a is shown as one
enantiomer in figure l8 for ease of discussion. Noteworthy features in the rH spectrum
include the differentiation of the diastereotopic protons on C-3 with signals at 6 2.94 (dd,
J = 9.9,15.3 Hz) and 6 2.62 (dd, J = 3.6,15.3 Hz). The large trans covpling of g.g Hz
between H-4 and H-3b enables us to assign the signal for H-3b at 6 2.94, and 3a therefore
at62.62' Ring protons H-7a and H-7b are also in quite distinct chemical environments
with signals at 6 2.93 and 6 2.26, respectively. As illustrated in figure 18, the shielding
eff'ect of the ring oxygens on H-7b accounts for its high field shift. A sunmary of the IH
and 'rC NMR spectral assignments for 65a is given in table 3.
-8 l-
Ilgure 17: III NI\dR sp€ctnlrn of 4u8-O-dlphenylsilanediSrl-5.rnothylo4-ten-Z-ane 6Sa
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Figure 18: 4,8-O-diphenylsi lanediyl-5-methylocr5-en-2-one 65a
Table 3: tH and '3C NMR data for 65a
10al t OU
2
'rrHrO
Position 6t3c 6tH
I
2
3a
3b
4
)
6
la
7b
8
9 (Me)
l0a
l0b
ll
t2
l3
30.9
247.6
49.6
71.7
140.8
125. I
3r.2
64.4
21.5
t33.7
133.4
134.8
t28.1
t30.4
2.25 (s,3 H)
2.62 (dd, J = 3.6,15.3 Hz, I H)
2.94 (dd, J =9.9,15.3 Hz, I H)
4.90 (dd, J =3.6,9.9 Hz, lH)
5.44 (t,./ = 8.1 Hz, I H)
2.93 (m, I H)
2.26 (m,lH)
4.05 (m,2 H)
1.60 (s,3 H)
7.64 (m,4H)
7.39 (m,6H)
7.39 (m,6H)
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With a plausible strategy for the synthesis of the requisite cyclic ethers in place,
model aldol studies were conducted, scheme 59. Initially diphenylsilane 65b was chosen
as the starting ketone, and was subjected to a LDA mediated aldol reaction, using
butyraldehyde as the aldehyde acceptor.'Although the absence of the methyl singlet
(formerly at 6 2.22) in the rH NMR of the crude reaction product indicated that an aldol
reaction had occurred, the reaction had not proceeded in the desired manner. Not only
had a menagerie of products been formed but it also appeared that the silyl tether had
been partially cleaved. TLC analysis of the crude product mixture indicated that many
polar products had been formed. Similar results were observed for the 4,8-O-
diphenylsilanediyl-5-methyloct-5-en-2-one 65a and 4,8-O-dimethylsilanediyloc15-en-2-
one 65e derivatives. Unfortunately, attempts made at deciphering the products were
unsuccessful due to the vast assortment of products formed.
1) LDA or LTMP, - 78 "C
2)P
H R3
65
Scheme 59: Model aldol reactions with the bfs-silyl ethers
Even though the aforementioned reactions were conducted under kinetic conditions
(-78 "C), it was postulated that potentially excess base had deprotonated an cr-methylene
proton resulting in elimination of the siloxy group via an El"otype mechanism. A series
of singlet peaks at approximately 6 7.3,7.2,6.3 and 6.2 ppm were observed in the rH
NMR spectra for the partically purified products, providing some evidence for the
formation of an unsaturated dienone analogous to 59. Thus, the above aldol reaction was
repeated, this time using LTMP, a more sterically hindered base. Extreme care was also
taken to ensure that no excess base was present. However, similar results were observed.
A change in aldehyde acceptor from butylaldehyde to pivaldehyde did not improve the
outcome. Again the aldol reaction was repeated, but this time the aprotic solvent
hexamethylphosphoramide (HMPA) was added in an attempt to solvate the lithium ion,
and hence, assist in the formation of the enolate. Unfortunately, once again similar results
were observed. It appeared as if an aldol reaction had occurred, yet the silyl tether was
simultaneously being cleaved. Due to the vast assortment of products, it was never
possible to isolate any single adduct to confirm these propositions.
These results were very frustrating as the silyl tether appeared to simply be not robust
enough for these particular aldol reactions. This was a particularly puzzlingobservation.
Although we were unaware of any literature procedures for the aldol reactions of similar
cyclic silyl tethered substrates, analogous substrates had been subjected to demanding
reaction conditions. For example, a seven membered bis cyclic ether had been
synthesised by the Fe(CO)r-promoted cyclocarbonylation of a diyne in toluene at lZ0 "C
fot 24 hours.rs0 However, based upon the above observations, one could only conclude
that a more robust tether was required.
An alternative silyl tether that may be a slightly more robust was the di-rer-butyl
silyl derivative. Without any ready access to di-tert-butyldichlorosilane, in a somewhat
unprecedented manner, attempts were made at forming the acyclic Dfs-ethers using di-
ref-butylsilylbis(trifluoromethanesulfonate) 70 as a starting substrate.Ktr To ascertain if
this methodology was feasible, a two-step, one-pot reaction was conducted whereby a
solution of 70 in DMF at -40 oC was first exposed to but-3-en-l-ol then quenched with
an excess of methanol, scheme 60. Indeed the desired Dis-ether 7l was formed in a
respectable 7l7o yield after purification by flash chromatography.
xtrr Although this is a commonly used reagent for the intramolecular silylation of diols, at the time
of these studies, the author was unaware of any reports of the intermolecular disilylation of
alcohols.
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tBurS(OTf),
70
1) HO\/\y'
DMF, -40 "C - rq 3 h
t\,o._f-/
'Btrs\olrrt"
71
2) MeOH, 15 min,71%
Scheme 60: Initial study on the dietherification of Z0
To further confirm the viability of this tethering strategy, a second model study was
conducted. A solution of 70 in DMF at 
-40 oC was exposed to one equivalent of bur3-
en-l-ol, followed by one equivalent of pyridine, then 1.1 equivalents of allyl alcohol,
scheme 61. Pyridine was added to neutralise the liberated triflic acid. (As this method
was to be adapted for the coupling of the B-hydroxy ketone to the mono substituted silyl
tether, it was proposed that the liberated triflic acid could cause the acid catalysed
dehydration of the B-hydroxy ketone). Again this modified strategy was successful with
the desired bis-ether being 72 obtained in 65Vo after purification by flash
chromatography.
'eurSi1Otl,
96
t)HO..'.-y?
DMF,40'C-rt3h
rau1^fau
\nd"b+,+.
72
2) p7, 1 eq
s) Ft\,,\
15 min, 65 %
scheme 61: second exploratory study into the dietherification of 70
Numerous attempts were then made at coupling the desired B-hydroxy ketone to the tert-
butylsilyl tether, scheme 62. After the addition of one equivalent of but-3-en-l-ol,
different ratios of pyridine, ranging from none to two equivalents were added before the
addition of the B-hydroxy ketone. In some instances DMAP was added, either in catalytic
or stoichiometric quantities, and the reaction temperature varied from 
- 
40 "C to 80 oC
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after the initial addition of but-3-en-l-ol. However in the best scenario, with two
equivalents of pyridine and catalytic DMAP, rH NMR analysis of the crude reaction
mixture indicated that the desired bis-silylether 73 had been formed in only
approximately ll%o yield. Under most conditions, starting material and a small fraction of
the unsaturated dienone 59 were isolated. Reversal of the addition of the alkoxy
substrates, with the B-hydroxy ketone being added before but-3-en-l-ol, once again
resulted in the formation of the unsaturated compound 59 (refer to page 79).
1) HO-v/\/,
'eqsi1or11,
70
scheme 62: Attempted formation of the tert-butyl tethered ether
Furthermore, the attempted RCM of the previously synthesised 4-(3-butenoxy)-3-
(allyloxy)-di-tert-butylsilane 72, using either Grubbs' first or second-generation
ruthenium catalyst, proved troublesome, scheme 63. Starting material was predominantly
isolated, even after the addition of six mol Vo of the second-generation catalyst 62. Thus,
even in the eventuality of synthesising the desired B-keto substituted derivative 73, it
seemed likely that this substrate would not be particularly amenable to RCM. Evidently, a
di-tert-butyl silyl tether was not a viable option.
'B\ .lBu\^6t[^,+. 61 o162
_----)--+
CHzClz, rt 18 h
'\ ,o--.
'a,rEi )
\_/
7472
Scheme 63: Attempted RCM of the dialkylated di-tert-butyl silyl deivativeT1
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5.22 Adaptation to a more linear approach for the synthesis of the
C-12 to C-24 fragment of peloruside A
In view of the previous results it appeared that a less than ideal linear synthesis,
involving the incorporation of the silyl tether at a later stage in the synthesis, was
required for the formation of pel A, scheme 64. This strategy commences with an aldol
reaction between the suitably protected B-hydroxyketone 75 and pyranose 5c.w The
resulting hydroxyl substituent would then be benzylated, to facilitate a globat
debenzylation at a later stage of the synthesis, and the protecting group (pt) removed to
allow for attachment of the sityl tether. (S/-2-ethyl-but-3-en-1-ol is then added ro the silyl
tether, followed by RCM, to give key intermediate 76.
1) Berzylation
2) Deprotection
3) CtzSiR2
(" ..oH
" "r.)-,y'
2) RCM
oPl 0
V-.-Jttt
I
75
."zOBn OMe
76
scheme 64: A more linear approach for the synthesis of peloruside A.
*'v It was anticipated that an asymmetric Mukiyama aldol reaction (using (R) or (S) BINOL as a
ligand' or a boron mediated L,S-anti aldol reaction (using PMB as a protecting group) would
eventually be used to control the stereochemistry of this aldol reaction.
"*&*o
i
OBn Olvle
-88-
The asymmetric reduction of 76 would be the challenging part in this synthesis. A series
of reducing agents would need to be investigated to ascertain which choice of reagent
would give the highest yield of the desired | ,3-anti product 77 . lf formation of the desired
anti adduct proves elusive, it is anticipated that the ketone could be selectively reduced
with ZnBHo to give the syn product, which could be subsequently inverted by a
Mitsunobu reaction.r5r Similar chemical transformations to those previously discussed in
the introduction, including the attachment of the C-l to C-2 carbon framework, and a
Yamaguchi macrolactonisation, are then required to complete the synthesis of pel A.
Asymmetric
reduction
(.
Scheme 65: Asymmetric reduction of key interm ediate 77
In order to test the feasibility of this new synthetic strategy, and in particular the
plausibility of the asymmetric reduction, model studies were conducted with pivaldehyde
as a substrate for the pyranose ring. Thus, the B-hydroxyketones 24 were first protected,
as either silyl derivatives, or the methoxymethylether (MOM) derivatives, schemes 66
and 67, respectively. Protection of the hydroxyl group as the methoxymerhylether
proceeded in noticeably lower yields than formation of the silyl derivatives.
TBSCI oTTBDPSCI
DMF, lmidazole, rt
f
:
o&"
I :
o&'
I
oLn ?ona"
24p.# =ue
24bR2 =tl
Scheme 66: Silylation of the B-hydroxy kerones
75a Rr 
= TBS, # =Me,7T/o
75b Rt=TBS, #= H,74o/o
75c Rl = TBDPS, R2 =Me,7S/o
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MoMcr.'PNEt"
0'C-rt3h
2& Rz =Me
24ba2 =u
75d R2 =Me,3?/o"
7* R2 =H,48To
*unoptimised
Scheme 67: Etherification of the B-hydroxy ketones
The subsequent aldol reactions of the protected B-hydroxy ketones with pivaldehyde as
the aldehyde acceptor proceeded smoothly and provided some much needed reassurance
that successful aldol reactions were indeed possible! Once again, yields for the reactions
with the silyl protecting groups were higher than those with the MOM protecting group,
suggesting that protection of the B-hydroxyketone as the methoxymethyl ether was not an
optimum strategy, scheme 68. Consequently, further studies with the MOM derivatives
were discontinued.
1) LTMP or LDA, THF, -78 t, '1h
-78 
"C, 30 min
75a n' 
= TBS, R2 = Me
75b Rl =TBS, R2 = H
75c R1 = TBDPS, FF = Me
75d R1 
= MOM, R2= Me
78a nl 
=TBS, R2=Me, 657o
78b Rl 
=TBS, R2 = H, G8yo
78c R1 = TBDPS, Rz =Me, d7o/o
78d R1 
= 
MOM, R2= Me,56o/o
Scheme 6E: Model aldol studies wirh pivaldehyde
Benzylation of the aldol adducts however, proved to be more challenging than expected
due to the presence of additional acidic protons o to the ketone. First aldol adduct 78a
was exposed to one equivalent of NaH followed by benzyl bromide. However these
conditions resulted in the decomposition of the starting material. In the event that excess
NaH was causing the unwanted decomposition of the substrate, a I M solution of
2)
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potassium /erl-butoxide in TIIF was used as the base as this can be more accurately
measured than a 607o dispersion of NaH in mineral oil. However once again, the starting
substrate decomposed. Obviously, a milder method of benzylating the hydroxyl
substituent was required.
Attempts were then made at benzylating 78a by using a suspension of freshly prepared
silver oxide and benzyl bromide in DMF.rsr Yet again, these conditions resulted in the
decomposition of the starting substrate. Analysis of the crude material by 'H NMR
indicated that the silyl group had been removed under these conditions. Reactions
involving a change of solvent from DMF to CHrClr, or the addition of catalytic KI in an
attempt to activate the alkyl halide, fared no better. In all instances, the substrate
decomposed.
It was thus decided that the hydroxy group could be more satisfactory benzylated under
mildly acidic conditions using benzyl trichloroacetimidate 79 as a benzyl donor.r52
Benzyl trichloroacetimidate can be readily synthesised by the NaH catalysed addition of
benzyl alcohol to trichloroacetonitrile."' Fortunately, this protocol worked well with the
benzyl adducts 80b and 80c being synthesised in72%o and7lc/o respectively, scheme 69.
c,.c4en o
TfOH, cyclohexane
0 "C,30 min
78b R1 = TBS, R2= H
78c nl = TBDPS, R2 = Me
€Db n1 = TBS, R2 = H,7?/o
8Dc R1= TBDPS, R2 =Me,71o/o
Scheme 69: Benzylation of the aldol adducts with benzyl trichloroacetimidate
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5.3: Revisiting the original cyclic Dis-silyl ether strategy
Although the above linear strategy was progressing at a satisfactory rate,
ultimately this was not the most desirable approach. Since these aldol reactions could be
successfully performed on the milligram scale and in respectable yields, it was apparent
that there was nothing technically wrong with the manner in which the previous aldol
reactions, involving the Dis-silyl ethers, were being conducted. Some underlying
phenomenon was preventing these cyclic Dis-silyl ethers from successfully participating
in aldol reactions.
After much consideration, it was proposed that a potential cause of our problems was the
bis-silyl cyclic ethers containing sub-milligram quantities of ruthenium by-products.
Indeed Maynard and Grubbsrsn surmised in a recent article that the highly-coloured
ruthenium complexes and the residual ruthenium that forms as a by-product during
ruthenium alkylidene catalysed RCM reactions often cause problems such as olefin
isomerization during product distillation and the decomposition of substrates over time.
Thus it seemed only logical that the residual ruthenium was responsible for the problems
encountered during the aforementioned aldol reactions.
To investigate this supposition,65b was subjected to rigorous purification by preparative
HPLC with detection by mass-spectromentry, before an aldol reaction between itself and
pivaldehyde was conducted, scheme 70. Gratifyingly, tH NMR analysis of the crude
reaction mixture indicated that the desired aldol adduct 81b had been formed.
1) l-DA, -78 "C, 90 min
2) -78 "C, 30 min
65b
Scheme 70: Aldol reaction of 65b purified by preparative IIPLC
81b
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Diisopropylsilyl ether 66d was then subjected to an aldol reaction with pivaldehyde,
scheme 71. Again this aldol reaction was a success, with the aldol adductS2 being
produced in a respectable 59Vo yield. Diene 82 was then subjected to RCM with catalyst
62 to give the bis-silyl cyclic 81d in a 777o yield. Alternatively 65d was synthesised by
the RCM of the acyclic adduct 66d and the residual oil rigorously purified three times by
flash chromatography, before being subjected to an aldol reaction with pivaldehyde,
figure 71. Fortunately, this aldol reaction was moderately successful with the desired
aldol adduct 81d being formed in30Vo. Presumably this low yield was due to the purity
of the starting material. However, more importantly, these studies indicated that aldol
reactions of the cyclic bis-ethers are indeed viable, provided the cyclic ether is of
adequate quality.
1) LTMP, -78 "C, t h
82
2) -78 "c, t h
5f/"
62 10 rnol%
CH2C|2, rt,8 h
77o/o
1) LTMP, -78'C, 45 min
4t/-b-/ PPQH
l-
81d65d
2)p
,\< -78"C,15 min, 30P/ot-
Scheme 71: Racemic aldol studies
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5.4: Removing the residual ruthenium
Ideally, the problems encountered with the removal
of the residual ruthenium could be largely alleviated if a
more active, or polymer bound, RCM catalyst was used.
Recently Hoyveda and Schrock reported the use of the
chiral Mo-based catalysts, such as 83, to synthesise six and
seven membered siloxanes bearing tertiary ether centres.r55
Although such molybdenum catalysts are extremely air and
:,Q,,,
tf
water sensitive, necessitating glove box conditions, the synthesis of the aforementioned
siloxanes could be achieved using I to 5 molVo of the molybdenum catalyst. Thus, it was
anticipated that the RCM of our silyl-tethered ethers could also be achieved with low
catalytic loadings (1-2 mol Vo) of 83.
In preparation for the Mo-catalysed RCM, benzene was added to precursor 66b and the
solvent removed under reduced pressure to allow for the azeotropic distillation of any
residual water. This process was repeated three times. The attempted Mo-catalysed RCM
of 66b was then conducted in a glove box, with the solution of the diene in benzene being
stirred for 24 h at room temperature in a manner analogous to that reported in the
literature,r56 scheme 72. Although this procedure was attempted on several occasions,
with the catalytic loading being increased to 5 mol%o, unfortunately only the acyclic ether
was ever isolated. Obviously this was not a suitable catalyst for our substrate.
&l
P\,Ph
P-si- 
- 
80 (1 mo%)/_ ? ? --*-) Benzene. rt
66b 65b
Scheme 72: Attempted synthesis of 65b by Mo-catalysed RCM
-94-
Even though more time could be invested in finding an alternative RCM catalyst, in the
interim, a method for removing the residual ruthenium from the RCM of the Dis-siloxy
ethers using Grubbs' second-generation catalyst was required. Purification by preparative
HPLC was too onerous to be synthetically useful. Reports of the purification of RCM
adducts by the addition of water soluble tris(hydroxymethyl)phosphine, as a ligand to
capture any unwanted ruthenium, indicated that this might a viable option.r55 However,
although readily available, P(CHTOH), is still a somewhat expensive reagent. Other
procedures for the removal of ruthenium by-products formed from the Grubbs reagent
include the use of the somewhat toxic Pb(OAc)o to oxidise the ruthenium metal,r56 or
treatment with PhrPO or DMSO.rsT These methods allowed for the reduction of the
ruthenium levels down to approximately l-2 pgper 5 mg of product(s).
More recently though, a superior methodology for the removal of residual ruthenium
from RCM reaction products was reported. This involves the sequential treatment of the
RCM adduct with silica gel, activated carbon (50 weight equivalent relative to the crude
products), and column chromatography on silica gel, to give compounds with residual
ruthenium levels of 0.06-0.53 pg per 5 mg of product.t58 Requiring both inexpensive and
non-toxic reagents, this methodology was successively applied for the purification of our
RCM adducts. Thus, the yields previously reported in Table 2 are those after purification
by this methodology.
A future objective of this research however, is to find a more suitable RCM
catalyst for this transformation. Either a more active RCM catalyst that can be used in
lower catalytic loadings, or a polymer bound catalyst that can be recycled and hence
removed from the reaction mixture by simple filtration, is required. Two recent
advancements in this area, both by Blechert et. aI., include the highly active ruthenium
metathesis catalyst E4r5e or the polymer bound derivative 85,ro figure 19. It is anticipated
that the applicability of these, or similar alternatives, will be explored at a later date.
-95-
n( ,IFME
84
Figure 19: Alterr,rative RSM eatalysts
85
Nevertheless, for the timo being a zuitable strategy for the raEemie synthesis, and
subsequont aldol re.action, of the C-l2 lCI C.24 fragment of pel A had been developed. It
wa$ now time to €xterd these basie principles and apply them to the asymmetric
synthesis of this fragmenr
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Chapter 6
Asymmetric synthesis of the C-LZ to C-24 fragment of
pelourside A
6.1.: Key stereochemical features
With guidelines in place for the synthesis of the C-12 to C-24 fragment of pel A,
the next challenge was to synthesise this fragment asymmetrically and develop a
methodology for its stereoselective coupling to the pyranose ring. Due to the apparent
structural similarity between pel A and the 16 membered macrolide, epothilone B, figure
20, it was initially thought that pel A may act as an epothilone sulrogate by binding to a
common site on B-tubulin.xv Initially our focus was on the synthesis of the enantiomer
shown below, however a flexible strategy was planned which would allow for the
synthesis of either enantiomer of pel A.
',,,oH
peloruskle A epothilone B
Figure 20: Structural similarities between peloruside A and epothilone B
xu This appeared to be a common misconception by many in the academic community. Until its
absolute stereochemistry was determined, all publications concerning the synthesis of pel A
focussed on synthesising the enantiomer shown.
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A review of the retrosynthetic analysis for pel A highlights the required |,S-anti
relationship between the C-ll and C-15 stereocentres, scheme 73. To achieve this 1,5-
anrt relatronship, a boron-mediated aldol reaction between the C-12 to C-24 fragment of
pel A and the aldehyde acceptor of the pyranose ring will be performed. Although
Evans'6t and Paterson'u2 pioneered this area of remote l,S-induction in boron-mediated
aldol reactions, to-date only limited explanations have been given for this surprising
phenomenon. Thus, in achieving the 1,S-anfi relationship required for the synthesis of pel
A, it is anticipated that further insight into the origin of these boron-mediated reactions
will be gained.
Scheme 73: Retrosynthesis of peloruside A showing the required \,S-anti relationship
between the C-I1 and C-I5 stereocentres with the C-12 to C-24 framework
in red
A review of the synthesis of the C-12 to C-24 fragment of pel A is given in
scheme 74. The cyclic bls-silyt ether 22 is the tethered version of the side chain shown in
red above. However, for simplicity, the ethyl side chain will be once again omitted. The
focus of this chapter is thus on asymmetrically synthesising the B-hydroxyketone 24 and
developing an appropriate protocol for the boron-mediated \,S-anri aldol reaction of the
Dfs-silyl ether. These two concepts will be discussed in turn.
#A,,. T* 
crzs'z-
Scheme 74: Retrosynthesis for the formation of the C-12 to C-24 fragment of pel A
P
a
22
ry
2324 25
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6.2. Synthesis of (R)-4-hydroxy-5-methylhex'5-en-2-one
From the outset, we were aware of a published procedure for the synthesis of the
desired (R)-4-hydroxy-5-methylhex-S-en-2-one 24. This required a diisopinocamphyl-
borane mediated enantioselective aldol reaction between acetone and methacrolein.163
However, as the enantiomeric excess for this reaction was 73Vo with a yield of 68Vo, we
optimistically proposed that an alternative, and indeed better, synthesis of this target
compound could be developed. Upon reviewing the literature, two general strategies for
the enantioselective synthesis of this B-hydroxy ketone emerged: a) the kinetic resolution
of the racemic alcohol and b) an alternative enantioselective aldol reaction.
6.2.1: The kinetic resolution of (t)-4-hydroxy-5-methylhex-5-en-2-one
The kinetic resolution of racemic substrates can be performed using one of two
approaches, figure 21.'e The first, and more established approach is a classic kinetic
resolution. Here resolution of the enantiomers (R + S) occurs when k** k. and when the
reaction is stopped at some stage at or near 50Vo conversion. The enantiomers are then
separated by obtaining the product (P), formed from R, and the non-converted starting
substrate (S). A difference in the specific rate constants (k*, kr) is obtained by using a
chiral catalyst, which may be either chemical or biological nature. Dynamic resolution
however, encompasses both classic resolution and an additional racemising process, lq*.
Again substrate racemisation may be achieved either by chemical or biological catalysis
and, provided that K".)kr, all of the substrate is transformed into a single product
enantiomer in 1007o theoretical yield. Due to the enhanced yields of dynamic kinetic
resolution, this is clearly the more desirable strategy for the resolution of racemic
substrates.
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Classic Resolution
ks
R-P
hst
Dynamic Resolution
kgs-o
slont
kp
R 
-
,11 hstk'", 
ll
,, kss 
-
slow
R,S 
= 
substate enantiorners
ks, ks = individual rate constants
P,Q = prodrct enantiomers
krac = facefilisation conshnt
Figure 21: Classic versus Dynamic Kinetic Resolution
However, upon reviewing the procedures required for dynamic kinetic
resolutions, it appeared that our B-hydroxy ketone would not be particularly amenable to
such methodology. Typically the dynamic kinetic resolution (DKR) of secondary
alcohols involves the transition metal-catalysed racemisation of the alcohol coupled with
enzymatic resolution.165 Ruthenium is frequently the transition metal of choice, with the
racemisation of the substrate commencing with a base-mediated hydrogen abstraction
from a hydrogen donor to form the intermediate ruthenium alkoxy species I, scheme
75.t66^ Abstraction of the o-proton then gives the intermediate ketone and a ruthenium
hydride complex II. Finally, the subsequent readdition of the hydrogens to the ketone
completes the catalytic cycle to give the racemised substrate.
:}4,- [-*,] - [--1,, +,il,, ]-*-r*,
Scheme 75: Mechanism of the ruthenium-catalysed hydrogen transfer reaction
Due to the presence of a ketone moiety in our starting substrate, it is unlikely that such a
DKR is feasible for the following reasons, scheme 76. First, the cr-ketone proton could be
II
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preferentially abstracted leading to the q,B-unsaturated adduct A, second, the original
ketone moiety itself could be reduced to give C, and third, readdition of the hydrogens in
a 1,4-fashion would give the diketone D. A biocatalytic DKR of our B-hydroxy ketone,
where dehydrogenases are required for the oxidative process and redox-enzymes are
required for the reductive process,'ut could also suffer a similar fate.
L+-H]-ly F]
. -z /l \rL+ Xk A,V
B' crlDl
Scheme 76: Proposed products from the in situ racemisation of the starting substrate
during the attempted DKR of the B-hydroxy ketone
Thus, in light of the potential pitfalls of the DKR of the B-hydroxy ketone,
investigations into classical kinetic resolution techniques were made. Traditionally this
requires the use of an esterase to resolve the secondary alcohol, however more recently,
non-enzymatic strategiesr6 such as palladium catalysed sparteine oxidative kinetic
resolutions,16T the Sharpless resolution of allylic alcohols,r6s or Fu's azaferrocene
catalysed enatioselective acylation,'u' have been developed.
Unfortunately, upon closer examination of the non-enzymatic strategies, some potential
problems were highlighted. For example, the palladium catalysed oxidative kinetic
resolution requires the use of the naturally occurring chiral base, (-)-sparteine, which
unfortunately can only be obtained in one enantiomeric form. Unlike traditional esterase
resolutions, where either enantiomer can be obtained either directly, or by the
deacetylation of acetylated alcohol, if the undesired enantiomer is formed during this
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oxidative strategy, there are no easy methods of obtaining the correct enantiomer. The
strategy by Fu also presented some practical difficulties as the synthesis of the
azaferrocene catalyst required the use of preparative chiral IIPLC, which was not readily
available. Although the Sharpless methodology appeared to offer some promise as either
enantiomer can be synthesised, due the extremely stringent conditions required for
effective epoxidation strategies and the potentially explosive nature of the requisite rer-
butyl hydroperoxide solution, we initially opted to explore alternative strategies.
Thus, the more traditional approach of resolving secondary alcohols using
esterases was investigated. Enantioselective esterases are particularly useful enzymes for
the kinetic resolution of secondary alcohols due to their efficiency, their applicability to a
wide range of substrates and the ease at which the reactions can be performed on a large
scale. Unfortunately though, there is little X-ray structural information available about
these esterases and the appropriate enzyme is usually chosen by screening. Hence two
candidates, lipases from Candia antarticatT0 and Pseudomonus cepia,tTt were investigated
for their ability to enantioselectively esterify, and hence kinetically resolve our B-hydroxy
ketone.
The racemic B-hydroxyketone 24b was dissolved in tert-butylmethyl ether with the
appropriate esterase and isopropenyl acetate as the acyl donor, scheme 77. The
heterogenous slurry was then stirred rapidly at room temperature with progress of these
reactions being monitored by tH NMR. After seven days for the Candida antartica
lipase, and five days for the Pseudomonus cepia lipase, the reactions reached 507o
completion and the lipase was removed by filtration. To determine the enantiomeric
excess of these esterification reactions, the B-hydroxy ketone was separated from the
acetylated compound by flash chromatography and a portion converted into the TBS silyl
ether. This silylation was necessary in order to make a less polar and bulkier derivative
that was more amenable to analysis by chiral gas chromatography. Unfortunately though,
chiral gas chromatography revealed that the enantiomeric excess for both esterases was
extremely low at approximately 5Vo.
-r02-
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-^-
I
+
9o' 3
)^^
86
*,,(A
I
24b
Aoo.
TBSCI,74%
5Y" e
Scheme 77: Attempted kinetic resolution of (+)-4-hydroxy-5-methylhex-5-en-2-one
using lipase from either Candida antartica or Pseudomonus Cepia
In many respects these results were not surprising. According to the empirical rules of
Kazlauskas,tt2 lipase stereoselectivity is set mainly by steric interactions between the
enzyme and substrate, with the enantioselectivity of the esterification of secondary
alcohols depending upon the relative size of the two neighbouring groups. Thus, if the
groups are similar, as with our B-hydroxyketone, poor resolution is obtained. Although
non-steric interactions between the enzyme and the substrate can provide for
enantioselective differentiation, the electron density of both the carbonyl and olefinic
functional groups of the B-hydroxy ketone provided for little electronic differentiation.
Thus, the enzymatic kinetic resolution of B-hydroxy ketone 24b did not appear to be
particularly viable and investigations into alternative enantioselective aldol reactions
were conducted.
6.2.22 Asymmetric aldol reaction
The search for catalysts that mimic the selectivity of biological aldolases has been
the subject of intense efforts in recent years. Many catalysts, including the (R)-
Lnli3tris(binapthoxide) catalyst 87 developed by Shibasaki et. aI.t73 and the dinuclear Zn
catalyst 88 developed by Trost et. al.t'o offered potential for the synthesis of our desired
B-hydroxy ketone, however the recently developed procedure by List for the (L)-proline
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(89) catalysed asymmetric aldol reaction between acetone and a variety of aldehydes,r?s
appeared to be the more straightforward strategy. Although the reaction between
methacrolein and acetone was not reported, we proposed that List's methodology could
be adapted for the synthesi s (R)-a-hydroxy -5-methyl-5-hexen -Z-one.
I FCqH
-N
H
89
Thus, 30 mol Vo of (L)-proline was added to a solution of methacrolein in 4:l v/v
DMSO:acetone in a procedure analogous to that reported by List, scheme 78. Initially we
had concerns that the ctr,B-unsaturated ketone would be preferentially formed, via a
proline catalysed elimination reaction, but with relief, the desired B-hydroxyketone 24
was formed in a modest 38Vo yield. The replacement of DMSO by acetone, which has
been reported to improve the yields of some proline catalysed reactions,rTubwas unfruitful
in our particular studies.
A+rk
(2V/o vol\ I
[]"qt
-|| 3o mot%
DMSO,38%
24
Scheme 78: (L)-proline catalysed asymmetric aldol reaction for the
hydroxy-5 -methylhex-5 -en-2-one
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synthesis of (R)-4-
At present it is assumed that this asymmetric aldol reaction occurs via an enamine
mechanism with proline acting as a "micro-aldolase" that provides both the nucleophilic
amino group and an acid/base co-catalyst in the form of the carboxylate, scheme 79.t76"
The enantioselectivity can be explained with a metal-free version of a Zimmernan-
Traxler type transition state,Es with the tricyclic hydrogen bonded framework accounting
for the enantiofacial selectivity. To determine the enantiomeric excess of this reaction'
the B-hydroxy ketone was again protected as the /er-butyldimethylsilyl ether. The GC
trace of the silylated reaction product is shown in figure 22 overleaf, with the (R)-
enantiomer, being formed in a respectableT4%o ee.M
n
* til{', 
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+Q,
to rfo
-HeoY
o
-*," ^fy$"
. ,Q,,
,...f,o
Scheme 79: Proposed mechanism the (L)-proline catalysed aldol reaction
xvt Precedent from List's work enables use to assign this as the major enantiomer
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Figure 2lz GC trace of the silylated enantiomers.
Unfortunately, when this methodology was repeated with acrolein as the aldehyde
substrate, none of the desired aldol product was observed. This result, was however, in
accordance with observations made by List, whereby significant proportions of ct,B-
unsaturated ketones were formed during the proline catalysed aldol reactions of C[-
unsubstituted aldehydes.rTob It is believed that this unsaturation occurs as a result of a
Mannich-type condensation reaction, and not by the proline catalysed dehydration of the
B-hydroxy ketone.
Nevertheless in the interim, a suitable strategy for the synthesis of (R)4-hydroxy-
5-methylhex-5-en-2-one had been developed. Although the yields for this proline
catalysed asymmetric aldol reaction are modest, due to the inexpensive, non-toxic and
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straightforward nature of this reaction, it was concluded that, for the synthesis of the (fi)-
4-hydroxy-5-methyl-hex-5-en-2-one, this was the best strategy.* Thus, our next major
challenge was to develop methodology suitable for obtaining the desired 1,S-anti aldol
product. However before our proposed methodology for achieving this transformation is
discussed, it is instructive to first highlight what is already known about boron mediated
1,S-anti aldol reactions.
6.3. Boron mediated |,S-anti aldol reactions
6.3.1.: A Brief Overview
The boron mediated L,S-anti aldol reaction commences with the enolisation of a
ketone, using a base (either triethylamine or diispropylethylamine) and the appropriate
boron reagent, L2BX, (where L = alkyl ligand and X = Cl or OT0.The enol boronate then
nucleophilically attacks an aldehyde moiety, forming a boryl ether. Oxidative workup
(MeOH, HrOr, pH 7 buffer solution) liberates the B-hydroxyketone. The notable feature
of these reactions, such as the one illustrated in scheme 80, is the often remarkable
diastereoselectivity observed in the product B-hydroxy ketone. More often than not, the
1,5-anti adduct is favoured.rT6
Br4BOTf,'Pr2NEt
Et2O, -78'C 2)HzQ, MeOH, pH 7
95:05 Anfl:Sln
89%
Scheme 80: The basic boron mediated I,S-anti aldol reaction
xurrAlthough (D) Proline is commercially available, it is more expensive than its (L) counterpart
and hence an alternative procedure for the synthesis of the (S)-B-hydroxy ketone will be sought. In
the future, investigations will be made into the BINOL-Ti catalysed Mukaiyama aldol reactions
between the silvl enol ether of acetone and methacrolein. Refer to reference 93.
lT^-']
1)P|(CHd2CHO
- 7g'c
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Although the diastereoselectivities of these reactions are enhanced by a variety of factors,
including the choice of boron reagent and the local asymmetric environment, the primary
influence in these reactions has long been speculated to be an electrostatic effect exerted
by the B-alkoxy substituent.t6b'171 Consequently, the nature of the B-oxygen protecting
group is critical in determining the level of asymmetric induction.163In general, high 1,5-
anti selectivities are almost always obtained when the B-hydroxy protecting group is a
para-methoxybenzyl ether or a benzylidine acetalr62a'r63 un6 as a result these protecting
groups are used almost exclusively, figure 23.To date, no studies or models have been
reported for this surprising process. However, the preference for aromatic substituents at
the B position initially suggested to us that a favourable fi-stacking interactions may, at
least, be partially responsible for the observed stereochemical outcome.
tn
?^? P\.--\.-,r\.-
FN
'^fiA
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Figure 23: Examples of boron mediated 1,S-anti aldol reactions
The phrase 'n-stacking' signifies, in its simplest form, the positioning of a
multiple bond (typically either C-O or C-C) parallel to and at approximately 3.5 A over
an aromatic ring.r78 Compelling evidence suggests that an attractive interaction is
involved in these n-n interactions, yet the exact nature of the n-stacking effect (either
charge transfer or simple Van der Waals forces) is still a subject of some debate in the
synthetic and computational arenas.'tn Nevertheless, since the first synthetic application
of n stacking interactions by Corey et. aI. in 1972 for the synthesis of the
1 ) Bu2BOTf
2)Ph(CHd2CHO
rn?^?PSwFh
>9307 Anti:Syn
52"/"
FN
1) Bu2BOrf , g^g o g||-l
2)Ph(cH2)2cHo TW*
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prostaglandins,rTe designed n-stacking effects have been encouraged for the control of
asymmetric bond forming reactions, under both stoichiometric (chiral auxiliaries) and
catalytic conditions, and more recently, for the purpose of assisting in molecular
recognition.rTe
Some examples where ru stacking effects have been applied in a stoichiometric manner
are given in figure 24. These include the use of (-)-8-phenylmenthol derivatives in both
asymmetric [3+2] cycloadditions catalysed by Ni(COD)2, equation (1),'* and in
nucleophilic additions with Grignard reagents, equation (2).ttt Perhaps the most focussed
study to date in this area however, was reported by Evans et. al. in 1987.182 By changing
the substituents on a oxazolidinone dieneophile, it was unambiguously established that
appropriately orientated aromatic rings, such as that shown in equation (3), contribute to
the enhanced diastereoselectivity of the Diels-Alder reactions of o,B-unsaturated N-
acvloxazolidinones.
Ni(coD)2
-A
90% yield, 64o/" de
MeMgBr, -78'C
(1)
(2)
86% yield, 99.4olo de
PP
-sAryAo =*',o 
-\_/ - 30'c
Ph-s' q--+
I
 
r';F (3)
Figure 24: n stacking effects in asymmetric synthesis.
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6.3.22 The proposed transition state for the boron mediated \,S-anti induction in the
synthesis of peloruside A
Coupling the C-12 to C-24 fragment of pel A to the pyranose requires efficient
anti-induction between C-l l and C-15 in which the stereochemical controlling element is
the silyl protected B-hydroxy substituent, scheme 81. Consequently, it was postulated that
the proximity of the initially formed boron enolate to the phenyl substituents on the silyl
tether, where Rr = Ph, would result in favourable n-stacking interactions and hence a
transition state geometry leading to efficient 1,S-anti induction.
1) rzBX
LzEX
Scheme 81: Proposed transition state for asymmetric control
The enolate would adopt the geometry, as depicted in scheme 81, to minimise the steric
interactions between the cyclohexyl boron substituents and the phenyl substituents. The
aldehyde 5d thus approaches the enolate from the opposite face to the phenyl substituent
R
B1
*(t'
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11 
.'
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and chelates to the boron enolate though a twist boat transition state with the large alkyl
group on the aldehyde adopting a geometry away from the phenyl ring and the aldehyde
proton orientated towards the phenyl ring. Although one normally expects chelation to
occur via a chair transition state, molecular calculations indicate that the twist-boat
transition state for analogous boron mediated aldol reaction is energetically more
favourable, by I to 4 kcal/mol.r8r In sum, this sequence of events leads to the desired 1,5-
anti product.
6.3.3: Studies into the synthesis of peloruside A
To investigate this hypothesis, both the acyclic 66 and cyclic 65 ketone
derivatives were subjected to boron mediated aldol reactions, with pivaldehyde being
used as a model for the pyranose ring, scheme 82. The enantiomerically pure derivatives,
where R2 = Me, were synthesised from (R)-4-hydroxy-5-methylhex-5-en-2-one using the
procedures detailed in chapter 5. By comparing both the acyclic and cyclic derivatives,
insight into the supposed 'electrostatic effect' exerted by the B-alkoxy substituent could
be gained. Similarly, being comparable in size, the effects of both the isopropyl and
phenyl silyl tethers (R') were investigated as this enabled distinctions to be made between
the electrostatic and steric effects of these tethers. The effects of the boron ligands, where
L = cyclohexyl or (-)-diisopinocampheyl were also investigated. Generally these boron
mediated reactions proceeded smoothly and in good yields. The diastereoselectivity of
these reactions was determined by t'C NMR analysis of the crude substrate, vide infra,
and results of these studies are surrmarised in Table 4 overleaf.
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Scheme 82: Boron mediated 1,5 - anti- aldol studies
Table 4: Boron mediated I.S-anti aldol studies
66
"\;' "xr;,
Entry Substrate Rr R'z Boron
Reagent
Yield Diastereoselectivitv
66a
66a
66b
65a
65b
65b
65c
65c
65d
I
2
3u
4n
)
6
7
8
9^
iPr
iPr
Ph
iPr
rPr
iPr
Ph
Ph
Ph
Me (-)-IpcrBCl
Me CyrBOTf
H (-)-IpcrBCl
H CyrBOTf
Me (-)-IpcrBCl
Me CyrBOTf
Me (-)-IpcrBCl
Me CyrBOTf
H (-)-IpcrBCl
93Vo
97Vo
98Vo
85Vo
88Vo
9SVo
94Vo
68Vob
6OVob
2.2:l (90a:91a)
1.2:l (90a:9la)
2:I (90b:91b)
1.2:I (92a:93a)
1.5:l (92b:93b)
1.2:l (92b:93b)
>99:1 (92c:93c)
>99:l (92c:93c)
>99:l (92d:93d)
lerformed using the racemic substrate; bunoptimised.
The most striking observation from the above studies is the poor diastereoselectivities
observed for all the acyclic derivatives, entries 1,2 and 3. Although moderate
improvements in the diastereoselectivities are observed with the use of (-)-IpcrBCl
(compare entries 1 and 2), the differences in the ratio of anti to syn products are
-n2-
negligible. (-)-IpcrBCl is reported to improve the zr-facial selectivity for the anti-
adducts.r& Thus, from this result alone, one can conclude that it is not the electrostatic
effect of the B-siloxy substituent that is predominantly influencing n-facial discrimination
in these boron mediated aldol reactions.
When comparing the aldol reactions of the cyclic derivatives (entries 4 to 9) some
striking observations are made. With the isopropyl silyl tether (entries 4, 5 and 6), once
again poor diastereoselectivities are observed. This is particularly evident in the ttC NIvm,
spectra with the two diastereomers producing different chemical shifts as expected. For
example the spectrum of 7,11-O-diisopropylsilanediyl-2,2-dimethyl-3-hydroxyundec-8-
en-S-one (entry 4) is shown in figure 25 (page 114) with an enlargement of the spectral
window from 6 45 to 76 ppm. The most notable change in the chemical environment of
the two diastereomers is reflected by the chemical shifts of the newly formed methine (C-
3) carbons, at 6 75.0 and 674.7 ppm, and the neighbouring methylene (C-4) carbons, at 6
46.5 and E 46.2 ppm. However, when synthesising 7,ll-O-diphenylsilanediyl-2,2-
dimethyl3-hydroxyundec-8-en-5-one 65d (entry 9), only one diastereomer was observed
by t'C NMR. The spectrum of 65d is shown in figure 26 (page 115) with an expansion of
the spectral window from 6 45 to 6 76 ppm clearly indicating that only one diastereomer
is present. The analogous chemical shifts of the C-3 and C-4 carbons of 65d are at 6 74.8
and 6 46.1 ppm respectively.
Given that the isopropyl and phenyl substituents on the silyl tether are of
comparable size, it was apparent that the size of the phenyl substituents was not primarily
responsible for the high levels of asymmetric induction. Furthefinore, by comparing
entries 7 and 8, it was evident that the chiral ligand was not responsible for the observed
asymmetric induction. Thus, one could conclude that the orbital interactions between the
phenyl group and the enolate were responsible for the observed stereochemical induction.
However, before this statement could be made, we first needed to determine that the anti
adduct had indeed been svnthesised.m
xvt One could speculate that the anti product predominates as the use of the (-)-Ipc2 enhances the
proportion of the anti product
- 113-
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Figure25: t3C NMR of racemic 7,ll-O-diisopropylsilanediyl-2,2-drmethyl-3-hydroxy-
undec-8-en-5-one
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Figure 25: ''C Ml{R of 7,ll-O-diphenylsilanediyl-2,2-dimethyl-3-hydroxyundec-8-en-
5-one
-l l5-
6.3.4: Determination of the anti stereochemistry
To determine the relative stereochemistry at C-3 of the aldol adduct, 92c was
subjected to rigorous NMR analysis. A summary of the tH, t'C, COSY and nOe NMR
spectral data for this substrate (recorded in CDCIr) is provided in table 5, with the tH and
t'C spectra given in figures 27 and28, respectively.
Table 5: NMR data for 92c
Position 6r3ca 6tH COSY
'Bu (l) 25.9
'Bu (2) 34.3
0.89 (s,3H)
C
CH 3,78 (dd,./ = 10.5, 1.8 Hz, lH)
CH, 2.58 (dd, J = 17.7,10.2 Hz, lH)
CH, 236 (dd, J = l'7.8,2.0Hz,,IH)
C
CH, 2.99 (dd, J= 14.9,9.8 Hz, lH)
CH, 2.62 (dd, J = 14.9,3.7 Hz, LH)
CH 4.90 (dd,.I= 9.8, 3.3 Hz, lH)
C
CH 5.42(t,J=9.6H2, lH)
CH, 2.28 (m, lH)
CH, 2.91 (m, lH)
- 4a,4b
4a,4b
3,4b r,6a
3,4a 1, 6b
74a
712
6a,6b
lOa, lOb
l0b,1l -
l0a, ll -
lOa, 10b
-3
3
4a
4b
5
6a
6b
7
8
9
l0a
10b
ll
74.8
46.1
ztt.5
49.5
7r.9
125,1
t40.7
30.9
64.3 CH, 4.05 (m,2H)
12 (Me) 21.5 CH, 1.60 (s,3H, lH)
"Multiplicity determined by HSQC Dept
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\\
Figure Z7ttIJ NMR spectrum of (3R,7R,82)-7,11-O-&phenylsilanedtyl-2,2,8-
trimethylundec-8-en-5-one
-Lt7-
tAE
Figure 27: t3C NMR spectrum of (3R ,7R,8A-7,11-O-diphenylsilanediyl-2,2,8-
himethylundec- 8 -en-S-one
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The starting point for determining the stereochemistry at C-3, was determining the
relative orientations of H-6a and H-6b, figure 28. The large tans coupling of 9.8 Hz
between H-7 and H-6a enabled H-6b to be differentiated, with H-6b being on the front
face of the molecule as shown. The difference in the chemical environment of H-6a and
H-6b also indicated that there was restricted movement of the C-6 to C-8 carbon
framework. Similarly, the trans coupling of 10.2 Hz between H-3 and H-4a enables H-4a
and H-4b to be differentiated.
The crucial part in this analysis, however, was determining the conformation of the C-l
to C-5 carbon framework. NOe's between H-l ('Bu) and both H-4a and H4b indicated
that the 'Bu group bissects both H-4a and H-4b, yet did not distinguish between the
geometry shown below or a more linear conformation with the side chain extended in a
zig-zag fashion from C-5. This information was obtained from the nOe correlations
between H-12 (Me) and H-6a and 3. NOes between H-12 and H-3 indicated that the C-l
to C-5 framework adopts the conformation shown below - these nOes would not be
observed if a more linear conformation was favoured. NOes between C-12 and H-6b
enabled us to determine that the methyl group (H-12) was sitting on the front face of the
compound, as depicted. Thus, if the methyl substituent is on the front face of the
molecule and nOes are observed between C-12 and H-3, then H-3 must be on the front
face of the molecule, with the hydroxyl behind. This corresponds to the anticipated
\,S-anti relationship. This analysis is further supported by the nOe between H-6a and H-
4a.
Ph
Me
Figure 29: NOe correlations of (3R,7R,84-7,LI-O-diphenylsilanediyl-3-hydroxy-2,2,8-
tri methylundec-8-en-5-one
rh
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Although it was impossible to perform the same spectral analysis of 4,8-O-
diphenylsilanediyl-5-octen-2-one 92d due to the absence of the methyl substituent, by
analogy we assumed that the \,S-anri diastereomer was preferentially formed. In any
case, a satisfactory strategy for the synthesis of the C-12 to C-24 ftagment of pel A and
its asymmetric coupling to the pyranose ring had been developed. Gratifyingly, this boron
mediated |,S-anti aldol reaction proceeded in both excellent yield and with excellent
diastereomeric selecti vity.
To provide further evidence for the involvement of r stacking in the observed 1,5-
anti induction, modelling studies on the cyclic substrates were performed.u The methyl
enol of ethers of the cyclic isopropyl derivative I and phenyl derivative II were modelled,
figure 30. As seen, excellent overlap between the enol ether and a phenyl ring is
occurring II, while with the isopropyl silanes I no interaction is available and the enol
ether adopts an open geometry. Consequently, this results in n-facial discrimination for
the phenyl substituents, while the open geometry of the isopropyl silyl derivatives is
conducive to the approach of the aldehyde from either face.
Figure 29: Molecular modelling of 'Prrsi and PhtSi enol ethers
u Courtesy of Dr Paul Teesdale-Spittle, SBS, Victoria University of Wellington. Molecular
models were energy minimized using the OPLSAA forcefield as implemented in Macromodel
v7.2 using the Maestro v4.l interface, and the lowest energy stnrctures retained.
-r20-
6.3.5: Putting the pieces of the puzzle together
The high diastereoselectivity observed in the above experiments certainly justifies
our hypothesis about the importance of fi-stacking in certain boron-mediated 1,S-anti
aldol reactions. The selectivities observed with entries 7-9 in table 7 are not due to
electronic properties but are a result of the enolate being fixed in a conformation
conducive to interaction with a single phenyl ring. These observations, however, raised
some puzzling issues. If n-stacking interactions are responsible for the aforementioned
I,S-anti induction, could similar interactions be responsible for the previously reported
|,S-anti induction observed in acyclic systems where a para-methoxy benzyl substituent
is placed at the B-position? Theoretically, a transition state, such as that depicted in
scheme 83, would account for the high 1,5-anti stereoselectivity observed. Similarly, if
the transition state depicted below is responsible for the high degree of asymmetric
induction for the PMB derivatives, a similar transition state could be proposed for the
acyclic phenyl derivatives 66. Theoretically, these transition states could also involve
aromatic-enolate interactions. Yet, referring back to table 4, entry 3 (pg 112) it is
apparent that only nominal 1,5 asymmetric induction is observed in these cases.
1) l4BCl [""o-A,t| $ro*'
L L2Bo
2) R2CHO
Scheme 83: Proposed conformation for the boron mediated \,S-anti aldol reaction with
substrates containing the PMB protecting group
After some consideration, it was proposed that the key difference between the above
PMB mediated inductive asymmetric aldol reaction and the non-inductive reactions with
the acyclic diphenyl sustituents 66 was the possibility of different transition states for the
two aforementioned derivatives. By incorporating two phenyl moieties on a flexible
-tzr-
acyclic tether, two transition state conformations are favourable for the acyclic phenyl
derivative, scheme 84.
The equatorial orientation of the olefinic side chain in conformation I, would initially
appear to favour conformation I over II. However, there may be some n-stacking
interactions between this olefinic side chain and an aromatic ring, as depicted in II. In
any case, having two phenyl substituents on the acyclic tether results in the possibility of
at least two seemingly favourable conformers, resulting in negligible n-facial
discrimination.
l) (-)-lpcCl, E2o
-78 "C,30 min
,,\
"\
Scheme 84: Proposed conformations for the acyclic phenyl derivatives
Although some answers to the origin of 1,S-anti asymmetric induction had been
gained, much still remained to adequately explain the inductive effects in other systems.
We could confidently state that it is not the frequently reported electrostatic effects of the
B-oxygen that is responsible for these observations, however the exact influence of many
qp
/}^&afrP-\'oi-A
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,*#)
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of the B-hydroxy protecting groupo was still unexplained. With the view that aromatic ru
interactions must be at least partially responsible for the asymmetric L,S-anti induction in
acyclic systoros further studies into the origin of the selectivity in boron mediatedl,S-mti
aldol reactions were conducled. These studies are disoussed in the subsequent chap-ter.
-123,
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Studies into the origin of \,S-anfi induction in boron-mediated
aldol reactions
7.lz Acyclic systems
7.l.lt The /ert-butyl diphenyl silyl derivative
As discussed in chapter 6, it was postulated that the reason for the poor
diastereoselectivities observed with the diphenysilyl acyclic adduct (66b, pg l12) could
be accounted for by the propensity of the substrate to exist in two conformers, as
reviewed below. Although one would normally expect conformer I to be more favourable
due to the equatorial orientation of the vinyl substituent, conformer II is simply a chain
flip that may also result in additional n-stacking interactions.
To clarify these results it was proposed that some additional aldol studies without
the olefinic substituents were required. This would enable us to determine the influence,
if any, of these substituents on the proposed conformations. The simplest way of
conducting these reactions was to synthesise B-hydroxyketones and subsequently protect
d
LrBO#
II
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them with 
^ 
tert-bttyldiphenylsilyl substituent. Although the boron-enolates could again
adopt the conformations as shown in figure 3 1, the influence of the alkyl substituent, Rr,
may favour one conformer over the other and lead to differences in the
diastereoselectivities. It was hoped that the larger, Rr substituents, such as the isopropyl
or tert-butyl derivative would favour conformation I, leading to enhanced
di astereoselectivies.
Figure 31.: Possible conformations for the tert-butyldiphenylsilyl boron-
enol ether
Thus List's't6u'oprocedure was once again used for the synthesis of the requisite B-
hydroxy ketones 94, which were subsequently protected as the tert-butyldiphenylsilyl
derivatives 95 using standard silylation techniques, scheme 85. Unfortunately, the most
desirable adduct, where Rr = terf-butyl, could not be synthesised. Numerous attempts
were made at protectingthe tert-butyl B-hydroxy precursor,94b, but with little avail.
Standard silylation techniques, as highlighted below, resulted in the isolation of starting
materials, even after extended reaction periods. Even the combination of pyridine,
AgNO, and rerr-butyldiphenylsilylchloride,rss which is believed to enhance silylation
reactions via the formation of the intermediate silyl nitrate,rE6 primarily resulted in the
reisolation of the starting B-hydroxy ketone. As anticipated, the use of one equivalent of
potassium hydride as a base, along with catalytic amounts of the chelating macrocycle
l8-Crown-6, and one equivalent of tert-butyldiphenylsilyl chloride resulted in
decomposition of the starting material.rs6
,rr'ffi
u
LzBO
-t25-
A *,T*,
20 molo/o
Scheme 85: Synthesis of the ren-butyldiphenyl silyl protected B-hydroxyl ketones
Nevertheless, with the suitable silylated derivatives 95a and 95c in hand, a selection of
CyrBCt mediated aldol studies were conducted, scheme 86. Unfortunately, the alkyl
substituent (Rt) appeared to have little influence on the diastereoselectivites of these
reactions with ratios from 2:l to 2.5:l being observed, table 6. By using both
isopropylaldehyde and pivaldehyde as the aldehyde acceptor, we were able to establish
that the aldehyde had only a limited effect on the observed diastereoselectivities.ts?
94a Bl = ipr 
rt' 18 h gsa R1 =,pr, z2o/o
94b Rl = tBu 95c Rl =;Vzsv"
e4c Ri= f( 'l
1) Cy2BCl, Et2O
-R--E::* rr'ffi,'-1r'",un. r,{A-flltt
ot HzOz, MeOH, PH 795 u",2h,n
Scheme 86: Aldol studies with the tert-butyldrphenylsilyl derivatives
Table 6: Boron mediated aldol studies with the rerr-butyldiphenylsilyl derivatives
96
Product Rr R'z Yield Diastereoselectivity"
96a iPr fPr 887o 2:l
96b iPr rBu 86Vo 2.5:l
96c 89Vo 2:lt'1 17
uDiastereoselectivities determined bv r3C NMR analysis of the crude substrate
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Thus it was apparent that the interconversion of the two proposed conformations was a
facile process. Consequently, a substituent with only one aromatic ring was required as
the B-hydroxy protecting group.
7.1.22 The dimethylphenyl silyl derivative
To eliminate the possibility of having two favourable conformations, it was
proposed that the analogous dimethylphenylsilyl derivative would more suitable at the B-
position. Thus, the B-hydroxy ketones 94 were protected as the dimethylphenyl silyl
derivatives, scheme 87.
AX*,
94
PhMqSiCl, DMF
,t--rf**tn
97a nt ='Pr, T4vo
97b Rl =ft rur"
lmidazole
rt,18h
Scheme 87: Synthesis of the dimethylphenylsilyl derivatives
A selection of CyrBCl mediated aldol reactions were then conducted with the
dimethylphenyl silyl derivatives 97, scheme 88. It was proposed that these silyl
derivatives would participate in the boron mediated aldol reactions by adopting the
conformation shown below to maximise fi-rt interactions. Such interactions would result
in the desired 1,S-anti adducts 98.
P pSMe2Ph
r CyzBCl 
_
97
O,+e
-ffi2-n
L2BO
o
nrAn oH fl fsureen
- 
pzA.,A.,Apr
Scheme 88: Aldol studies with the dimethylphenylsilyl derivatives
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98
Although the yields for these reactions were good, exceptionally poor
diastereoselectivities were observed, table 7. Obviously n-stacking interactions were not
involved in these particular transition states.
Table 7: Boron mediated aldol studies with the dimethylphenylsilyl derivatives
Product Rr R2 Yield Diaste reoselectivity"
98a
98b
,BU 80Vo
82Vo
l.l: I
l.l: I
,Pr
r7 f7
uDiastereoselectivities determined by "C NMR analysis of the crude product
The lack of asymmetric induction in these aldol studies was initially particularly
puzzling. However upon closely reviewing the literature, it became apparent that the
PMB ether was used exclusively for good |,S-anti induction in acyclic systems,
suggesting that an electron-donating group is required for effective asymmetric induction
and that a benzyl ether would be less effective. To investigate this supposition, the
appropriately protected benzyl derivative was synthesised.
7.1.32 The benzyl ether as a protecting group
Synthesis of the requisite benzyl derivative began with the benzylation of (R)-5-
methyl-4-hydroxylhexan-2-one using the previously described benzyl imidate
methodology.'5' This reaction proceeded smoothly, giving the desired benzylated adduct
99 in a modest 60Vo yield, scheme 89. A boron-mediated aldol reaction with pivaldehyde
was then conducted and, as anticipated, only moderate diastereoselectivity was observed.
The ratio of diastereomers, determined to be 3: I by '3C NMR analysis, was significantly
inferior to the almost exclusive ratios observed for the para-methoxy benzyl derivatives.
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,*4"', 1) Cy2BCl, CH2CI2-78"c, th
- 78'C, 6 h
H
11;1, ds= 3:1
Scheme 89: Aldol study with the benzvl
3) H2O2, MeOH, PH 7
2h,.1,74o/"
protected derivative
As the steric size of the paramethoxy benzyl and the benzyl derivatives are comparable,
this suggests that it is not a steric factor that is responsible for the differing levels of
asymmetric induction observed for both derivatives. Rather, these results suggest that it is
the elecffon donating ability of the OMe substituent that is crucial for efficient interaction
between the enolate and aromatic substituent. It is a well renowned phenomenon that
methoxy substituents donate electron density to an aromatic ring, and by doing so,
presumably increase the capacity of the aromatic ring to participate in n stacking
interactions. For example, the tH chemical shifts of the ring protons in anisole are 6.65,
7.14 and 6.74 ppm respectively, for the ortho, meta and para postitions, compared to the
tH chemical shift of 7.37 for benzene,'88 showing that these protons are shielded by an
increase in electron density.
An example of a subtle change to an electronic environment and its effect on fi stacking
interactions is the fluorescent quenching abilities of the glyoxylates 101 and 102.t8e By
removing the cyclohexyl moiety to give derivative 102, intramolecular quenching for this
derivative proved to be even more efficient. Less rigidly defined conformations, such as
that of glyoxylate I02, are particularly sensitive to subtle changes in their electronic
environment.rTe We observed a similar phenomenon for the flexible, acyclic benzyl99
and the PMB derivatives (scheme 80, pg 107), as evidenced by a difference in the
di astereoselecti vities of the analogous aldol reactions.
cH2cl2, TfoH
Cyclohexane
0 "C to rt,30 min
6V/o
2)
101
-r29-
7.1.5: Conclusions
The above results suggest that these boron mediated |,S-anti aldol reactions are
particularly sensitive to slight changes in the substituent at the B-position. If subtle n-
stacking interactions are responsible for the differences between the benzyl and PMB
derivatives, then the proposed transition state will also be influenced by other subtle
changes to the B-substituent. Indeed, by considering the conformers A and B for the
previously discussed silyl derivatives, one can see how the phenyl, or methyl, substituents
on the silyl tethers affect the diastereoselectivities. In both A and B, unfavourable 1,3-
diaxial interactions between the methyl, or phenyl, substituent on the silyl tether, the axial
H (as depicted) and the boron enolate oxygen results in a less favourable, higher energy,
conformation. Consequently, low diastereoselectivities are observed for the subsequent
aldol reactions.
This proposition is further verified by an additional study whereby the analogous
paramethoxyphenyldimethylsilyl substituted substrate C was synthesised and subjected to
boron mediated aldol reactions, using CyrBCl as the boron reagent. u Again, poor
diastereoselectivities, ranging from 1.2:I to 2:1 were observed. From this observation,
two important conclusions can be made. First, it is not the steric influence of the OMe
substituent that is somehow enhancing the diastereoselectivity for the previously reported
PMB mediated \,5-anti aldol reactions. Second, the presence of the methyl substituents
significantly disfavours the proposed conformation C. Apparently these unfavourable
I,3-diaxial interactions cannot be overcome by an increase in the electron density of the
aromatic ring.
L2BO H
A
ds:2:1 to 2.5:1
B
ds: 1.1:1
c
ds:1 .21 to 2:1
u Results courtesy of Dr Y. Dong, Victoria University of Wellington
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Thus, in summarising the above information, a few general statements concerning
boron mediated acyclic 1,S-anti aldol reactions can be made. An electron rich aromatic
system is required at the B-position of the parent B-hydroxy ketone, conformation D.
Although moderate selectivity is observed with a benzyloxy substituent at the B-postion
E, diastereoselectivities are greatly enhanced by the electron rich, paramethoxybenzyl
derivative. The steric effect of the paramethoxybenzyl substituent is not responsible for
the high levels of 1,S-anti induction, as observed with the poor diastereoselectives
obtained with the paramethoxydimethylsilyl derivative C. Although the electron donating
abilities of the paramethoxy substituent greatly enhance the diastereoselectivities for the
PMB derivatives, the additional methyl substituents in C, disfavour the formation of the
n-stacked transition state and outweigh any additional positive influence of the methoxy
substituent. However it is not solely these methyl substituents that result in decreased
levels of 1,5-asymmetric induction, again compare aldol reactions with the OBn (E) and
PMB (D) derivatives. Unfavourable 1,3-diaxial interactions and a relatively electron poor
aromatic ring explains the poor diastereosectivites observed with the dimethylphenylsilyl
B and tert-butyldiphenylsilyl A derivatives. The presence of two phenyl substituents in A
also leads to two possible transition state conformations.
Meo-//-\
\r\-P
--..1a.Z. +./-'
L2BO
D
ds: >95:5
L2BO
E
ds:3:1
Thus to date, all of these observations are consistent with a model in which n-stacking
interactions are responsible for the high degree of boron mediated 1,S-anti induction
observed with the PMB derivatives. For effective fi-stacking interactions, and hence
efficient boron mediated 1,5-anti-induction, an electron rich aromatic system, attached to
the B-oxygen via a methylene linkage, is required.
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7.22 Cyclic systems
7.2.1: The pyranose system
Next, we turned our attention to other cyclic systems, such as 103, in which
excellent 1,S-anti induction has been observed, scheme 90. Kozmin reported selectivities
of over 99:l with pyrans of the type 103 where Rr = benzyl, and R2 = allyl.'t8 Kozmin
rationalized the high stereoselectivity to be a consequence of the B-alkoxy group and
cited the studies conducted by Evans'62 on alternative cyclic systems as precedence for
this observation.
1) hBCl
R1 2) RsCHO
104
Scheme 90: Boron mediatedl,S-anti aldol studies in cyclic systems
However, due to the presence of benzyl substituent Rr, we proposed that a conformation
such as I, where Rt = allyl, Rt = OBn, in figure 32, was responsible for the high
diastereoselectivity. Our initial impression was that fl-stacking interactions were
responsible for this preferred conformation, however upon closer examination, the
intramolecular distance of approximately 7.5 A between the benzyl substituent and the
boron enolate was not amenable to n stacking. Thus, it appeared that with these systems,
aldehyde facial discrimination was achieved by simple steric hinderance from the C-4
(Rt) substituent. This was confirmed by the molecular modelling of the methyl enol ether
of 103 (where Rr = allyl, R2 = OBn), figure 32.H
ur Courtesy of Dr Paul Teesdale Spittle, SBS, Victoria University of Wellington
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IFigure 32: Proposed conformation for the boron enolate of 103
OBn
e t^l
u"'\O-"',r,4.
Figure 33: Molecular modelling of the methoxy enol ether of pyranose 103
To further verify this hypothesis, a similar cyclic derivative with a different
substituent at C-4 was synthesised. In an attempt to simplify the system, a derivative
where R2 = H, was made by the addition of the readily available but-3-en-l-ol to 4-
methoxybut-3-en-2-one, as depicted in scheme 91. Unfortunately the subsequent Prins
reatrangementrs resulted in a 4:l mixture of diastereomers. Presumably this
diasteromeric mixture was a consequence of the absence of a R2 substituent (scheme 90),
which would normally adopt an equatorial position to favour the intermediate chair
transition state during the Prins reanangement.
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A^o""
104
no* LN
1(F
1) TFA CHzCIz
5'C, 48 h
PPTS, toluene
5 h, reflux, 667o
2) LjOH, THF, HzO
10 min,75%
Scheme 91: Attempted synthesis of aldol precursor 106
To avoid the added complications of accounting for the effects of the diastereomers
during the subsequent aldol studies, the original synthesis, as reported by Kozmin was
repeated, to give the intermediate pyranose adduct 108 in good diastereoselectivity,
scheme 92. The free hydroxyl group was then protected, in excellent yield, with a 
'fBS
group to form the aldol precursor 109, scheme 93.
j 
o*" PPTS, toluene
5 h ref u, 9?/o104
Scheme 92: Synthesis of the intermediate pyranose adduct 108t78
TBSCI, DMF
oFl
-,L....Q2..\ : lmidazole
rl, 18 h,95% OTBS
108 108
Scheme 93: Synthesis of novel aldol precursor 109
A boron mediated aldol reaction between L09 and isobutyraldehyde was then conducted,
scheme 94, and as anticipated, excellent levels of diastereoselective induction were
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observed.m From these results, it can be verified that rg-stacking interactions were not
responsible for the observed high levels of diastereoselectivity in these cyclic systems,
and it appeared that it was the steric influence of the substituent at C-4 that predominantly
influenced the stereochemical outcome of these reactions. However, based on these
studies alone, there was still not sufficient evidence to confidently make this proposition.
An aldol study on a similar substrate without a C-4 substituent would be required to
produce low levels of selectivity.
1) Cy2BCl, Et2O
-78"C, th
d.s >99:1
- 78r,6 h
H
3) H2Oz, MeOH, pH 7
2 h, rl, 81o/o
Scheme 94: Boron mediated |,S-anti aldol reaction with pyranose 109
Fortunately, a review of the literature revealed that such studies had already been
conducted. During the synthesis of the C-1 to C-21 fragment of the dimeric polyketide
natural product SCH 351448, De Brabander et. a/. conducted a boron mediated aldol
reaction using 111, scheme 95.Ier Again, De Brabander cited studies by the Evansr6e and
Paterson'630 groups as precedent for this 1,S-anti induction. However, in De Brabander's
subsequent studies, only low to modest levels of diastereodifferentation were observed.
1) )tsL2, EI2O,O -79"C
Bn
d.s: 1.4:1 tr 5.5:1
X= Cy, Elu, Et
2) RCHO, -79 .C
111 112
Scheme 95: Boron mediated |,S-anti aldol studies conducted by De Brabander et. aI.
HlDetermined by t3C NMR analysis of the crude product
109 110
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Although the intrinsic facial bias of the enolborinate partner was reported to be
responsible for some of the more subtle differences in the levels of stereochemical
induction for the different aldehyde partners, no explanation was given for the overall
decreased levels of stereochemical induction when compared to the examples reported by
Evans, Paterson, or Kozmin. Enhanced stereoselectivities in De Brabander's studies were
only obtained after screening a variety of boron reagents with different ligands. However,
after comparing our studies with those by Kozmin and De Brabander, it seemed apparent
that the steric nature of the C-4 substituent greatly influences the degree of
stereochemical induction. Where there is no appendage atC-4, as in De Brabander's case,
poor diastereoselectives are observed.
This concept is illustrated by considering the conformation of the pyran ring and the
proposed transition state shown in figure 34. Here the enolate side chain adopts an
equatorial orientation, with the larger boron substituent positioning itself furthest away
from the cyclohexyl ring to minimise the electrostatic repulsive effects of the ring oxygen
and the steric effects of the boron ligands. Where R' is large, such as OTBS or OBn, the
aldehyde preferentially approaches the enolate from the front face with the larger R3
substituent on the aldehyde adopting an equatorial position in the intermediate transition
state.m Such a transition state gives the desired anti- diastereoselectivity. A summary of
the diastereoselectivities for the various R', Rt and boron ligands (L) is provided in Table
8 overleaf.
$A"t-. nsc'o
L2BO
Figure 34: Proposed transition state for the boron-mediated aldol reaction
*n Due to the minimal energy difference between the chair and twist boat transition state, this
transition state has been shown in the chair conformation as this is easier to depict pictoriatly and
does not alter the stereochemical outcome
R3H+.\1T-R'
165
L
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Table 8: Boron mediated aldol studies with derivatives of pyranose 103
RI R2 RCHO Diastereoselectivity Ref
(anti:syn)
OBn
OTBS
H
H
allyl
allyl
CMerCOrBn
CMerCOrBn
,J.ro
'BuCHO
ETCHO
ETCHO
Cy
Cy
Cy
Et
> 99:1
> 99:l
1.8:l
5.5:l
178
r92
t92
r92
X=t
o_/
From this analysis, a lack of a substituent at C-4 clearly results in inherently lower
diastereoselectivities as there is no R' substituent to hinder the approach of the aldehyde
from the back face. Thus, the analysis becomes a little more complicated. With no
substituents to obstruct the approach of the aldehyde from the back face, it becomes more
difficuft to determine the relative energies of the both the anti andsyn transition states.re3
In these cases, the choice of ligands on the boron enolate will have a much greater
influence on the preferred transition state, but without an in depth knowledge of the
preferred transition state conformation, it is difficult to predict the stereochemical
outcome of these aldol reactions.
7.32 Boron mediated |.]-anti induction 
- 
a summarv
From the studies discussed in this and the preceding chapter, some general
observations concerning the origin of diastereoselectivity in boron mediated |,S-anti
aldol reactions can be made. Although the statement that these reactions are 'influenced
by the B-hydroxy substituent' has not been disputed, it needs to be addressed with
caution. A more in depth analysis of each system is required. Thus in general, we have
identified and proposed transition states for three different systems that arise when
conducting boron-mediated aldol reactions. These are summarised below:
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iii)
i) Acyclic l,S-anti boron mediated aldol reactions
The judicious use of electron rich n systems at the B-hydroxy protecting group is
required for favourable n interactions and hence selectivities in acyclic boron mediated
L,S-anti induction. Unfavourable 1,3-diaxial interactions are observed if there are
substituents on the carbon, or silicon, linkage to these electron rich aromatic groups.
These interactions greatly disfavour the formation of the proposed n-stacked transition
state, resultin g in negligible selectivities.
ii) Rigid cyclic systetns withfavourable n-stacking interactions
In some cyclic systems, such as that developed for the synthesis of pel A, the
cyclic system is rigid enough to hold the aromatic ring in close proximity to the enolate.
This Ieads to favourable zu stacking interactions, and hence selectivities.
Cyclic systems where steric hinderance directs the approach of the aldehyde
The carbon framework of the cyclic system dictates the stereochemical outcome
of the reaction. Such systems are more difficult to analyse and require careful
consideration of the proposed transition states.
-t38-
ChaoterS:
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Concluding Remarks
Although we were unsuccessful in determining the absolute stereochemistry of
peloruside A, presumably due to the small sample size or complex nature of this
molecule, significant advancements have been made towards its synthesis. To-date, a
successful strategy for the synthesis of the C-8 to C-24 framework has been developed.
This carbon framework is depicted in figure 35.
Figure 35: Peloruside A with the C-8 to C-24 framework highlighted
The synthesis of the C-8 to C-11 fragment proceeds smoothly and needs no further
investigation. This five-step synthesis proceeds in good overall yield and has been
successfully performed on the multigram scale.
A short, facile synthesis of the C-12 to C-24 fragment has also been developed. To date,
the ethyl side chain has not been incorporated into the synthesis, however precedent by
HoyvedaraT indicates that this should be a relatively uncomplicated adaptation.
Nevertheless, we are equally interested in the analogue without the ethyl substituent as
this may provide valuable insight into the biological activity of pel A and potentially lead
to the development of simplified analogues. Similarly, our strategy facilitates the
synthesis of both the C-16 methylated, and unmethylated, analogues which again will be
of interest during biological testing.
''oMe
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There are however, a few improvements and changes that need be made to our
strategy. Since the determination of pel A's absolute stereochemistry by De Brabander,e
the most pressing adaptation required is the synthesis of the correct enantiomer of the
C-I2 to C-24 fragment, In particular, this requires the synthesis of the (S)-enantiomer of
the key intermediate B-hydroxyketone 24. Although precedent by Patersonrs could be
followed for the synthesis of 24, it would be valuable to first investigate some alternative
strategies including the BINOL-Ti catalysed Mukaiyama aldol reaction between the silyl
enol ether of acetone and methacrolein. or acrolein.e3
A future objective of this research is also to find a more active RCM catalyst for the
synthesis of the Dis-silyl ether 65. Not only would this reduce the amount of catalyst
required but would greatly facilitate the purification process.
However, more importantly, during the synthesis of the C-12 to C-24 fragment of
pel A and subsequent aldol studies, valuable insight into the origin of |,S-anti induction in
boron-mediated aldol reactions has been gained.rea Our studies point to three modes of
operation in effect during boron-mediated aldol reactions. First, in acyclic systems, the
judicious use of electron-rich n-systems as B-hydroxy protecting groups must be used to
provide for favourable n stacking and hence high selectivities. Second, in some cyclic
systems containing aromatic moieties, such as those studied during the synthesis of pel A,
the rigidity of the system facilitates favourable fi-stacking interactions, and hence,
diastereoselectivies. And finally, in other cyclic systems, simple steric hindrance is
responsible for the observed selectivities. These insights will undoubtedly aid in the
planning of synthetic routes during the synthesis of further natural products.
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Experimental Section
9.1. General:
Unless otherwise stated, the following conditions apply. All reactions were
performed under argon in oven-dried glassware using dry solvents and standard syringe
techniques. Diethyl ether and TIIF were distilled from sodium benzophenone ketyl
radical ion. Dichloromethane, triethylamine and methanol were distilled from calcium
hydride. Diisopropylamine and pyridine were distilled from sodium hydroxide. Benzene
was successively shaken with concentrated sulfuric acid, water, dilute sodium hydroxide
and water, before being dried with calcium hydride and distilled. Acetone was distilled
from potassium carbonate. Anhydrous dimethylformamide was purchased from Aldrich
Chemical Company and used without further purification. All other reagents were of
commercial quality and distilled prior to use if necessary.
Reaction progress was monitored using aluminium backed TLC plates pre-coated with
silica UV254 and visualised by either UV radiation (254 nm), ceric ammonium
molybdate dip or using an iodine tank unless otherwise stated. Purification of products
via flash chromatography was conducted using a column filled with silica gel 60 (220-
240 mesh) with the solvent systems as indicted. rH and'3C NN{R spectra were recorded
in CDCI, on a Varian Inova at 300 and 75 MHz respectively; and are referenced to
solvent peaks (tH 
- 
residual CHCI, (7.26 ppm), 
"C - CDCI3,(77.0 ppm)). Infrared spectra
were obtained on a Biorad FIS-7 spectrometer or a Bruker Tensor 27 FTIR spectrometer.
Electrospray High-resolution mass spectroscopy was recorded on a Mariner time of flight
spectrometer. Diastereoselectivities were determined by averaging the t3C NN{R peak
heights for the diastereotopic signals of the crude product,
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Experimental data is reported in chronological order. The following compounds
were synthesised according to literature precedent: 3-(tert-butyldimethylsiloxy)propanol
(32)," Des Martin Periodinane,t 1S1-4-benzyl-3-butyryl-2-oxazolidinone (37)t*, (+)-(4S)-
3-[(2'R)-2'-((tert-butyldimethylsiloxy)-methyl)-butanoyl]-4-benzyl-Z-oxazolidinone
(38),tn(-)-(25)-2-((terr-butyldimethyl-siloxy)methyl)butanol (39),7e (-)-(25)-2-((ten-
butyldimethylsiloxy)methyl)-butanal (3c),7e isopropyltriphenylphosphonium bromide,r0s
dihydro-2-(tosyloxy)-3,3-dimethyl-(2H)-furanone (17b),"3 4-hydroxy-5-hexene-2-one
(24a),'37 Grubbs second generation ruthenium catalyst (62\,tn'benzyltrichloroacetimidate
(79;t:r'xxv' dicyclohexylboron hydride (CyrBH),r% dicyclohexylborontriflate
(CyrBOTflre7, dicyclohexylboronchloride (CyrBCl),te7 diisopinocampheylboron hydride
(IpcBH)'e8, diisopinocamphenylboron chloride (IpcrBCl)'ry, (R)-4-hydroxyl-S-methyl-
hexan-2-one (94a),r76a'trou (R )-4-hydroxy-5,5-dimethyl-hexan-2-one (94b1,t26"'trot 4-
methoxy-3-butene-2-one (104),m 3-butene-4-(hepta-1,6-diene-4-oxy)-2-one (L07)t78 and
I -(6-allyl-4-hydroxy)tetrahydrop yran-2-yl)-propan-2-one (108). r7E
xxry The purification procedure reported in the literature for the synthesis of benzyl
trichloroacetimidate, involving the washing the initially formed filtrate with pentane, proved to be
unsuitable as rwo immiscible layers were formed. Consequently, the residual oil was purified by
rapid distillation at 0.1 mm/Hg. It is imperative that this distillation is performed rapidly as the
intramolecular thermal reiurangement of benzyl trichloroacetimidate to the N-benzyl amide is
frequently observed after prolonged heating of the substrate.
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9.2. Experimental for Chapter 2z
3-(tert-Butyldimethylsiloxy)propanal (33). To a stirred solution of 3-(tert-
butyldimethylsiloxy)propanol (32) (2.20 g, 11.55 mmol) in CHrCl, (80 ml)was added
water (200 ttL) followed Dess-Martin periodinane (6.30 g, 13.86 mmol). After 4 h at
room temperature additional Dess-Martin periodinane (6.30 g, 13.86 mmol) was added
and the reaction stined at room temperature overnight. The solution was then diluted with
100 mL of EtrO and treated with a l:1 mixture of saturated NaHCO3:NaS,O, (100 mL)
for 15 minutes. The ether layer was collected and the aqueous phase extracted once with
ether. The combined organic layers were then washed with brine, dried over MgSOn and
the solvent carefully removed under reduced pressure. The residual oil was then purified
by flash chromatography (10:l pentane:EtrO) to give 3-(tert-butyldimethylsiloxy)-
propanal (33) (1.09 g,50Vo). NMR spectral data matched that previously reported.nr
2-(Ilydroxymethyl)butan-1-ol (35). This was synthesised in the manner previously
reported'm with the exception that the solution was refluxed in EtrO for 2.5 h and the
product purified by bulb+o-bulb di stil I ati on.
2-((tert-Butyldimethyl-siloxy)methyl)butanol (36). To solid NaH (204 mg, 8.49 mmol),
washed three times with hexanes, was added dropwise a solution of 2-ethyl-1,3-
propanediol (35) (590 mg, 5.66 mmol) in TFIF (13 mL). The reaction was stirred
vigorously for 45 min at room temperature. Tert-butyldimethylsilylchloride (854 mg,
5.66 mmol) in TIIF (4 mL) was then added in one portion and the reaction stirred
vigorously for 45 minutes before being quenched cautiously with water. The resulting
solution was extracted with EtrO, washed with lAVo K2COr, brine and dried over NarSOo.
After removal of the solvent under reduced pressure, the residual oil was purified by flash
chromatography (10:l hexanes:EtoAc), to give 36 (l.ll g,90vo\ as a colourless oil.
NMR spectral data matched that previously reported.rm
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2-(tert-Butyldimethylsiloxymethyl)butanal (3b). To a stirred solution of 2-(tert-
butyldimethyl-siloxymethyl) butanol (37) (395 mg, 1.81 mmol) in CHrClr (12.4 mL) was
added Dess-Martin periodinane (1.15 g,2.7I mmol) and the reaction stirred for 6 h at
room temperature. 'H NMR analysis of a small portion of the reaction product indicated
that some of the starting substrate 37 was still present and a further 1.15 g of the
periodinane was added and the reaction stirred at room temperature overnight. The
solution was diluted further with CHrClz (50 mL) and filtered through a small, 0.5 cm
thick, plug of silica gel. The residual oil was purified by flash chromatography (10:l
pentane:EtrO) to give 3b (170 mg, 44Vo). NMR spectral data matched that previously
reported.Te
2-(Acetoxymethyl)butanol (43b) and 2-(Acetoxymethyl)but-1-ylacetate (42).To a
rapidly stirred solution of 2-(hydroxymethyl)butan-1-ol (35) in pyridine (20 mL) at 0 oC
was added dropwise acetyl chloride (942 1tL,13.25 mmol). The reaction was allowed to
wann to room temperature overnight before being quenched with water and extracted
twice with EtOAc. The organic extracts were washed once with satd. aq. NaHCO,
solution, brine and dried over NarSOo. The residual pyridine was removed by co-
distillation with toluene and the crude material purified by gradient flash chromatography
(5:1 to 3:l hexanes:EtOAc) to give 43b (637 mg,407o) and 42 (821 mg, 40Vo). NMR
spectral data matched those previously reported.'m
2-(Acetoxymethyl)butanal (44b). This compound was synthesised using a variety of
conditions, as indicated below. In all instances, the NMR spectral data matched that
previously reported. rm
a) Small scale Des-Martin oxidation of 2-(acetorymethyl)butanol (43b). To a stirred
solution of 43b (8 mg, 0.055 mmol) in CHrCl, (500 pL) was added Dess-Martin
periodinane (35 mg, 0.082 mmol). The solution was stirred for 2.5 h at room temperature
then an additional 35 mg of Dess-Martin periodinane was added. After an additional 3 h
the resulting solution was loaded onto a Pasteur pipette sized silica gel column and eluted
with CHrCl2 (2 mL) to give 44b as a colourless oil.
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b) Modified Swern oxidation of 43b. To a solution of oxalyl chloride (773 1tL, 8.87
mmol) in CHrCl, (72mL) at-78 oC, was added dropwise DMSO (1.26 1t"L,17.73 mmol).
The solution was stined for l5 minutes before a solution of 43b (1.08 g, 7.39 mmol) in
CHrCl, (21 mL) was added dropwise. The resulting solution was stirred at:78'C for 30
minutes, Et3N (4.02 mL, 28.8 mmol) was slowly added, at which point the cloudy
solution turned clear. The solution was stined for an additional 1.25 h at 
-78 oC then at 0
oC for 5 minutes before being diluted with sat. aq. NaHCOr. The resulting solution was
then extracted twice with CHrCl2, and the organic extracts washed twice with a lM
sodium bisulfite solution, once with brine and dried over MgSOo. The solvent was
removed under reduced pressure and the residual oil diluted with CH'CI? (20 mL) and
purified immediately by passage through a small, 1.5 cm thick, 3 cm diameter, silica gel
plug. The silica plug was then washed with a further CH2CI2, (20 mL) and the solvent
removed under reduced pressure to give 44b (672 mg,63Vo) that was used without further
purification.
c) From the periodate oxidative cleavage of 4-(acetorymethyl)-2-methyl-hex-2-ene (46).
4-(acetoxymethyl)-2-methyl-hex-2-ene (46) (6 mg) was dissolved in TFIF (540 pL) HrO
(300 pL). A 70 1rL aliquot of this solution, which equates to 0.5 mg or 2S4 pmol of 9,
was then transferred to a second flask and 3 p"L (O.3 pmol) of a 2.5 wt 7o solution of
osmium tetraoxide in ten-butanol added. The solution was stirred at room temperature for
10 minutes before NaIOo (2.5 mg, 11.5 pmol) was added. The solution was stirred
vigorously at room temperature, and the progress of the reaction monitored by GC using
a 60 m x 0.25 mm Cyclodex-BrM column and the following conditions: Inlet: Split
275'C; Detector: FID 320"C; Carrier gas: hydrogen; Flow: 35.8 cm's''; Temperature
programme: Isothermal at 60'C. The GC conditions were as follows. After 2 h no starting
material was present and two peaks with retention times of I16.5 and I19.5 minutes were
observed on the GC trace.
This experiment was previously conducted using 15 mg of 46. After 3 hours the solution
was diluted with EtrO, (20mL), washed with brine, dried over MgSOo and filtered. The
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solvent was then removed under reduced pressure to give 44b as a colourless oil. NMR
spectral data matched that previously reported.tm
4-(Acetoxymethyl)-2-methyl-hex-2-ene (47). To a mixture of isopropyltriphenyl-
phosphonium bromide (720 mg,1.87 mmol) in TFIF (20 mL) at 0 oC was added a 1.6 M
solution of n-Buli in hexanes (1.17 mL, 1.87 mmol). A red solution was observed due to
the formation of triphenylphosphoranylidene isopropane. After the mixture was stirred
for I h at room temperature, a solution of 44b (245 m9,1.70 mmol) in dry TItr (1.5 mL)
was added dropwise. The resulting mixture was stirred at room temperature for 4 h then
poured into 50 mL of hexanes. The precipitated triphenylphosphine oxide was removed
by filtration and the resulting solution concentrated in vacuo. The residue was purified by
gradient flash chromatography (hexane, 50: I hexanes:EtOAc) to give 47 (l2O mg, 42Vo)
as a colourless oil.tH Mlm.: 6 4.S5 (d, 
"I= 9.9Hz,IH),392 (d,,/= 6.9Ifz,2lt), 2.51 (m,
lH), 2.06 (s, 3H), l.74 (s, 3H), 1.65 (s, 3H), 1.51 (m, 1H), I .21 (m, lH), 0.87 (t, J = 7 .5
Hz, 3H) ppm. t'C NMR: 6 17l .5, 134.4, I25.3,68.0, 39.3, 26.1,25.2,2I.3, 18.5, lI.7
ppm. IR (neat): 2966,1739,1230. 1035, 733 cm-r.
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9.3: Experimental for Chapter 3:
Dihydro-2-(allyloxy)-4n4-dimethyl-(2H)-furanone (17c). To a solution of pantolactone
(fD (10.0 g,76.8 mmol) in DMF (80 rnl-) at 0 oC was added a lM solution of potassium
tert-butoxide in TIIF (76.8 mL,76.8 mmol). The cooling bath was then removed and the
solution stirred at room temperature for 30 minutes. A solution of allyl bromide (6.99
mL, 80.6 mmol) in TFIF (7 mL) was then added dropwise and the resulting mixture
stirred at room temperature overnight before being quenched with water and extracted
twice with Et2O. The combined organic extracts were washed twice with sat. aq.
NaHCOr, once with brine, dried over MgSOo and the solvent removed under reduced
pressure. Flash chromatography of the crude product (5:l hexanes:EtOAc) gave 17c (10.6
g,8lVo) as a colourless oil.rH IIIIIIR: 6 5.90 (m, lH), 5.32 (dd, J = 17.1,l.2Hz,IH),5.24
(d, ,I = l0.2Hz, I H),4.46 (dd, "/ = 12.9, 5.I Hz, I H),4.20 (dd, "/ = 12.9,6.3 Hz, I H),
3.99 (d, J = 8.7 Hz, I [I), 3.89 (d, J = 8.7 Hz, lH), 3.74 (s,lH), 1.17 (s, 3H), 1.10 (s, 3H)
ppm. t'c NMR: 6 r75.3, 133.8, llg.0, 9o.7,76.3,71.6,40.3,23.i,19.z ppm. IR (neat):
2971,1788, I124 cm't. HRMS: Calcd for CnH,oO, (M+H*): 171.1016. Found: l7l.l021.
2'2-Dimethyl-3-(3-propeneoxy)butane-1-4-diol (53). A 25 mL flask equipped with side
arm and reflux condensor was charged with LiAlH4 (305 mg, 7.85 mmol) and TIIF (10
mL). A solution of 17c (891 mg, 5.23 mmol) in TFIF (5 mL) was then added cautiously
dropwise over 15 minutes. The resulting solution was refluxed for 3 h before being
cooled to 0 oC and quenched by the portion-wise addition of hydrated sodium sulfate.
The residue was diluted with ethanol (50 mL), filtered though a 0.5 cm x 3 cm diameter
silica gel plug, dried with anhydrous NarSOr, and the solvents removed under reduced
pressure. Flash chromatography of the crude product (1:1 hexanes:EtOAc) gave 53 (690
mg,767o) as a colourless oil. 'H MrdR: 6 5.95 (m, lH), 5.29 (dd, J = 17 .1, 1.5 Hz, lfl),
5.19 (dd, ,I = 10.5, I.2IIz,l H), 4.19 (ddt, 
"I = 12.6,5.4,l.5I{2, IFI), 4.07 (ddt, J = 12.6,
5.4, 1.5 Hz, lH), 3.80 (dd, J = L2.0,3.90H2,1H), 3.70 (dd, J = 12.0,4.2H2,1H), 3.20
(dd, J = 4.2,3.9 Hz,lH), 2.36 (bs, 2H), 0.96 (s, 3H), 0.94 (s, 3H) ppm.''C NMR: 6
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134.7, I 17. 1, 85.7, 72.6, 69. l, 60.6, 39.1, 23.0, 2l .3 ppm. IR (neat): 3345, 2967, 287 6,
1048 cm-'. HRMS: Calcd for C'II,*O 3175J334 (M+H.). Found 175.1329.
1,4-Dibenzyloxy-2,2-dimethyl-3-(3-propeneoxy)-butane (54). To a 25 mL flask
containing NaH (491 mg, 20.5 mmol) (washed three times with hexanes) in DMF (6.5
mL) at 0 oC was added a solution of 53 (713 mg, 4.09 mmol) in DMF (5 mL) over five
minutes. When gas evolution had ceased, benzyl bromide (998 pl, 8.39 mmol) was added
dropwise and the reaction mixture allowed to warm to room temperature overnight. The
solution was then cautiously quenched with water, extracted twice with EtrO and the
combined organic extracts washed twice with sat. aq. NaCO, solution, once with brine,
dried over MgSOo and the solvent removed under reduced pressure. Flash
chromatography of the crude product (hexanes) gave the benzylated ether 54 (1.30 g,
90To) as a colourless oil. 'H Mlm.: 6 Llz (m, l0[I), 5.93 (m, lH), 5.24 (dd, "/ = 17.1, 1.8
Hz, 1H), 5.10 (dd, J = 1O.2, 1.5 Hz, lH),4.52 (s, 2H), 4.46 (s,2H),4.34 (ddt, ,/ = 12.6,
5.4, 1.5 Hz, 1H), 4.03 (ddt, J = 12.6,5.4, 1.5 Hz, lH), 3.58 (m, 2H), 3.38 (d, ,/ = 8.7 Hz,
lH), 3.15 (d, J = 8.7 Hz,lH), 0.95 (s, 3H) 0.92, (s, 3H) ppm. ''C l.nUR: 6 138.9, 138.6,
135.8, 128.3,121.9, 127.7,127.4, 1L5,7,92.5,77.2,73.2,72.O,39.7,20.9,22.2ppm.IR
(neat): 3028, 2906, 2859, 1092 cm-'.
1,4-Dibenzyloxy-2r2-dimethyl-3-hydroxy-butane (55). p-Toluenesulfinic acid (82 mg,
0.52 mmol) was added at room temperature to a solution of 54 (167 mg,0.47 mmol) and
Pd(PPhj)4 (33 mg, 0.03 mmol) in TFIF (4.7 mL). The reaction mixture was stirred at room
temperature for 7 h before Et3N (13 pl) was added. The solvent was then removed under
reduced pressure and the residue purified immediately by gradient flash chromatography
(50:l to 20: I hexanes:EtOAc) to give 5 (122 mg, 83Vo) as a colourless oil. tH MUR: 6
7.37 (m,lOH), 4.57 (s, 2H),4.5O (s, 2H), 3.78 (ddd, J = 8.4,3.3, 3.0 FIz, 1H), 3.64 (dd, J
= 9.6, 3.0 Hz, 1H), 3.49 (dd, J = 9.6, 8.4 Hz, 1H), 3.38 (d, J = 8.7 Hz, IH),3.27 (d, ./ =
8.7 Hz,lH), 3.03 (d, 
"/ - 3.3 Hz,lfD, 0.97 (s, 3H), 0.96 (s, 3FI) ppm. t'C NIUR:6 138.4,
129.5, I28.2, 127.9, 127.6,127.5,79.2,75.7,73.4,73.3,7r.7,37.4,21.6,20.3 ppm. IR
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(neat): 3498,2987,2848, ll05 cm-'. HRMS: Calcd for CroHruO3 315.1950 (M+H").
Found 315.1955.
1,4-Dibenzyloxy-3,3-dimethyl-2-butanone (8). To a solution of 54 (100 m9,0.32 mmol)
in CHrCl, (1.6 mL) was added pyridinium dichromate (181 mg, 0.48 mmol), freshly
activated 3A molecular sieve powder (260 mg) then anhydrous AcOH (32 pl, 0.55
mmol). The reaction was stirred at room temperature for 15 minutes before being diluted
with CHrCl, and filtered though a small (0.5 cm) bilayer Celiteru/silica gel plug. The
filtrate was washed with water then brine and the organic phase dried over MgSOo. The
solvent was removed under reduced pressure and residue purified via flash
chromatography (50:1 hexanes:EtO,A.c) to give 8 (81 mg, 82 7o) as a colourless oil.tH
NMR:67.35 (m, lOH),4.58 (s,2H),4.48 (s,2H),4.38 (s,2m,3.44 (s,2[I),1.17 (s,6II)
pp*. t'c NMR: 6 210.8, 138.2, r37.8, rzl.i, 128.6, 128.2, r2g.r, rz7.g, r27.8,77.3,
73.6, 73.3, 72.4, 47.6, 22.I ppm.IR (neat): 3031, 2967, 2932, 2869, 1723, 1100 cm-t.
HRMS: Calcd for C,H*O3 313.1805 M+H.).Found 3L3.I798.
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9.4. Experimental for Chapter 4:
4-Hydroxy-5-methylhex-5-en-2-one (24b). To a solution of diisopropylamine (1.37 mL,
9.81 mmol) in dry THF (40 mL) cooled to 
-78 "C was added a 2M solution of n-Buli in
hexanes (4.90 mL, 9.81 mmol). After stirring at 
-78 oC for l0 min, a solution of acetone
(600 pl, 8.17 mmol) in THF (a mL) was added slowly over 5 min. Stirring at 
-78 oC was
continued for 50 min and then a solution of methacrolein (811 pl, 9.81 mmol) in TFIF (4
mL) added. The mixture was stirred at 
-78 oC for a further 10 min, followed by the
addition of sat. aq. NHoCl. The mixture was then extracted twice with EtrO and the
organic extracts washed with brine, dried over MgSOo and the solvent removed under
reduced prossure. Bulb-to-bulb distillation (58-60 oC, 0.4 mm/Hg) gave 24b (882 mg,
84Vo) as a colourless oil. NMR spectral data matched that previously reported.m2
4-(3-Butenoyl)hex-5-en-2-one (57a). To a solution of the B-hydroxy-ketone 24a (1.00 g,
9.64 mmol) in CHrClz (45 mL) was added vinylacetic acid (819 1.tL, 9.64 mmol),
dicyclohexylcarbodiimide (1.99 g,9.64 mmol) and DMAP (54 mg,0.45 mmol) and the
reaction stirred at room temperature overnight. The precipitated dicyclohexyl urea was
removed by filtration and the precipitate washed with 60 mL of ice-cold CHrClr. The
combined organic extracts were then washed once with water, dried over MgSOr, filtered,
and the solvent removed under reduced pressure. The crude material was initially purified
by flash chromatography (5:l hexanes:EtOAc) to give 57a containing small amounts of
dicyclohexyl urea. This was further purified by bulb-to-bulb distillation (90-100 oC, 0.4
mm/Hg) to give pure 57a (1.28 g, 80Vo) as a colourless oil. 'H NMR: 6 5.89 (m,2H) 5.70
(m, lH), 5.26 (m,4H),3.12 (dd, J = l.4H4 tH), 3.10 (dd, / = L4Hz,1H), 2.88 (dd, ,/ =
L6.5,7.7 Hz, lH), 211 (dd, J = 16.5,5.5H2,lH),2.20 (s, 3FI).t'C NTN,IR: 6 204.5, 170.3,
135.2,130.0, 118.6, 117.1,70.5,47.7,39.1,3O.4 ppm. IR (neat):3087, 2934,1738, 1723,
1167 cm-t. HRMS: Calcd for C,oFI,*Nq200JZgl (M+NH.*). Found 200.1281.
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4-(3-Butenoyl)-5-methylhex-5-en-2-one (57b). To a solution of 4-hydroxy-5-methyl-5-
hexen-2-one (24b) (824 mg, 6.43 mmol) in CHrCl2 (30 mL) was added vinylacetic acid
(601 pL, 7.07 mmol), dicyclohexylcarbodiimide (1.46 g, 7.07 mmol) and DMAP (40 mg,
0.32 mmol) and the reaction stirred at room temperature overnight. The precipitated
dicyclohexyl urea was then removed by filtration, and the precipitate washed with 50 mL
of ice-cold CH2CI2. The combined organic extracts were then washed once with water,
dried over MgSOo, filtered, and the solvent removed under reduced pressure. The crude
material was initially purified by flash chromatography (5:l hexanes:EtOAc) to give 57b
containing small amounts of dicyclohexyl urea. Further purification by bulb-to-bulb
distillation (85-95oC, 0.4 mm/tlg) gave pure 57b (1.06 g, 84 Vo) as a colourless oil. tH
NMR: 6 5.92 (m, lH), 5.64 (dd, J = 8.8, 4.5 Hz, lH), 5.21 (m, lFf), 5.17 (m, lH), 5.02 (d,
"/= 0.85 Hz, 1H),4.94(t,J = 1.4 Hz, lH),3.L2(t,J = 1.4 Hz, lH),3.10 (t, J = l.4Hz,
1H), 2.88 (dd, ,/ = 16.3, 8.8 Hz, lH),210 (dd, J = 16.3, 4.5 Hz, lH),2.21 (s, 3H), 1.77
(s,3II) ppm. 
'3C NMR: 6 204.8, 170.2,142.2,130.0, n8.6, 113.0, 72.9,46.5,39.1,30.3,
18.3 ppm. IR (neat): 1736, 1719,1360, 1158, 1057 cm-'. HRMS: Calcd for C,,HrNO,
214.1441 (M+NH,.). Found 214.1438.
5-Acetonyl-6-lact-3-en-1-one (56a). To a side-armed flask equipped with a reflux
condenser containing 57a (56 mg, 0.31 mmol) was added CH'CI2 (20 mL) and
tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene-
[benzylidine]ruthenium (IV) dichloride (62) (3 mg, 3.4 pmol). The resulting maroon
solution was refluxed for 2.5 h then the solvent was removed under reduced pressure.
Gradient flash chromatography (5:l to 2:l hexanes:EtOAc) of the brown residue gave
56a (43 mg,90Vo) a colourless oil. rH NMR: 6 5.85 (s, 2H), 5.43 (m, ltt), 3.09 (m, 2H),
3.01 (dd, J = 17.2, 6.4 Hz, 1H), 2.81 (dd, J = 17 .2, 6.5 Hz, l}I),2.22 (s, 3H) ppm. t'C
NMR: 6 204.3, 168.2, 125.6, 122.5,75.4, 48.4, 30.7,29.8 ppm. IR (neat):1732, I7!3,
1362, 1272, 1220, 1072 cm't. HRMS: Calcd for CrH,oNO3 L72.0973 (M+NH.*). Found
172.0968.
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5-Acetonyl-4-methyl-&lact-3-en-1-one (56b). To a side-armed flask equipped with a
reflux condensor containing 57b (250 mg,1.27 mmol) was added CHrCl, (100 mL) and
tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)4,5-dihydroimidazol-Z-vlidene-
[benzylidine]ruthenium (IV) dichloride (62) (11 mg,0.013 mmol). The resulting maroon
solution was refluxed for 2.5 h then the solvent was removed under reduced pressure.
Gradient flash chromatogaphy (5:l to 2:1 hexanes:EtOAc) of the brown residue gave
57b (182 mg,85Vo) as a colourless oil. tH I.IIUR.: 6 5.54 (m, 1H), 5.22 (m,1H), 3.06 (m,
2H),2.83 (m, 2H), 2.22 (s,3H), I.74 (s, 3H) ppm. t'C NMR: 6 204.8, 169.0, 131.9,
117.6,78.9,46.8,31.3,30.2,18.8 ppm. IR (neat): 1730,1715, 1355, r2L4, 1154' 1063
cm-r. FRMS: Calcd for QH,'NO3 186.1134 (M+NH*). Found 186.1 125.
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9.5. Experimental for Chapter 5:
But-3-en-1-oxydiphenylsilyl chloride (68a). To a stirred mixture of diphenylsilyl-
dichloride (330 pl, 1.57 mmol) and EtrN (241 1t1,1.73 mmol) in CHrCl, (6 mL) at 0 oC
was added a solution of 3-buten-l-ol (135 1t"1, 1.57 mmol) in CHrClr(2 mL) dropwise.
The reaction mixture was stirred at room temperature before being heated at reflux for 36
h. The solution was then cooled to room temperature and concentrated under reduced
pressure. The resultant oil was dissolved in a l:l vol:vol ether:pentane mixture (15 mL),
suction filtered, and reconcentrated to afford an oil, which was used without further
purification.
But-3-en-1-oxydiisopropylsilyl chloride (68b). To a stirred mixture of diisopropylsilyl-
dichforide (4 mL, 22.2 mmol) and EtrN (3.4 mL, 24.4 mmol) in CHrClz 85 mL at 0 oC
was added a solution of 3-buten-l-ol (1.91 mL,22.2 mmol) in CHrCl, (20 mL) over 30
min. The reaction mixture was stirred at room temperature for 6 h before being heated at
reflux for 48 h. After cooling to room temperature and concentrating under reduced
pressure, the resultant oil was dissolved in a l:l vol:vol ether:pentane mixture (100 mL),
suction filtered and reconcentrated to afford an oil. Fractional distillation of the crude
material gave 68b as a colourless oil (bp 53 
- 
60oC, I mm/Ilg, 2.649,547o).'H l.[tffi.: 6
5.82 (m, lH), 5.06 (m, 2H), 3.83 (t, J = 6.6H2,2H),2.32 (dt" J = 13.5,6.9 Hz,2H) 1.07
(m, l4H) ppm.t'C NMR:6 135.1, 117.0, 63.6,37.0,12.0, 16.9, 15.2 ppm. IR (neat):
2954,2876, ll0g, gg4,922, gg6 cm't .
But-3-en-1-oxydimethylsilyl chloride (68c). To a stirred mixture of
dimethylsilyldichloride (4.54 mL, 37.5 mmol) and EtrN (5.75 mL, 41.25 mmol) in
CH2CI, (120 mL) at 0 oC was added a solution of 3-buten-l-ol (3.23 mL, 37.5 mmol) in
CH2CI2 (45 mL) ropwise over 45 min. The reaction mixture was then stirred at room
temperature for 16 h before being heated at reflux for 12 h. After cooling to room
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temperature and concentrating under reduced pressure, the resultant oil was dissolved in a
1:l vol:vol ether:pentane mixture (120 mL), suction filtered and reconcentrated to afford
an oil. Fractional distillation of the crude material gave 1.06 g (I7 Vo) of 68c as a
colourless oil (bp 63 
- 
65oC, 7 mm/Hg).tH MI{II: 6 5.82 (m, 1H), 5.10 (m,lID, 3.81 (t,,f
= 6.9 Hz,2H),2.36 (dt, J = 13.5, 6.9 Hz,2H\,0.49 (s, 6FI) ppm'*
General procedure for the formation of Diphenylsilyl derivatives (66a) and (66h)
To a 0 oC stirred solution of the crude but-3-enoxydiphenylsilylchloride (68a) (2.5 mmol)
and the appropriate p-hydroxyketone (1.57 mmol) in CHrCl, (5 mL) was added Et3N (218
1tl,1.57 mmol) dropwise. The ice bath was then removed and the solution stirred at room
temparature for 2.5 h before being quenched with satd. aq. NaHCOr. The solution was
then extracted twice with EtrO and the organic extracts washed with water, brine, and
dried over MgSOo. Filtration and concentration gave a residual oil, which was purified by
flash chromatography on silica get (20:l hexanes:EtOAc) to give the diphenyl Drs-
silylether as a colourless oil. Yields are reported for the total conversion from
dichlorodiphenyl silylchloride (68a).
4-(But-3-en- 1-oxydiphenylsilyloxy)-5-methylhex-5-en-2-one (66a).
Dichlorodiphenylsilane (68a) (330 pl, 1.57 mmol) gave 66a (335 mg, 0.95 mmol) in an
overall yield of 6Ivo.IHNMR: 6 7.65 (m,4H), 7.41(m,6H),5.84 (m, 1H), 5.07 (m,2H),
4.93 (s, 1H), 4.80 (m, 2H), 3.80 (t, J = 6.9 Hz,2H),2.82 (dd,,/ = 15, 7.5 Hz,1H), 2.58
(dd, 
"/ = 15, 5.4 Hz, 1H), 2.35 (dt, J = 13.2, 6.6lfz,2H),2.10 (s, 3H), 1.73 (s, 3H) ppm.
''c NMR: 6 206.9, 145.7, r35.4, 135.3, 132.9, 130.6, 130.5, 128.0, I16.8, 112.5,73.5,
62.9, 50.5,37.1,3I.2,17.6 ppm. IR (neat): 3079,2924,2878, 1714,1087, 719 cm-'.
HRMS: Calcd. for CrrHrrOrSiNa 403.1680 (M + Na*). Found: 403.1699.
ou Unfortunately only rH l.Ilvm. spectral data is available. Due to the compounds unsuitability in the
synthetic strategy it was deemed of little value to resynthesise this derivative for characterisation purposes
only.
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4-(But-3-en-1-oxydiphenylsilyloxy)hex-5-en-2-one (66b). Dichlorodiphenylsilane (330
1tl, 1.57 mmol) produced 66b (374 mg, 1.02 mmol) in an overall yield of 657o.'H Mlm,:
6 7.65 (m, 4 H),7.4I (m, 6 H), 5.50 (m, 2 H), 5.09 (m, 4 H), 4.84 (dt, J = 12.9,6.0 Hz,
1H), 3.81 (t, J = 6.9 Hz,2H}2.79 (dd, ,/ = 15.0, 6.6 Hz, 1H), 2.61 (dd, "/ = 15.4, 5.7 Hz,
1H), 2.35, (dr, J = 13.8, 6.9 lfz,2H),2.11 (s, 3H) ppm. t'C NMR: 6 206.7, 139.5, 135.4,
135.3, 130.6, 128.1, 128.0, 116.8, 115.5,70.8,63.0,51.8,37.1,31.3 ppm. IR (neat):
307I,3003, 2874,1715, 1115, 1079,9I4,717 cm'r. Fm.MS: Calcd. for CrrH*OrSiNa:
389.L542 (M + Na*). Found: 389.1543.
General procedure for the formation of diisopropylsilylethers (66c) and (66d)
To a stirred solution of but-3-en-l-oxydiisopropylsilylchloride (68b) (1.2 mmol), the
appropriate p-hydroxyketone (1 mmol), and DMAP (0.05 mmol) in CHrCl, (5 mL) was
added Et3N (1.2 mmol) dropwise. The resulting solution was stirred at room temperature
for 18 h then quenched with satd. aq. NaHCO, and extracted twice with EtrO. The
organic extracts were washed with water, brine, dried over MgSOo, filtered and
concentrated under reduced pressure. The residual oil was purified by flash
chromatography (20: I hexanes:EtOAc) to give the requisite diisopropylsilylethers.
4-(But-3-en-1-oxydiisopropylsilyloxy)-5-methylhex-5-en-2-one (66c). P-
Hydroxyketone 24a (329 mg,2.57 mmol) gave 66c (687 mg, 86Vo) as a colourless oil. tH
NMR: 6 5.84 (m, lH), 5.04 (m, 2H), 4.81(s, 1H), 4.76 (t, J = 6.3 Hz, 1H), 3.74 (t, J = 6.9
Hz,2H),2.74 (dd,,/ = 15.0, '1.2 Hz, lH),2.57 (dd, "/ = 14.0, 5.4 Hz, lH), 2.30, (dt, "/ -
13.8,6.6 Hz,2H),2.17 (s,3H), 1.73 (s,3H), 1.02 (m, l4H) ppm.t'C NMR: 62O7.4,
146.5, 135.6, 116.6, 1ll.g, 73.0,62.9,50.9,37.5,31.7,17.6, 17.5, 12.5,12.4 ppm. IR
(neat): 2945,2867, 1716, 1085, 1060,999, 883,688 cm-r. HRMS: Calcd. for
CrTH3zO3SiNa 335.2012 (M + Na*). Found: 335.2013.
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4-(But-3-en-1-oxydiisopropylsilyloxy)hex-5-en-2-one (66d). p-Hydroxyketone 24b
(243 mg,2.13 mmol) gave 66d (521 mg,82Vo) as a colourless oil. tH NMR: 6 5.84 (m,
2H),5.20 (m, 4H), 4.78 (dt, J= 12.3,6.3lfz,lH), 3.75 (t, .f - 6.9 Hz,2H),2.74 (dd, J =
15.3,6.6 Hz, lH),2.57 (dd,J= 15.3, 6.3H2,Im,2.29 (dt,"/= 13.5,6.6 Hz,2lI),2.16 (s,
3H), 1.01 (m, l4H) ppm.t'C NMR: 6 207.2,140.3, 135.6, 116.6, 114.8, 70.2,62.8,52.2,
37 .5,31.7, I7 .6, 17 .5, 12.5, 12.4 ppm. IR (neat): 2944, 2867, I7l7 , 1087, 990, 883, 689
cm-t. FRMS: Calcd. for C,uHroOrSiNa 321.1847 (M + Na*). Found: 321.1856.
4-(But-3-en-l-oxydimethylsilyloxy)hex-5.en-2-one (66e). To a stirred solution of 3-
buteneoxydimethylsilylchloride (68c) (386 mg, 2.34 mmol) and p-hydroxyketone 24a
(243 mg, 2.l3 mmol) in CHrCl, (10.5 mL) was added Et N (386 1t"1, 2.77 mmol)
dropwise. The solution was then stirred at room temperature for 3 h before being
quenched with satd. aq. NaHCO3, eXtracted twice with EtrO, and the organic extracts
washed with water, brine, and dried over MgSOo. Filtration and concentration gave a
residual oil, which was purified by gradient flash chromatography (10:l to 5:1
hexanes:EtOAc) to give 68e (396 mg,77Vo) as a colourless oil.tH NIlm.: 6 5.85 (m,2H),
5.26 (m,4H), 4.75 (m, 1H), 3.70 (t, J = 6.9 Hz,2H),2.76 (dd, J = 15.3,7 .glfz,lH), 2.53
(dd, 
"/= 15.3, 5.1 Hz, LIJ),2.31(dt, "r= 13.9, 6.9 Hz,2H),2.I9 (s,3H),0.15 (s, 3H),0.13
(s, 3H) ppm.t'C NMR: 6 206.9, 139.7,135.1, 116.5, 114.6,69.9,62.0,51.3,36.9, 31.4, -
2.7, -2,8 ppm. IR (neat): 2962,2873, 1718, 1257, 1072, 1034,796 cm-t.
General procedure for RCM reactions
To a solution of the diene (l mmol) in CH2Clz (100 mL) was added
tricyclohexylphosphine[,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroi midazol-2-ylidene-
[benzylidine]ruthenium (IV) dichloride (62) (0.09 mmol for R2 = H, 0.12 mmol for R2 =
Me). The reaction mixture was stirred for 8-12 h at room temperature, the solvent was
removed under reduced pressure and the dark residue filtered through a short pad of silica
gel (10:l hexanes:EtOAc). The filtered solution was then stirred with activated charcoal
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(8.5 g) for 24 h. The mixture was filtered, concentrated in vacuo and purified by careful
gradient flash chromatography (50:1 to l0:1 hexanes:EtOAc) to provide the cyclic olefin
as a colourless oil.
(4R,52)-4,E-O-diphenylsilanediyl-5-methyloct-5-en-2-one (65a). Diene 66a (270 mg,
0.71 mmol) gave 65a in 54 Vo yield (135 mg). 'H NMR: 6 7.64 (m, 4H), 7.39 (m, 6H),
5.M (t,./ = 8.1 Hz, lH), 4.90 (dd, J = 9.6.3.9H7,,ltl), 4.05 (m, 2H), 2.94 (dd, J = 15.3,
9.9 Hz,lH), 2.93 (m, lH), 2.62 (dd, J = 15.3,3.6H2, LH),2.26 (m, lH), 2.25 (s, 3Ff)'
1.60 (s, 3H) ppm. t3C l.[vIR: 6 207.6, 140.8, 134.8, 133.8, 133.5, 130.5, 130.4, 128.1'
125.1,71.7, 64.4, 49.6,3I.2, 30.9, 2L5 ppm. IR (neat): 3070, 2919,2876, 1713, 1115'
1083,716,699 cm-'. HRMS: Cald for C2rH25OrSi 353.1568 (M + H.). Found: 353.1565.
(52)-4,8-O-diphenylsilanediytoct-5-en-2-one (65b). Diene 66b (80 mg, 0.22 mmol)
gave 65b in 8l vo yield (60 mg).'H NMR: 6 7.65 (m, 4H), 7.39 (m, 6H),5.73 (m, 2H),
5.13 (m, lH), 4.09 (m, 1H), 3.94 (m, lH), 2.96 (dd, ./ = 15.0, 8.1 Hz, lH), 2.64 (dd, J=
15.0, 4.5 Hz, lH), 2.63 (m, LH), 2.+2 (m, 1H), 2.22 (s,3H) ppm. '3C NIvIR: 6 2O7 .3,
r35.2,135.0, 134.8, 133.7,130.5, 130.4, L29.3, r28.2, r28.1,67.4,63.7,51.5, 31.3, 3l.l
ppm. IR (neat): 3067,3013, 2955,2926,2878,1715, 1128,1082,720,70O cm-t' HRMS:
Calcd. for CrHrrO3Si 339.1408 (M + H*). Found: 339.141 l.
(4R, 5z')-4,8-O-di-(isopropyl)silanediyl-5-methyloct-5-en-2-one (65c). Diene 66c (l l0
mg, 0.35 mmol) gave 65c in 60 Vo yield (60 mg). 'H NMR: 6 5.42 (m, I H), 4.89 (dd, "/ =
9.6,3.6 Hz, 1 H), 3.9 (m, 2H),2.82 (dd, J = 14.4,9.6H2,lH),2.72 (m, I H), 2.50 (dq J
=L4.7,3.6I1z.,1H),2.25 (s,3H),2.24(m. lIFi),1.74(s,3H), 1.00(m, 14H)ppm.t'C
NMR: 6 208.1 , 140.6, 125.0,71.O, 64.3, 49.6, 3I.6, 30.8, 21.1, 17.6, 17.5, l2-8, 12.5
ppm. IR (neat): 2943, 2866, 1715, lII2, 1036, 883, 693 cm-t. HRMS: Calcd for
Cr5HzeO3Si (M + H.) 285.1891. Found: 285.1881.
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(52\-4,8-O-di-(isopropyl)silanediyloct-5-en-2-one (65d). Diene 66d (340 mg, Ll4
mmol) gave 65d in74Vo yield (229 mg). 'H NMR: 6 5.72 (m, 2H),4.93 (m, lH), 3.91 (m,
2H),2.80 (dd,,f =14.7,8.4Hz,I[t,2.56 (m, 1H),2.54(dd,J=14.7,4.8Hz,lH),2.40
(m, lH), 2.23 (s,3H), 1.02 (m, l4FI) ppm. ''C NMR: 6 207.9,135.3, 129.4,66.9,63.8,
51.5, 31.7,31.1, 17.7,17.6, 17.5, 12.8, 12.5 ppm. IR (neat): 2944,2867,1715, lI2O,
lOlI,732 cm-t. m.MS: Calcd. for C,oHrrO3Si 271.1717 (M + H*). Found 271.1724.
(52)-4r8-O-di-methylsilanediyloct-5-en-2-one (65e). (Unoptimised). To a solution of
diene 66e (60 mg, 0.25 mmol) in CHrCl, (18 mL) was added tricyclohexylkphosphine-
[,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimi dazol-2-ylidene-[benzylidine]ruthenium
(IV) dichloride (62) (10 mg, 0.12 mmol) and the solution stirred at room temperature for
16 h. The solvent was removed under reduced pressure, and the dark brown residue
purified by gradient flash chromatography (50:l to l0:l hexanes:EtOAc) to give 65e (90
mg,42c/o). (Substrate characrerised by 'H NN{R only). tH Mr4R: 6 5.78 (m, 2H), 4.94 (m,
lH), 3.94 (m, 1H), 3.78 (m, lH), 2.81 (dd, 
"/ = 15.0, 8.4 }Jz, LH),2.56 (dd, J = 15.3, 4.5
Hz, lH), 2.20 (s,3H),0.15 (s, 3H),0.12 (s, 3H) ppm.
But-3-ene-l-oxymethoxydi-tert-butylsilane (71). To a solution of di+en-butylsilyl-Dis-
(trifluoromethanesulfonate) (500 1tL, 1.39 mmol) in DMF (5 mL) at - 40 oC was added
dropwise a solution of but-3-en-l-ol (120 1.tL, 1.39 mmol) in DMF (5 mL). The cooling
bath was removed and the reaction stirred for 2 h before being quenched with methanol
then extracted twice with EtrO. The combined organic fractions were washed three times
with satd. aq. NaHCO3, oilce with brine and dried over MgSOo. Filtration and
concentration under reduced pressure gave a residual oil which was purified by flash
chromatography (50:1 hexanes:EtOAc) to give 7t (240 mg,TlVo) as a colourless oil. tH
NMR: 6 5.88 (m, lH), 5.08 (m, 2H),3.91(r, J = 6.6 Hz,2H),3.66 (s, 3H), 2.36 (dt, J =
13.2, 6.6 Hz, 2H), 1.04 (s, lgH) ppm. t3c NN{R: 6 135.7, I16.6, 63.7, 52.3, 37.7,29.1,
21.4 ppm.
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But-3-ene-l,-oxyallyloxy-di-tert-butylsilane (72).To a solution of di-tert-butylsilyl-bis-
(trifluoromethanesulfonate) (300 1tL,0.82 mmol) in DMF (3 mL) at - 40 oC was added
dropwise a solution of but-3-en-1-ol (71 1t"L,0.82 mmol) in DMF (1.5 mL). The cooling
bath was removed and the reaction allowed to gradually warm to room temperature. After
I h, pyridine (67 1tL,0.82 mmol) then allyl alcohol (Il2 1t"L, 1.65 mmol) were added and
the reaction stirred for a further 30 min before being quenched by pyridine (67 ttL,0.82
mmol). The solution was diluted with water, extracted twice with EtrO, and the combined
organic fractions washed three times with satd. aq. NaHCO3, onc€ with brine and dried
over MgSOo before being filtered and the solvents removed under reduced pressure. The
residual oil was purified by flash chromatography (hexanes) to give 72 (I45 mg,65Vo) as
a colourless oil. tH NMR: 6 5.92 (m, 2H), 5.35 (m, lH), 5.10 (m, 3H),4.40 (dd, J =3.9,
L8 lfz,2H), 3.88 (t, J = 6.9 llz, 2H), 2.34 (d,t, J = L3.2, 6.6 Hz, 2H), 1.04 (s, l8H) ppm.
''c Mlfi,:137.6,135.8, 116.6, 113.7,64.6,63.6,37 .7,29.1,21.4 6 ppm. IR (neat): 2968,
2933,2858, 1093,913, 825 cm'r.
4-tert-Butyldimethylsiloxy-5-methyl-5-hexen-2-one (75a). To a solution of 4-hydroxyl-
5-methy-hex-5-ene-2-one (24a) (300 mg, 2.34 mmol) in DMF (2.5 mL) was added lert-
butyldimethylsilylchloride (388 mg, 2.58 mmol) and imidazole (351 mg, 5.15 mmol).
After stining at room temperature for 24 h, the solution was quenched with water and
extracted twice with EtrO. The organic extracts were washed twice with satd. aq.
NaHCOr, once with brine and dried over MgSOo before being filtered and the solvent
removed under reduced pressure. The residual oil was purified by gradient flash
chromatography (hexanes to 50:l: hexanes:EtOAc) to give 75a (4L3 mg,73Vo) as a
colourless oil. 'H NMR:6 4.95 (s, III), 4.78 (s, lFf), 4.54 (dd, J = 8.4,3.g Hz, Lm,2.74
(dd, 
"/= 14.7,8|7Hz, lH),2.39 (dd,J= 18.3,3.9Hz,lH),2.16 (s,3H), 1.69, (s,3H),
0.85 (s, 9H), 0.02 (s, 3H), 0.00, (s, 3H) ppm. "c NN{R: 6 207.9, 147.0,1I1.5, 73.7,50.6,
32.0, 26.0, 18.3, 17.46, -4.6, -5.1 ppm. IR (neat): 2930, 2857 , 1360, 1718, 1251, L074,
835,776 cm-r. HRMS: Calcd. for C,rHrrO 25i243.1774 (M + H.): Found. 243.1780.
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4-tert-Butyldimethylsiloxyhex-5-en-2-one (75b). To a solution of 4-hydroxy-5-hexen-2-
one (24b) (300 mg, 2.63 mmol) in DMF (2 mL) was added tert-butyldimethylsilyl-
chloride (436 mg, 2.89 mmol) and imidazole (394 mg, 5.78 mmol). After stirring at room
temperature for 24 h, the solution was quenched with satd. aq. NH4CI and extracted twice
with Et2O. The organic extracts were washed with brine, dried over MgSOr, filtered and
the solvents removed under reduced pressure. The residual oil was purified by flash
chromatography (50:l hexanes:EtOAc) to give 75b (446 mg,74Va) as a colourless oil. tH
NMR: 6 5.78 (dd,,f = 12.0,6.0 Hz, lH), 5.15 (m, lH), 5.01 (m, lH),4.55 (m, 1H),2.43
(dd,.I= 15.0,9.0Hz.,1H),2.43 (dd,J= 15.0,3.0Hz,1H), 1.90(s,3H),0.83 (s,9H),-0.2
(s, 6H) ppm. t'C NMR: 620i.4,140.6, I14.5, 70.7, sL.9,i2.0,26.0, !8.3, -4.2, -4.9 ppm.
IR (near): 2956,2930,2858, 1718, 1078 ,834,776 cm't . HRMS: Calcd. for C,rHrrOrSiNa
229.1624 (M + Na*). Found: 229.1618.
4-tert-Butyldiphenylsiloxy-5-methylhex-5-en-2-one (75c), To a solution of 4-hydroxy-
5-methylhex-5-en-2-one (24a) (437 mg,3.4 mmol) in DMF (4.5 mL) was added tert-
butyldiphenylsilylchloride (976 1tL,3.75 mmol) and imidazole (464 mg, 6.82 mmol).
After stirring at room temperature for 36 h, the solution was quenched with water and
extracted twice with EtzO. The organic extracts were then washed twice with satd. aq.
NaHCO3, once with brine and dried over MgSOo before being filtered and the solvent
removed under reduced pressure. The residual oil was purified by gradient flash
chromatography (hexanes to 50:l: hexanes:EtOAc) to give 75c (920 mg,'759o) as a
colourless oil. tH NMR: E 7.65 (m, 4H), 7.3g (m, 6H),4.79 (s, lH), 4.72 (s,lH), 4.59 (t,
J = 6 Hz, 1H), 2.61 (dd, J = I4.7,6.0 Hz,lH),2.52 (dd, ,/ = 14.7,6.6 Hz, 1H), 2.10 (s,
3H), 1.68 (s, 3II), 1.06 (s, gH) ppm. t'C MUR: 6 206.9, 145.9, 136.2,134.1,133.7,130.0,
128.0,127.8,I27.7,112.6,74.1,50.8, 31.1,27.2,19.6, L7.4 ppm. IR (neat): 3072,2931,
2857, 1713, 1427, 1360, 1162, 1106, 1063, 739,700 cm-'. HRMS: Calcd. for
CzrH3'OzSiNa 389.1922 (M + Na*). Found: 389.1907.
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4-O-Methoxymethylory)-5-methylhex-5-en-2-one (75d). To a solution of 4-hydroxy-5-
methylhex-5-ene-2-one (?Aa\ (1.0g, 7.80 mmol), in N,.tV-diisopropylethylamine (2.72 mL)
at 0 oC was added methoxymethylchloride (593 1t"L,7.80 mmol) dropwise. The reaction
was stirred for 3 h, gradually warming to room temperature, before being quenched with
water and extracted twice with EtrO. The organic extracts were washed with satd. aq.
NaHCO3, brine, dried over MgSOo, filtrated and concentrated under reduced pressure. The
residual oil was purified by flash chromatography (5:l hexanes:EtOAc) to give 75d (430
mg,32Vo, unoptimised) as a colourless oil. 'H NMR: 6 5.01 (s, lH), 4.94 (t, J = O.6Hz,
lH), 4.60 (d, J - 6.6}Jz,lH), 4.53 (dd, 
"/ = 9.3, 3,9 Hz,lH), 4.48 (d, J - 6.6 Hz, 1H),
3.34 (s, 3H),232 (dd, 
"/ = 15.6, 9.3 Hz, IH), ?.46 (dd, J = 15.9, 3.9 IIz, lH),2.20 (s, 3H),
1.68 (s,3H) ppm. r3C NNm.:6 206.g, 1,43.2,114.7,94.0,76.0,56.0,49.2,31,2,17.3ppm.
IR (neat): 2947,2824,1715, 1096,1026, 914 cm-r.
4-O-(Methoxymethyloxy)hex-5-en-2-one (75e). To a solution of 4-hydroxy-5-hexene-2-
one (24b) (350 mg, 3.07 mmol), in N,N-diisopropylethylamine (1.06 mL,6.13 mmol) at
0 oC was added methoxymethylchlori de (221 1tL,2.9I mmol) dropwise. The reaction was
stirred for 3 h, gradually warming to room temperature, before being quenched with water
and extracted twice with EtrO. The organic extracts were washed with satd. aq. NaHCO3,
brine, dried over MgSOu, filtrated and concentrated under reduced pressure. The residual
oil was purified by flash chromatography (5: I hexanes:EtOAc) to give 75e (221mg,48 c/o)
as a colourless oil. 'H NMR: 6 5.71 (dd, J = 10.5, 7.8H:-, lH),5.22 (m, 2H), 4.67 (d, J =
6.9 Hz, lm, 4.52 (d, ./ = 6.9 Hz, lH), 3.34 (s, 3H), 2.80 (dd, J = 15.9, 8.7 lfz, 1H), 2.53
(dd, J= 15.6,4.8 lH),2.19 (s,3H) ppm.'3C NMR:6 206.3, 136.9, 117.9,94.1,73.4,
55.6, 49.2, 3 1. 1 ppm. IR (neat): 2935, 2894, 17 16, 1027, 9 19 cm-r.
-161-
Representative procedure for aldol reactions
To a solution of diisopropylamine or tetramethylpiperidine (1.05 mmol) in dry Tfm (3
mL) cooled to 
-78 oC was added butyllithium (1.00 mmol, 1.6 M solution in hexanes)
dropwise. After stirring at 
-78 oC for l0 min, a solution of the ketone (1.00 mmol) in
TItr (3 mL) was added dropwise. Stirring was continued for 50 min before a solution of
pivaldehyde (I.20 mmol) in TFIF (2 mL) was added. The resultant solution was then
stirred at 
-78 oC for a further 15 minutes, before being quenched by the addition of satd.
aq. NHoCl. The resultant mixture was then extracted twice with EtrO and the organic
extracts washed with brine, dried over MgSOo and the solvent removed under reduced
pressure, The residual product was purified by flash chromatography to give the
corresponding aldol adducts as colourless oils.
7-tert-Batyldimethylsiloxy-3-hydroxy-2,2r8-trimethylnon-8-ene-5-one (78a). Ketone
75a (755 mg, 3.11 mmol) gave 78a (664 mg,65Vo) as a colourless oil after purification
by gradient flash chromatography (50:l to I0:1 hexanes:EtOAc). Spectral data reported
for one diastereomer, separated by flash chromatography. 
'H NMR: 6 4.99 (s, lH), 4.82
(s, lH), 4.56 (dd, J = 8.7,3.9 IJz,lH), 3.71 (ddd, 
"/ = L0.2, 4.8,2.7 Hz, 1H), 3.06 (d, J =
2.7 FJz, IFI), 2.80 (dd, 
"I = 14.'7 , 8.7 Hz, lH), 2.lO (dd, "/ = 17 .4, 1.8 Hz, 1H), 2.50 (dd, J =
17.7, I0.2 Hz, lH), 2.46 (dd, J = 14.4,3.6 Hz, lH), 1.73 (s, 3H), 0.92 (s, 9tI), 0.89 (s,
9H), 0.06 (s, 3H), 0.03 (s, 3Ff) ppm.tsc MvIR: 6 211.5, 146.9, 111.7,74.6,73.7,50.5,
46.7,34.2,26.0,25.9, 18.3, 17.6, -4.6, -5.0 ppm. IR (neat): 3507,2955,2858, 1709,
I074,835,776 cm-'.
7-tert-Butyldimethylsiloxy-3-hydroxy-2,2-dimethylnon-8-ene-5-one (78b). Ketone
75b (410 mg, 1.78 mmol) gave 78b (320 mg, 68Vo) as a colourless oil after purification
by gradient flash chromatography (50:l to l0:1 hexanes:EtoAc). Spectral data is reported
for the racemic product. tH NMR: 6 5.g4 (ddd, ,r = 10.5, 6.0, 1.2 Hz,2H), 5.24 (d,, J =
17 .l Hz,2H), 5.09 (d, ,f = 10.5 Hz, ZH), 4.63 (m, 2H), 3.72 (m, 2H),2.79 - 2.45 (m, 8H),
-t62-
0.92 (s, 18H), 0.90 (s, 9H), 0.88 (s, 9H), 0.06 (s, 6H), 0.05 (s, 6H) ppm. "C NMR: 6
211.5,140.5, 114.8,74.9,74.6,70.9,70.9,52.0,5r.9,46.7,46.4,26.L,34.1,25.9,18.4,-
4.2, -4.8 ppm. IR (neat): 3500, 2956,2858, 1707, 1076, 835, 776 cm't.
7-tert-Butyldiphenylsiloxy-3-hydlrory-2,2,8-trimethylnon-8-ene-5-one (78c). Ketone
75c (755 mg, 3.1I mmol) gave 78c (681 mg, 67Vo) as a colourless oil after purification by
gradient flash chromatography (50:l to l0:l hexanes:EtOAc). Spectral data reported for
rhe racemic producr.'H NMR: 6 4.99 (s, 1H),4.82 (s, 1H), 4.56 (dd, ,r = 8.7,3.9 Hz, lH),
3.71 (m, lH), 3.05 (d, ./ = 2.1 Hz, LH),2.84 - 2.43 (m, 4H), 1.73 (s, 3H), 0.92 (s, 9H),
0.89 (s,9H),0.06 (s,3H),0.03 (s,3H) ppm. "C Mlfi.: 6 211.8,211.5, 146.8, 111.7,75.0,
74.6, 73.7,73.6, 50.5, 46.7, 46.5, 34.3, 34.2, 26.0, 25.9, 19.7, 17.6, -4.6, -5.1 ppm. IR
(neat): 3507,2955,2858, 1709, 1072, 835, 776 cm't.
7-O-(Methoxymethyloxy)-3-hydroxy-2,2r8-trimethylnon-8-ene-5-one (78d). Ketone
75d (390 mg,2.26 mmol) gave 78d (325 mg, 56Vo) as a colourless oil after purification
by gradient flash chromatography(5:l to 3:1 hexanes:EtOAc) on a silica gel column
neutralised with 0.017o EtrN in 5:l hexane:EtOAc. Spectral data reported for the racemic
product. 'H NIIG.: 6 5.05 (s, lH), 4.gg (s,lH), 4.62 (d, ,r - 6.6 Hz,1H), 4.60 (m, 1H),
4.50 (d, J =6.6 Hz, 1H), 3.76 (m,lH), 3.36 (d, J= 2.4Hz,lfD, 2.89 (m, lH), 2.74-2.46
(m,3H), 1.71 (s,3H),0.93 (s, gH) pp-.'rC NMR: 6206.2,114.g,94.0,76.0,75.9,75.1,
74.8, 56.1, 48.1, 48.0, 45.8, 32.4,25.9,17.4 ppm. (The compound decomposed before
further spectral data could be obtained).
3-Benzyloxy-7-tert-butyldimethylsiloxy-2,2,8-trimethylnon-8-ene-5'one (80b). To a
solution of aldol adduct 78b (662m9,2.0 mmol) in cyclohexane (20 mL) cooled to 0 oC
was added benzyltrichloroacetimidate (79) (385 pl, 2.L2 mmol) followed by freshly
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distilled trifluoromethanesulfonic acid (8.8 pl, 0.10 mmol) dropwise. A cream precipitate
was immediately observed. The resulting mixture was stirred at room temperature for 30
min before being quenched with water then extracted twice with hexanes. The organic
extracts were washed with satd. aq. NaHCOr, brine, dried over MgSO*, filtered and
concentrated under reduced pressure. Purification of the crude material by gradient flash
chromatography (hexanes to 50:1; hexanes:EtOAc) gave 80b (601 mg, 72Vo) as a
colourless oil. Spectral data reported for the racemic product. 'H NIUR: 6 7.33 (m, 5H),
4.97 (s, lH), 439 (s, 1H), 4.55 (m, 3H),3.76 (m, lH), 2.84 - 2.37 (m, 4H), 1.74 (s, 3lf),
0.95 (s, 9H), 0.87 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H) ppm.''C NMR: 6 208.9, 208.6,
L47.r,147.0, L39.4,139.3, 128.5, 128.L, 127.7,127.5, r27.2,111.6, 111.5,82.9,82.8,
74.4,74.0,73.4,73,1, 51.0, 47.1,46.3,35.9,35.8, 26.4,26.3,26.0, 17.6,17-5, -4.6, -5.0
ppm. IR (neat): 2955,2859,1717,1073, 835 cm-'.
3-Benzyloxy-7-tert-butyldiphenylsiloxy-2,2,8-trimethylnon-8-ene-5-one (80c)' To a
solution of aldol adduct 78c (172 mg, 0.48 mmol) in cyclohexane (5 mL) cooled to 0 oC
was added benzyltrichloroacetimidate (92 pl, 0.51 mmol) followed by freshly distilled
trifluoromethanesulfonic acid (5 pl, 0.06 mmol) dropwise. A cream precipitate was
immediately observed and the resulting mixture was stirred at room temperature for 30
min before being quenched with water. The solution was then extracted with hexanes and
the organic extracts washed with satd. aq. NaHCO3, brine, dried over MgSOo, filtered and
concentrated under reduced pressure. Purification of the crude material by gradient flash
chromatography (hexanes to 50:1; hexanes:EtOAc) gave EOc (143 mg' 7l To) as a
colourless oil. Spectral data is reported for the racemic product. tH NIvR.: 6 7.69 (m, 4H),
7.34(m,1lH),4,80(m, lH),4.74(m, 1H),4.62(m,lH),4.46(m,2H),3.62(dd'J=7.8,
3.9 Hz, lH),2.71 
- 
2.25 (m, 4H), l.7l (s, 3H), 1.08 (s, 9H), 0.89 (s, 3H), 0.88 (s, 3FI)
ppm.''c NMR: 6 208.0, 207.8,145.8, r45.6, 139.4,136.3, 136.2,134.1, 133.6, 130.0,
r29.9, 128.4, 127.9, r27.8, 127.7, r27.5, 1L2.7,82.8,82.6,74.1,74.O,73.9, 51.1, 50.9,
46.0, 45.8, 35.8, 27.2, 26.4, 26.3, 19.6, 17.5, 17.4 ppm. IR (neat): 3070, 2956,2859,
17t4,1106, 1067, 736, 700cm-'.
-r&-
4-(But-3-en-1-oxydiisopropylsilyloxy)-7-hydroxy-8,8-dimethyl-non-E-ene-5-one (82).
To a solution tetramethylpiperidine (60 1.tL,0.36 mmol) in dry TIIF (1.5 mL) cooled to
:78 
"C was added n-Buli (222 1tL,0.36 mmol, 1.6 M solution in hexanes). After stirring
at 
-78 oC for 10 min a solution of the ketone 66d (106 mg, 0.36 mmol) in TIIF (2 mL)
was added dropwise. Stirring was continued for 90 min before pivaldehyde (58 pL, 0.53
mmol) was added dropwise, and the solution was stirred at-78 oC for a further 30 min
before being quenched with water. The solution was then extracted twice with EtrO and
the organic extracts washed with brine, dried over MgSOo and the solvent removed under
reduced pressure. The residual oil was purified by gradient flash chromatography (50:1 to
l0:l hexanes:EtOAc) to give 82 (80 mg, 59Vo) as a colourless oil. Spectral data reported
for the racemic product. 'H NMR: 6 5.S4 (m, 2H), 5.12 (m, 4H), 4.83 (m, lH), 3.78 (t, J
=6.6H2,2H),2.93 (d,"/=3H2, lH),2.78-2.52(m,4H}2.33 (dt,,/= 13.5,6.6H2,2H),
1.04 (s, 6H), 1.03 (s, 6H), 1.00 (m, 2H),0.92 (s, 9H) ppm."C NMR: 6 210.8, 139.9,
135.3, 116.5, ll4.g, rr4.7,74.6,70.0,69.9,62.6,52.0,51.9,46.0,45.9,37.2,34.1,34.0,
25.6, 17.4, 17 .3, 17.1, 17.0, 12.2 ppm. IR (neat): 3500, 2946,2868, 1707, 1092, 1094,
885.69lcm-r.
(82)-7,11-O-diisopropylsilanediyl-3-hydroxy 
-2,2-dimethyl-undec-8-ene-5-one (81d).
Strategy A. To a solution of diene S2d (60 mg, 0.16 mmol) in CHrCl, (10 mL) was
added tricyclohexylphosphine[,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-
ylidene-[benzylidine]ruthenium (IV) dichloride (62) (13 mg, 0.016 mmol) and the
reaction stirred for 8 h at room temperature. The solvent was then removed under reduced
pressure and the resultant brown oil purified rigorously three times by flash
chromatography (10:1 hexanes:EtOAc) to give 81d (43 mg,77Vo) as a colourless oil.
Spectral data is reported for the racemic product.'H Mlm.: 6 5.71 (m, 2H),4.93 (m, lH),
3.88(m,2H)3.71(m, lH),3.05(d, J=3.3H2, lH),3.00(d,J=3.0H2, 1H),2.87-2.32
(m,6H), 1.00 (m, l4H),0.91 (s,3H) ppm.r3c Nil\4R:6 211.9, 211.7,135.1, 135.0, t29.5,
129.4,75.L,74.7,67.1,67.0,63.7,51.3,5r.2,46.5,46.2,34.3,31.1,25.0, 17.7,17.6,
17.5,I2.7,12.5 ppm. IR (neat): 3502,2945,2869,L706,1112,1064,1004,695 cm-r.
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(82)-7,1!-O-diisopropylsilanediyl.3-hydroxy-2,2-dimethyl-undec-8-ene'5'one (Eld).
Strategy B. To a solution of tetramethylpiperidine (143 pL, 0.85 mmol) in dry TIiF (3
mL) cooled to 
-78"C was added n-Buli (529 1tL,0.86 mmol, 1.6M solution in hexanes).
After stirring at 
-78 oC for l0 min a solution of bis-silyl ether 65d (229 mg,0.86 mmol)
in THF (3 mL) was added dropwise. Stirring was continued for 45 min before
pivaldehyde (110 1tL,l.O2 mmol) was added dropwise and the resultant solution stirred
for a further 15 min before being quenched by the addition of water. The solution was
then extracted twice with Et O and the organic extracts washed with brine, dried over
MgSOo and the solvent removed under reduced pressure. The residual product was
purified by flash chromatography (10:1 hexanes:EtOAc) to give Eld (90 mg,30Vo,
unoptimised) as a colourless oil. Spectral data matched that reported above.
-r66-
9.6: Experimental for Chapter 6:
(R)-4-Hydroxy-5-methyl-5-hexen-2-one (24).r-proline (438 mg, 3.76 mmol) was
added to a solution of DMSO:acetone (a:l) (125 mL) and the resulting suspension stirred
for 15 min at room temperature. Freshly distilled methacrolein (1.04 mL, L2.5 mmol) was
then added. After being stirred at room temperature overnight, the resulting yellow
solution was quenched with satd. aq. NH4CI, extracted twice with EtrO and the organic
extracts washed with brine, dried over MgSOo and filtered. The solvent was removed
under reduced pressure and the residual oil purified by flash chromatography on a silica
gel column neutralised with 0.017o EtrN (3:l hexanes:EtOAc) to give 24 (6ll mg, 387o)
which was used immediately.to3 The enantiomeric excess of this reaction was determined
by silylation followed by chiral GC analysis, as detailed below.
(R)-4-tert-Butyldimethylsilyl-5-methyl-hex-5-en-2-one. To a solution of the p-hydroxy
ketone 24 (200 mg, 1.56 mmol) in DMF (3 mL) was added tert-butyldimethylsilyl-
chloride (259 mg,1.72 mmol) and imidazole (212m9,3.I2 mmol). After stirring at room
temperature for 24 h, the solution was quenched with water, extracted twice with Et2O,
and the organic extracts washed with brine, dried over MgSOo, filtered and the solvents
removed under reduced pressure. The residual oil was purified by flash chromatography
(50:l hexanes: EtOAc) to give (R)-4+ertbutyldimethylsilyl-5-methyl-hex-5-en-2-one
(202 mg;74Vo ee determined using a 60 m x 0.25 mm Cyclodex-Bro column and the
following conditions: Inlet: Split 275"C; Detector: FID 320'C; Carrier gas: hydrogen;
Flow: 35.8 cm3s-r; Temperature programme: Isothermal at 75oC. tH MUR:6 4.95 (s, lH),
4.?8 (s, lH), 4.54 (dd, ./ = 8.4, 3.9 Hz, lH),2.74 (dd, ,r = 14.7 ,8.7 Hz, lH),2.39 (dd' "I -
18.3, 3.9, Hz, lH), 2.16 (s, 3H), 1.69, (s, 3H), 0.85 (s, 9H),0.02 (s, 3H), 0.00, (s, 3H)
ppm. t'c NMR: 6 207.8, 147.0,111.5, 73.7,50.6,32.0,26.0,18.3,17.46, -4.6, -5.1 ppm.
lR (neat): 2930,2857,1360, 1718, 125L, 1074,835,776 cm'. HRMS: Calcd for
Cr3H27O2Si 243.1774 (M + H.). Found. 243.1780.
-167-
Representative procedure for aldol reactions
To a stirred solution of CyrOBTf or (-)-IpcrBCl (1.5 mmol) in 4 mL of anhydrous EtrO
^t -78 
oC or 0 oC respectively, was slowly added Et3N (1.7 mmol). A solution of the
ketone (l mmol) in Et O (4 mL) was then added via cannula. The reaction mixture was
stirred for 30 minutes, before being cooled to 
-78 'C (if necessary) at which point
pivaldehyde (2 mmol) was added slowly dropwise. The solution was stirred at 
-78 oC for
2 h then for l0 h at 
-20 oC before being quenched 
^t -20 
oC by the addition of pH 7
buffer solution, methanol and hydrogen peroxide (30Vo solution). The solution was then
stirred at room temperature for 3 h before being extracted twice with EtrO. The organic
extracts were washed with water, brine, dried over MgS0o, filtered and concentrated
under reduced pressure. Purification of the crude material by gradient flash
chromatography (50:l to 10:l hexanes:EtOAc) gave the aldol adducts as colourless oils.
3-(3-Butenoxydiisopropylsilyloxy)-7-hydroxy-2,E,8-trimethyl-non-1.-ene-S-one
(90a/91a). (Entry l, table 4): Reaction of 66a (50 mg, 0.16 mmol) with (-)-IpcrBCl gave
90a/91a in 937o (59 mg), d,s = 2.2;1. Spectral data is reported for the combined
diastereomers. tH NMR: 6 5.86 (m, I H), 5.06 (m, 2H), 5.00 (s, lH),4.84 (s, lH),4.78 (t,
J = 6.3 Hz, lH), 3.74 (m,2}{),2.79 - 2.44 (m, 4H), 2.31 (dt, J = 1,3.5,6.9 Hz,2H), 1.75
(s,3H), 1.03 (m, 14r0,0.92 (s, gH) ppm. 
'3c NNm: 6 211 .2,211.1,146.4,135.5, 116.6,
1L2.0, 1l1.9, 74.9, 74.9, 72.9, 62.9,50.9, 50.7, 46.2, 46.1, 37 .5, 34.3, 26.O, 25.9, 17 .6,
17.5, 17.3,12.5,12.4 ppm. IR (neat): 3530, 2948,2868, 1709,1101,909 cm-'. HRMS:
Calcd. for CrrHorOoSiNa 421.2734 (M + Na*). Found: 421.2744.
3-(3-Butenoxydiisopropylsilyloxy)-7-hydroxy-2,8,8-trimethyl-non-L.ene-S-one
(90a/91a). (Entry 2, table 4). Reaction of (66a) (50 mg, 0.16 mmol) with CyrBOTf gave
90al9lain977o (61 mg), ds = 1.2:1.
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3-(3-Butenoxydiphenylsilyloxy)-7-hydroxy-8,E-dimethylnon-1-ene-5-one (90b/91b).
@ntry 3, table 4). Reaction of 66b (62mg,0.17 mmol) with (-)-IpcrBCl gave 90b/91b in
98Vo (75 mg), ds = 2:1. Spectral data is reported for the combined diastereomers. tH
NMR: 6 7.65 (m, 2H), 7.43 (m,3H), 5.89 (m, 2H), 5.25 (m, 4H),4.84 (dd,I = 12.0,6.0
Hz, lH), 3.81 (t, J = 12 Hz, 1H), 3.69 (m, lH),2.9 - 2.4 (m,4H),2.35 (dt, J = 15.0, 6.9
Hz,2H),0.88 (s, 9H) ppm. r3C NMR: 6 210.6, 210.5, 139.3, 135.3, 135.2, 132.8, 132.7,
I30.7, 130.6, 128.1, 128.0, 116.9, I15.6, 75.O, 70.7,63.0, 51.8, 51.6, 45.9, 45.7, 37.I,
34.4, 34.3,25.9. IR (neat): 3517, 3073, 2954, 2875, 1707 , 1125, I I 15, 1086, 74L, 720,
698 cm-t. HRMS: Calcd for CrrHruOoSiNa 475.2267 (M + Na*). Found: 475.2275.
4-(3-Butenoxydiisopropylsilyloxy)-7-hydroxy-8,8-dimethyl-non-8-ene-5-one
(92a193a). (Entry 4, table 4). Reaction of 65a (71 mg, 0.26 mmol) with CyrBOTf gave
l92al93ain85Vo (79 mg), ds = 2:1. Spectral data reported for the racemic product. rH
NMR: 6 5.84 (m, 2H), 5.12 (m, 4H), 4.83 (m, lH), 3.78 (t, J = 6.6H2,2H),2.93 (d, J =
3Hz, lfl), 2.78 
-2.52 (m,4H),2.33 (dt, J = 13.5, 6.6 Hz,2H),1.04 (s, 6H), 1.03 (s, 6H),
1.00 (m, 2H),0.92 (s, gH) ppm.t,C NMR:6 210.g, L39.9,135.3, 116.5, 114.g, !14.7,
74.6,70.0,69.9,62.6,52.0,51.9,46.0, 45.9,37.2,34.1,34.0,25.6,L7.4,17.3,17.L,r7.0,
12.2 ppm.IR (neat): 3500, 2946,2868, 1707, 1092, 1094,885, 69lcm-'.
(3RS,7R'82)-7,11-O-diisopropylsilanediyl-3-hydroxy-2,2,8-trimethyl-undec-8-ene-5-
one (92b193b). (Entry 5, table 4) Reaction of 65b (106 mg, 0.37 mmol) with (-)-IpcrBCl
gave 92bl93b in 887o (120 mg), ds = 1.5:1. Spectral data reported for one diastereomer,
separated by flash chromatography. tH MvIR: 6 5.43 (t, J - 8.7 Hz,lH), 4.89 (dd, J = 9.6,
3.3, Hz, 1H), 3.85 (m, 2H), 3.00 
- 
2.48 (m, 5H),2.22 (m, lH), 1.75 (s, 3H), 1.02 (m,
l4H), 0.93 (s, 9H) ppm. r3C NMR: 6 211.9, 140.5, 125.0,74.7,7L.2,64.3,49.5,46.4,
34.3, 30.8, 25.9,2L.2, l'l;7,17.6,I7.5,17.4, 12.8,12.5 ppm. IR (neat): 3479,2954,2868,
1709,1114, 1006,940,733,696 cm'r. Ifi.MS: CalcdforCroHrrO4Si 371.2602 (M + H*).
Found:371.2612.
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QRS,7R,8Z\-7rll-O-diisopropylsilanediyl-3-hydroxy-2,2,8-trimethylundec-8-ene-5-
one (92b193b). (Entry 6, table 4) Reaction of 65b (30 mg, 0.11 mmol) with CyrBOTf
gave 92bl93b in 95Vo (37 mg), ds = L2:l. Spectral data matched that reported above.
(3R,7R,82)-7,1l-O-diphenylsilanediyl-3-hydroxy-2r2,8-trimethylundec-8-ene-5-one
(92c). (Entry 7, table 4) Reaction of 65c (100 mg, 0.28 mmol) with (-)-IpcPCl gave 92c
in 94Vo (l 15 mg), ds = 99>1. 'H Nlv{R: 6 7.61 (m, 4H), 7.38 (m, 6H), 5.44 (t, J - 9.6IIz,
lH), 4.90 (dd, .I = 9.6,3.3 Hz, lH), 4.06 (m, 2H), 3.76 (dd, J = 10.5, 1.8 Hz, LH),2.99
(dd, J =14.9,9.8 Hz, lH), 2.91 (m, lH), 2,76 (dd, J = L7.8, 1.8 Hz, lH),2.62 (dd, J =
L4.7,3.6 Hz, lH),2.58 (dd, J = 17.7, LQ.zHz,IH),2.28 (m, lH), 1.61 (s,3H),0.89 (s,
9H) ppm. "c NMR: 6 211.5, 140.7,134.8, 134.7,133.6,133.3, 130.5, 130.4, L28.1,74.8,
71.9, 64.3, 49.5, 46.I,34.3,30.9,25.9,21.5 ppm. IR (neat): 3480, 3070,2955,2873,
2247, L7O6, ll16, 1073, 909,730,716, 699 cm-'. HRMS: Calcd for CruHrnOoSiNa
461.2120 (M + Na.). Found: 461.2119.
(3Rr7R,8Z)-7,11-O-diphenylsilanediyl-3-hydroxy-2,2,8-trimethylundec-8-ene-5-one
(92c). (Entry 8, table 4). (Unoptimised). Reaction of 65c (127 mg,0.36 mmol) with
CyrBOTf gave 92c in 68Vo (108 mg), ds = 99>1. Spectral data matched that reported
above.
(3R,,7R,82)-7,I1-O-diphenylsilanediyl-3-hydroxy-2,2-dimethylundec-8ene-5-one
(92d). (Entry 9, table 4). (Unoptimised). Reaction of 92d ( I 14 mg, 0.34 mmol) with (-)-
IpcrBCl gave 19d in 60Vo (86 mg), ds = 99>1. 'H NMR: 6 7.64 (m, 4H), 7.40 (m, 6H),
5.74 (m,2H),5.14 (m, 1H), 4.09 (m, lH), 3.94 (m, lH), 3.74 (d, J = 10.2, Hz, lH), 3.03 -
2.39 (m,6H), 0.88 (s, 9H) ppm. ''C NMR: 6 211.2,135.0, 134J,133.5, 133,4,130.6,
130.4, 1.29.4, 128.2,128.1, 74.8,67.6,63.7, 51.3,46.1,34.3,31.0,25.9 ppm. IR (neat):
3509, 3019, 2959,2873, 1709, L125, 1070, 723 cm't. HRMS: Calcd. for CrrHrrOoSiNa
M7.l96L (M + Na*). Found: 447.1962.
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9.7. Experimental for chapter 7z
Representative procedure for the synthesis of the tert-butyldiphenylsiloxy ketones
To a solution of the p-hydroxyketone (l mmol) in DMF (1.5 mL) was added len-
butyldiphenylsilylchloride (1.1 mmol) and imidazole (2 mmol). After stirring at room
temperature for 24 h the solution was quenched with water then extracted twice with
EtrO. The organic extracts were washed with brine, dried over MgSOo, filtered and the
solvents removed under reduced pressure. The residual oil was purified by flash
chromatography, (50:l hexanes:EtOAc) to give the silylated adducts as colourless oils.
(4R)-4-tert-Butyldiphenylsiloxy-5-methylhexan-2-one (95a). 4-hydroxy-5-methyl-
hexane-2-one (94a) (646 mg, 5.0 mmol) gave 95a (L.32 g,72Vo yield). 'H Mv[R: 6 7.70
(m, 4H), 7 .42 (m,6H), 4.18 (m,1H), 2.56 (dd, J = 15.9, 6.6 Hz, L}l), 2.42 (d4 J = 15.9,
5.4H2,1H), 1.88 (s, 3H), 1]2 (m,lH), 1.06 (s, 9H), 0.94 (d, J = 6.6 Hz)' 0.81 (d, J = 6.9
Hz) ppm. '3c NNm.: 6207.6,136.3, 1362,134.5,134.3,129.9,127.8, r27.7,73.9,47.8,
33.7, 30.8, 27 .3, 19.8, 18.0, 17.5 ppm. IR (neat): 3072, 2960, 2932, 2857, 1715, 1660,
lll0, 1068, 74O,703cm't. HRMS: Calcd for CrrHrrOzsi 369.2305 (M + H.). Found:
369.224s.
(R)-4-tert-Butyldiphenylsitoxy-5-methylhex-5-en-2-one (95c). 4-hydroxy-5-methylhex-
5-ene-2-one (94c) (546 mg, 4.2 mmol) gave l. 15 g (757o) of 95c. 'H NIv{R: 6 7.65 (m,
4H), 7.38 (m, 6H), 4.78 (s, lH), 4.72 (s, 1H), 4.59 (t, J = 6 Hz, lH), 2.61 (dd, ./ = 14.7 ,
6.0 Hz,lH) , 2.52 (dd, .f = 14.7 , 6.6 Hz, lH), 2.10 (s, 3H), 1.68 (s, 3H), 1.06 (s, 9H) ppm.
t3c NIvIR: 6 206.8, 145.8, 136.2, 134.1, 133.7 , 130.0, 128.0, 127.8, r27.7, 112.6,74.r,
50.8, 31.1, 27.2, L9.6,17.4 ppm. IR (neat): 3072,2931,2857, 1713, 1427, 1360, 1162'
1106, 1063 ,739,700 cm-r. FIRMS: Calcd. for CrrHroOrSiNa 389.1922 (M + Na*). Found:
389.1907.
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Representative procedure for aldol reactions
All aldol reactions reported in this section were conducted in the following manner: To a
stirred solution of CyrBCl (1.5 mmol) in anhydrous EtrO (4 mL) at 0 oC was slowly
added Et3N (1.7 mmol). A solution of the ketone (l mmol) in EtrO (2 mL) was then
added via cannula. The reaction mixture was stirred at 0 "C for 30 min before being
cooled to 
-78 oC at which point the aldehyde (1.5 mmol) was slowly added dropwise.
The solution was then stirred at 
-78 "C for 5-6 h, before being quenched at -78 'C by the
addition of pH 7 buffer solution, methanol and hydrogen peroxide (3O7o solution). The
solution was stirred at room temperature for 2.5 h then extracted twice with Et2O. The
organic extracts were washed with water, brine, dried over MgSO., filtered and
concentrated under reduced pressure. Purification of the crude material by gradient flash
chromatography (50:1 to l0:l hexanes:EtOAc) gave the aldol adducts as colourless oils.
(3RS,7R)-7-tert-Butyldiphenylsiloxy-3-hydroxy-2r2,S.trimethylnonan-S-one (96a).
The aldol reaction of 95a (201 mg, 0.52 mmol) with pivaldehyde gave 96a (201 mg,88Vo
yield), ds = 2:1. Spectral data reported for one diastereomer, separated by flash
chromatography. 'H l.[l4R: 67.74 (dd, "/ =7.2,1.2112,2H),7.68 (dd, J ='l.5,l.2lfz,2H),
7.42 (m, 6H), 4.20 (m, lH), 3.52 (dd, J = 9.0,2.L Hz, lH), 2.61 (dd, "/ = 16.2, 6.6 Hz,
IH),2.43 (dd,"/=16.2,4.8H2,1H),2.28 (m,2H), 1.73(m, lH), 1,06(s,9H),0.95(d,"/
= 6.3HL3H), 0.86 (bs, 6H), 0.81 (d, J = 6.6 Hz) ppm. r3C NN{R: 5 211.3, 136.3, 136.2,
L34.6, 134.1, l2g.g, 127.9,74.7,73.6, 47.7, 45.2,34.2,33.7,27.3,25.9, 19.7, 17.9, 17.6
ppm. IR (neat): 3502,3072,2957,2858, 1709, 1110, 1057, 823,702cm-'. FIR.MS: Calcd
for Cr*HorOrSiNa 477.2854 (M + Na*). Found: 477.2796.
(3RS'7R)-7-tert-Butyldiphenylsiloxy-3-hydroxy-2,8-dimethylnonan-5-one (96b), The
aldol reaction of 95a (l 19 mg, 0.32 mmol) and isobutylaldehyde gave 96b (125 mg,86Vo
yield), ds = 2.5:1. Spectral data reported for one diastereomer (separated by flash
chromatography). 
'H l.l-lt4R: 6 7.69 (dd, ,r = 7.8, L.5 Hz,2H),7.63 (dd, J = 7.8,1.5 Hz,
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2H),7.37 (m, 6H), 4.16 (m, 1H), 3.55 (dt, 
"/ = 11,7, 6.0 Hz, lH),239 (bs, lH), 2.55 -
2.24 (m,4H), 1.68 (m, lH), 1.54 (m, 1H), 1.02 (s, 9H), 0.90 (d, J = 6.9 Hz, 3H), 0.84 (d,
J = 6.9 Hz, 3H), 0.81 (d, J = 6.9 Hz, 3H), 037 (d, J = 6.9 tlz) ppm. ttc NN{R: 6 21I.2,
136.3, 136.2, 134.6,134.1, 130.0, l2g.g, 127.9, r27.7,73.6,72.0,47.6,47.1, 33.7, 33.0,
27.3, 19.7, 18.6, 18.0, 17.9, 17.6 ppm. IR (neat): 3478,3072, 2929, 2932, 2859, 1707,
I109, 1006,760,701cm't. HRMS: Calcd for CrrHooOrSiNa 463.2653 (M + Na.). Found:
463.2638.
(3RS,7R)-7-tert-Butyldiphenylsiloxy-2,8-dimethyl-3-hydroxynona-1-8-diene-5-one
(96c). The aldol reaction of 95c (453 mg, 1.23 mmol) with methacrolein gave 96c (505
mg,89Vo yield), ds = 1.2:1. Spectral data reported for the combined diastereomers. 'H
NMR: 6 7.67 (m, 4H), 7.40 (m,6H), 4.95 (s, lH), 4.83 (bs, 2H), 4.77 (s, 1H), 4.61 (m,
lH),432 (m, 1H),3.90 (bs, lH),2.73 
-2.2.40 (m,4H), 1.70 (s,3H), 1.68 (s,3H), 1.07
(s, 9H).'3C NMR: 6 209.5, 145.7,136.2,136.1, 134.1, 133.5, 130.1, 130.0, 127.9, r27.9,
lr2.7,lll.4, 73.9,73.7,70.9, 50.5, 49.0, 49.9, 27.2, 19.6, 19.6, 19.5, 17.5 ppm. IR
(neat): 3450, 3073,2932,2858, 1709, I IlI, 1072, 822,702,612 cm-t. HRMS: Calcd for
C27H37O3Si: 437 .2528 (M + H.). Found: 437 .2507 .
Representative procedure for the synthesis of the dimethylphenylsiloxy ketones
To a solution of the p-hydroxyketone (1 mmol) in DMF (1.5 mL) was added
dimethylphenylsilylchloride (1.1 mmol) and imidazole (2.2 mmol). After stirring at room
temperature for 24 h, the solution was quenched with water then extracted twice with
EtrO. The organic extracts were washed with brine, dried over MgSOo, filtered and the
solvents removed under reduced pressure. The residual oil was purified by flash
chromatography (20:1 hexanes:EtOAc) to give the silylated adducts as colourless oils.
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(R)-4-Dimethylphenytsitoxy-5-methyt-hexan-2-one (97a). Silylation of (R)-4-hydroxy-
5-methyl-hexan-2-one (94a) (450 mg, 3.48 mmol) gave 97a (682 mg,74Vo yield) after
purification by flash chromatography. tH NlvR: 67.57 (m, 2H), 7.34 (m,3H), 4.06 (ddd'
J = 12.3,8.1, 3.9 Hz, lH), 2.60 (d,,/ = 15.6, 8.1 Hz, lH),236 (dd,,f = 15.6, 3.9 Hz, I H),
2.14, s (3H), 1.66 (m, 1H), 0.85 (d, J = 6.9 Hz, 3H), 0.82 (d, J = 6.9llz,3H),0.37 (s'
3H), 0.36 (s, 3H) ppm. "C NMR: 6 207.9, 138.2,133.3, 129.3, 127.6,73-5, 47 .3,33.6,
31.2, L7.7, L7.5, -1.3, -1.4 ppm. IR (neat): 3071,2960, 1717, 1357, 1250, 1117, 1079,
1051, 829, 782,699 cm't.
(4R)-4-Dimethylphenylsiloxy-5-methylhex-5-en-2-one (97b). Silylation of (4^R)-4-
hydroxy-5-methylhex-5-en-2-one (94a) (250 mg, 1.95 mmol) gave nb @04 mg,72Vo
yield) as a colourless oil after purification by flash chromatography. 'H Mvm.: 6 7.55 (m,
2H\,7.36 (m, 3H), 4.90 (s, LH),4.77 (s, lH), 4.57 (dd, J = 8'7,3.9H2, lH),2.75 (dd, J =
14j,8.7 Hz, lH), 2.42 (dd, J = L4j,3.9H2, l}l),2.10 (s, 3H), 1.67 (s, lH)' 0.36 (s, 3H),
0.35 (s, 3H) ppm. t'C I.[v{R: 6 206.9, 146.1, 137.5,133.3, I29.4,127.5, 1I1.4,73.2,50.O,
31.1,17.2,-1.5, -1.8 ppm; IR (neat): 3072,2958,1714,125L,1162,1070, 830, 814, 783,
699 cm-'. HRMS: Cald for Cr5H2zO2NSi 280.1719 (M + NH4). Found: 280.1727.
(3RS,7R)-3-Hydroxy-2,2,8-trimethyl-7-dimethylphenylsiloxy-nonane-5-one (98a).
The aldol reaction of ketone 97a (100 mg, 0.38 mmol) with pivaldehyde gave the
corresponding aldol adduct 98a (106 mg,80Vo yield), ds: l:1.1. Spectral data reported for
one diastereomer (separated by flash chromatography). tH NMR: 6 7.58 (m, 2H), 7.38
(m, 3H),4.10 (ddd, J =9.0,8.4,3.6 Hz, 1H), 3.63 (dd, J = 10.4,l.9I1z,lH),2.7L -2.31
(m,4H), 1.68 (m, 1H),0.88 (s,9H),0.84 (m,6H),0.39 (s, 6H) ppm. "C NMR: 6212.3,
!38.2, 133.5, 130.0, 127.7,74.9,73.7, 47.1, 45.8,34.1,33.6,25.6, 17 .9, 17.5, -1.2, -1.4
ppm. IR (neat): 3500, 2959,2905,2873, 1709, 1252, 1117,1056, 829, 785,744,700 cm-'.
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(3Rs,7R)-3-Hydroxy-2,8-dimethyl-7-dimethylphenylsiloxynona-1,8-dien-5-one (98b).
The aldol reaction of ketone 97b (100 mg, 0.38 mmol) with methacrolein gave the
corresponding aldol adduct 98b (104 mg, 827o yield), ds: 1: l.l. Spectral data reported for
the combined diastereomers. tH NIUR: 6 7.59 (m, 2H), 7.40 (m, 3II), 5.00 (d,,/ - 0.6H2,
lH),4.94 (s, lH), 4.86 (s, 1H), 4.81 (t, J - l.2Hz,1H), 4.61 (m, 1H), 4.45 (t, J = 6.3H2,
lH),2.85 
-2.41(m,4H), 1.72(d,J=3.6 Hz,3H), 1.69(s,3H),0.40(s,6H),0.39(s,
3H), 0.38 (s, 3H) ppm;'3C NMR: 6 210.4, 210.3, 146.4, t46.3, 145.8, 133.8, 133.3,
130.0, 129.9,128.1, L28.0,112.2, l12.l, I11.4,73.7,7L.3,71.0, 50.3, 50.2,49.7,49.6,
18.6, 18.5, -1.0, - 1.1, -1.5 ppm. IR (neat):3420,3A72,2958,1708, l25l,LIl7,L07l,
829, 784,700 cm-r. HRMS: Cald for C,fIrrNOrSi 350.2135 (M + NHo*). Found:
350.2t46.
(ft)-4-Benzyloxy-5-methyl-hexan-2-one (99). To a solution of (R)-4-hydroxy-5-methyl-
hexane-2-one (240 mg, 1.86 mmol) in 6 mL of CHrClr:cyclohexane (2:l) cooled to 0 oC
was added benzyl trichloroacetimidate (79) (345 pl, 1.86 mmol) followed by freshly
distilled trifluoromethanesulfonic acid (33 pl, 0.37 mmol) dropwise. The appearance of a
cream precipitate was immediately observed and the resulting mixture stirred at room
temperature for 30 min before being quenched with water (5 mL). The solution was then
extracted twice with hexanes and the organic extracts washed with satd. aq. NaHCOr,
brine, dried over MgSOo, filtered and concentrated under reduced pressure. Purification
of the crude material by flash chromatography (20:1 hexanes:EtOAc) gave 99 (216 mg,
6OVo) as a colourless oil. 'H NNm.: 6 7.33 (m, 5H), 4.57 (d, J = ll.4 Hz, lH), 4.51 (d, J=
ll.4Hz,lH),3.83 (m, lH),2.71(d,J=15.9,8.4H2,1I{),4.46(d,J- 15.9,3.6II2, lH),
2.16 (s, 3II), 1.98 (m, lH), 0.96 (d, J = 6.9 Hz, 6H) ppm.',C NMR: 6 207.g, 138.4, 12g.5,
128.0, 127.4,127.3,127.2,79.9,71.8,44.6,30.9,30.6,17.9,17.2ppm.IR(neat):3032,
2960,2874, 17L2, 1355, 1070, 733, 697 cm''. HRMS: Cald for C,'H,O r22l.l54g (M +
H*). Found:22I.1536.
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(3RS,7ft)-7-Benzyloxy-3-hydroxy-2,2,8-trimethylnonan-5-one (100). The altlol
reaction of ketone 99 (240 mg, 1.09 mmol) with pivaldehyde gave the corresponding
afdol adduct L00 (246 mg,74Vo yield), ds: 3:1. Spectral data reported for the combined
diastereomers). rH NMR: 6 7.33 (m, 5H), 4.53 (m, 2H), 3.85 (m, lH), 3.73 (dd, J = 10.2,
1.8 Hz, lH),2.79 
- 
2.42 (m, 4H), 1.98 (m, lH), 0.95 (d, 
"/ = 6.9 Hz,6H), 0.89 (s, 9H)
ppm. "c NMR: 6 212.3, 138.8, Lzg.2, 128.6, 128.3, 128.2, 128.0, Lz7 .9, 127.8, 89.7,
80.5,74.9,72.5,72.4,46.2,45.5,45.2,45.1,34.4,31.1,25.9,19.6,19.5, 17.7, 17.6ppm.
IR (neat): 3500, 3032,2959,287t, 1706, 1067,734,697 cm't. HRMS: Cald for
CrfI34NOj 324.2529 (M + NHo") Found:324.2533.
4-(But-1-ene-4-yloxy)-but-3-ene-2-one (fOt. A 50 mL round bottom flask equipped
with stir bar, 8 cm Vigreux column and distillation head was charged with but-3-enol
(1.07 mL, 12.49 mmol),4-methoxybut-3-en-Z-one (1.53 mL, 14.98 mmol), pyridiniump-
toluenesulfonate (31 mg, 0.12 mmol) and toluene (25 mL). The reaction mixture was
heated for 4 h at a gentle reflux, allowing for a slow distillation of the methanol-toluene
mixture. After cooling the solution to room temperature, the solvent was removed under
reduced pressure to give a red./brown oil. The crude material was purified by flash
chromatography (10:l hexanes:EtOAc) to give 105 (1.15 g,667o) as an orange oil.tH
NMR: 6 7.50 (d, 
"I = 12.6I12,1H), 5.76 (m, lH), 5.55 (d, J = 12.6 Hz, 1H), 5.09 (m, 2H),
3.88 (t, J = 6.6 Hz, 1H), 2.43 (dt, J = 13.2, 6.6, Hz, 2:m, 2.14 (s, 3H) ppm. 'rC N[UR: 6
197 .2, 162.3, 133.2, 117.6, lO7 .1, 70.0, 33.0, 27.6 ppm. IR (neat): 3079, 2947, 1618,
I59I, 1202, 1147,957,920 cm't,
1-[(2S,4n,65)-(6-4llyl-a-Qert-butyldimethylsiloxy)tetrahydro-pyran-2-yl]-propan-2-
one (109). To a solution of alcohol 108 (200mg, l.0l mmol) in DMF (3 ml)was added
ten-butyldimethylsilylchloride (167 mg, 1.11 mmol) and imidazole (137 mg,2.OZ mmol).
After stirring at room temperature for 24 h, the solution was quenched with water and
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extracted twice with Et2O. The organic extracts were then washed with brine, dried over
MgSOo, filtered and the solvents removed under reduced pressure. The residual oil was
purified by gradient flash chromatography (hexanes:20:1; hexanxes:EtOAc) to give 109
(300 mg, g5%) as a colourless oil.tH NN4R: 6 5.07 (m, lH), 5.03 (m, 2H),3.75 (m, 2H),
3.35 (m, IH),2.71(dd, J= 15.6,7.8 Hz, lH), 2.41 (dd, J= l5'6, 4.8lfz, lH),2'26 (m,
lH\,2.17 (s, 3H), 2.16 (m, 1H), 1.80 (m, 2H), 1.20 (m, 2H)' 0.89 (s, 9H), 0.05 (s' 6H)
ppm.''cNMR:6207.7,134.9,117.0,75.4,72.3,68.6,49.9,4r.6,41.1,40.6,31.4,26.0,
18.3, -4.4 ppm. IR (neat): 2929, 2856, 1716, 1251, 1124, 1068, 835,774 cm-t. FR'MS:
Cald for Cr7H33O3Si 313.2205 (M + H.). Found: 313.2194.
(4R)-1-t(2S,4R,65)-(6-Allyl-4-(tert-butyldimethylsilyloxy)tetrahydro-pyran-2-yl]'4'
hydroxy-5,5-dimethylhexan-2-one (110). Reaction of ketone t09 (287 mg,0.92 mmol)
with pivaldehyde gave the corresponding aldol adduct ll0 (296 mg, SlVo) as a colourless
oil; d.s: >95:5. tH I.[UR: 65.74 (m, lH), 5.02 (m, 2H),3.37 (m, 3H), 3.32 (m,1H)' 2.95
(d, 
"/ - 3Hz, 1H), 2.73 (dd,,I = 15.0, 8.4 Hz, lH), 2.65 (m, 1H), 2.46 (dd,,I = 17.1' 10.5,
Hz, 1H), 2.36 (dd, 
"/ = 15.0, 3.9 lH), 2.22 (m,lIJ),2.14 (m, lH), 1.77 (m,2H), 1.19 (m'
2H), 0.88 (s, 9H), 0.85 (s, 9H), 0.03 (s, 6H) ppm. "C NMR: 6 21L.2, 134.4, 116.9, 75.1,
74.5,72.3,68.3,49.2,46.L,4r.3,40.7,40-1,34.1,25.7,25.6, 18.0, -4.7 ppm. IR (neat):
3478,2952,2857,1708, 1643, 1071, 835,774 cm't. HRMS: Cald for c?2HorooSi
399.2928 (M + H*) Found: 399.2925.
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Progress towards the synthesis of peloruside A
The unique biological activity of peloruside A has resulted in this compound being
a particularly attractive target for many synthetic chemists. Accordingly, in the past few
years, several publications regarding the total or partial synthesis of peloruside A have
appeared in the literature. Provided below is a review of those publications that appeared
prior to the submission of this thesis.
Paterson, Di Francesco and Ktihn206 reported the first partial synthesis of
peloruside A in January 2003, and of the strategies reported thus far, this partial synthesis
most closely resembles the strategy pursued by Stocker, Teesdale-Spittle and Hoberg.re3
The retrosynthetic disconnects for Paterson's synthesis of peloruside A are depicted in
scheme 96. Here peloruside A has been divided into three key segments; the C-12 to C-24
fragment 113, the C-7 to C-l I fragment 114 and the C-l to C-6 fragment 1.15.
{ -oPMB
OTBS
113 114 115
Scheme 96: Paterson, Di Francesco and Kijhn's retrosynthesis of peloruside A
TIPS
OPMB
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The similarity between Paterson's strategy for the synthesis of the C-I2 to C-24 fragment
of peloruside A and the strategy pursued by Stocker et. aI. for the synthesis of the similar
carbon framework is most noteworthy. These two fragments are reviewed in figure 36.
113 22aR = Et22bR=H
Figure 36: The C-12 to C-24 fragments for Paterson's and Stocker's synthesis of
peloruside A
Paterson's synthesis for 113 commences with the (S)-lactate-derived ketone 114 - itself
synthesisedin three steps in a647o yield, scheme 97. Aten step synthesis isrequiredfor
the formation of 113 and although the individual yields for each of the ten reactions are
excellent, due to the linear nature of this strategy, 113 is synthesised in an overall yield of
l8%o. In contrast, 22b is synthesised in four linear steps with an overall yield of 33Vo.
Paterson subsequently utilizes boron mediated 1,S-anti aldol methodology to achieve the
desired I,5 anti- relationship between C-15 and C-11. However, in contrast to the
synthesis developed by Stocker et. al., whereby the cyclic silyl tether of 22 induces 1,5-
anti indvction, Paterson relied upon the more highly precedented PMB protecting group at
the B-position of 113 for diastereoselective induction.
^&"*
I
10 steps. 18% l. Cy2BCl, Et3NEtzO, -78 "C I
114
Rl = PMB
113
ds > 95:5
Rl = PMB
115
studies for the C-12Scheme 97: Paterson, Di Francesco and Kiihn's synthesis and aldol
to C-24 fragment of peloruside A
\
TIPS
9PMB
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o
l*.'n
o
-t79-
Paterson's synthesis of the C-12 to C-7 fragment of peloruside A starts with
neopentylglycol 116. Glycal 116 is subjected to mono benzylation, a Swern oxidation, a
Horner-Wadsworth Evans homologation and a Sharpless dihydroxylation, to give key
intermediate 117. Perhaps the most interesting feature of this strategy however, was the
subsequent DDQ mediated oxidative cyclization of ll7 that resulted in an unexpected
mixture of PMP acetals 118 and 119. Fortunately though, equilibration of this mixture of
acetals with CSA afforded solely the desired, and thermodynamically more stable, six-
membered cyclic acetal 119.
v'
116
oEt +
Scheme 98: Paterson, Di Francesco and Ki.ihn's synthesis of the C-11 to C-7 fragment
of peloruside A
The protection, reduction and oxidation of 119 gave the key retrosynthetic fragment 120,
which was subsequently subjected to a variety of aldol reactions, with acetone as a model
substrate, in order to ascertain which conditions would favour formation of the desired
ar?/i diastereomer 121a. (+)-IpcrBCl was reported to give the highest, although still rather
modest, 3:l ratio of diastereomers, scheme 99.
(+)-lpc2BCl
r-H 69/o, ds: 3:1
o
,,Jt'--
PMB Doe, aA us
^ar- cH2cl2
OTBS
1n 121a
Scheme 99: Model aldol studies with kev intermediate 120.
118 PMB
I csn,4AMS, cHrcr, I
'? 6ttt
121b
-180-
Finally, Paterson's synthesis of the C-6 to C-l fragment of peloruside A commenced with
methylacetoacetate 122, with the key retrosynthetic fragment 115 being synthesised in 12
steps, yet with an excellent overall yield of 28Vo, scheme 100. The desiredC-2 and C-3
syn relationship was established by a Sharpless asymmetric dihydroxylation. Again, a
boron-mediated 1,5- anti aldol reaction was used to control the diastereoselectivity of the
subsequent aldol reaction. As depicted in scheme 100, isopropylaldehyde was used as a
model substrate, and although the desired anti adduct 123 was synthesised in 617o yield,
due to the presence of the methoxy substituent at the B position, the diastereoselectivities
were again, rather modest.
AX* P 9Me vtzvv''
t-oPMB i*cHo,61%, ds: 3:1:
OTBS
Scheme 100: Synthesis of the C-6 to C-l
studies
Cy2BCl, Et3N, -7t "C
. 
-OPMB
OTBS
1B
fragment of peloruside A and model aldol
- 1151?,2
Shortly following Paterson's fragment synthesis of peloruside A, De Brabander,
Liao and Wu published the first, and to date, only total synthesis of peloruside A.205
Although somewhat of a linear strategy was adopted, which in turn resulted in an overall
yield of less than 2Vo, this was nonetheless elegant work given the complexity of the
target molecule. Additionally, by completing the first total synthesis, De Brabander was
able to establish the absolute stereochemistry of peloruside A 
- 
this being the opposite to
that initially reported by West and Northcote.rs
Only two fundamental disconnects were made by
De Brabander in his retrosynthetic analysis,
figure 37. lt is interesting to note that De
Brabander's synthesis of the C-14 to C-24 side
chain commenced with the zirconium catalysed
ethylmagnesation of 2,S-dihydrofuran 124, in
i"oue
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Figure 37: De Brabander's retrosynthesis
much the same manner as that proposed by Stocker et, aI. The homoallylic alcohol 125
was subsequently acylated with methacryloyl chloride, subjected to RCM (using Grubb's
second generation catalyst), the resulting lactone treated with methyl lithium and the
ensuing hydroxyl silylated to give 126 in an overall yield of approximately l7To, scheme
101.
124 126
Scheme 101: De Brabander's synthesis of the C-14 to C-24 fragment of peloruside A
De Brabander's synthesis for the remainder of peloruside A began with the silylation and
dihydroxylation of the previously reported alcohol 127, scheme lO2. A Pb(OAc)o assisted
cleavage of the ensuing diol then gave alcohol 128. A five step, linear strategy was then
followed to give dihydropyranone 129, in 477o overall yield.
U
:
125
TESO O 5 steps
: ll
PMBO- V V
47e/"
)j
rils{ i
9H 1) TESCI 
,pMeo% 2)osoo
3) Pb(OAc)a
78o/o
127 128
Scheme 102: De Brabander's synthesis of the key intermediate dihydropyranonel2g.
Formation of 129 thus provided a key starting point for establishing the correct
stereochemistry of the pyranose ring of peloruside A. A five step strategy involving a
Luche reduction, a hydroxyl-directed epoxidation followed by an in situ methylation,
selective methylation of the ensuing equatorial hydroxyl and finally silylation of the
remaining axial hydroxyl gave pyranose 130, scheme 103. A series of functional group
modifications then gave methyl ester 131.
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7 steps
+
-
68%
Scheme 103: De Brabander's synthesis of the key intermediate methyl ester 131.
The final transformations required for De Branbander's synthesis of peloruside A first
required a diastereoselective aldol reaction with the previously synthesised C-14 to C-24
fragment, scheme 104. Although the aldol reaction of 131 with 126 was rather
unselective, the 2:1 ratio of diastereomers was nonetheless welcomed as previous
problems had been encountered when attempting to synthesise peloruside by an
alternative strategy. It is also interesting [o note, that this aldol reaction was conducted in
the presence of an unprotected hydroxyl group.
1301n
9HB
..i/
a 
-z--./
,=so,..k""IY
MeOt'V ""1
nlr"ofoMoM
CO,ME
131
qH
TESO,,.
MeOu"
1) PPhs, DIAD
2) 4M HCt, THF
45o/o
1
Scheme 104: The final chemical transformations required
synthesis of peloruside A
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cH2cl2, g7o/o
ds:2:1
MeO
I s4%
r'r"otoMoM
/
OHv""', lt'""'
neo{ rBs
FOltllO[,1
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in De Brabander's total
Perhaps the most salient feature of De Brabander's synthesis of peloruside A however,
was the final Mitsunobu-type lactonisation, scheme 104. It was found that the same
desired lactone was produced, regardless of the stereochemistry at C-15. It was
subsequently speculated that geometrical/conformation constraints preclude formation of
the C-15 epimeric lactone, forcing the cyclisation to occur via an alkoxyphosphonium
i ntermedi ate, or the less famili ar, acyloxyphosphonium intermedi ate.
Following De Brabander's total synthesis of peloruside A, Ghosh and Kim
reported, in two separate papers, a synthesis for the C-l to C-9 and C-10 to C-24
fragments of peloruside A.m7'208 These fragments are highlighted in scheme 105.
''oMe
134
Scheme 105: Ghosh and Kim's retrosynthetic analysis of peloruside A
Of the two aforementioned fragments, synthesis of the C-l to C-9 fragment 135 was
reported first - commencing with the preparation of the q,,B-unsaturated ester L36 using
known procedures. After installation of the C-2 to C-3 syn relationship using Sharpless
asymmetric dihyroxylation methodology, a series of basic functional group
transformations lead to aldehyde 137 in a 47Vo overall yield, scheme 106. Allylation of
137 using allyl magnesium bromide, followed by oxidation of the resulting alcohol gave
ketone 138.
V*N.oof
135 '
J
,d-t foP
,/ ( o
a
av-
,ror*/
136
r eiK
et4{--oen:
t0
OEt ----- +
Scheme 106: Gosh and Kim's partial synthesis of the C-1 to C-9 fragment of peloruside
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A unique feature of this C-l to C-9 fragment synthesis was the subsequent chelation
controlled asymmetric reduction of ketone 138 using a solution of LiAlo and LiI in
diethylether, scheme 107. As depicted in transition state 138a, the observed
diastereoselectivity can be rationalised by the presence of the gem-dimethyl group on the
B-face, resulting in the reduction of the carbonyl from the less hindered cr-face.
Subsequent esterification with acrolyl chloride and RCM of the corresponding acrylated
ester provided the o,B-unsaturated 6-lactone 140. A six-step strategy was then used to
convert 140 into the desired C-l to C-9 fragment 135. Key features of this transformation
include the saponification of lactone 140 and an asymmetric dihydroxylation (using A-D
mix) to give the C-7 and C-8 syn relationship.
LiAlH4, Lil
Et2O, -79"C
87o/"
l/m l, -
| | 6 stepsil 36"/.
o
135
Me
Ah:x
1 38a
Seheme 107: Gosh and Kim's synthesis of the C-l to C-9 fragment of peloruside A
Gosh's synthesis of the C-10 to C-24 fragment of peloruside A commenced with the
asymmetric allylation of Evan's chiral oxazolidinone 144, using a slightly different
procedure to that reported in this thesis for the synthesis of the enantiomerically pure side
chain 39 (refer to page 37, chapter 2), scheme 108. Following some basic functional
group transformations, the subsequent installation of the Z olefin using Horner-Emmons
protocol and further functional group manipulations, the correct stereochemistry at C-15
was then established by using Brown's asymmetric allylboration protocol. Esterification
and RCM protocol followed to give the cr,B-unsaturated lactone 1.42.
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141
1)H2O2,6N NaOl-l
2) NaBH4, PeSeSePh, AcOH
3)TBDPSCI
74o/o
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2) MEMCI
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Scheme 108: Gosh and Kim's synthesis of the C-10 to C-24 fragment of peloruside A
An elegant feature of Gosh's strategy for the installation of the correct stereochemistry at
C-13 involved the stereoselective epoxidation of 142 and treatment of the resulting
epoxide with diphenyldiselenide and sodium borohydride, scheme 108. Protection of the
ensuing alcohol then gave 143 in a747o overall yield for the three steps. It was initially
anticipated that lactone 143 could be directly opened with isopropylmagnesium chloride,
however this procedure proved elusive. Thus conversion of lactone 143 to the Weinred
amide 144 was first required before synthesis of the final fragment 134 could be
achieved.
Taylor and Jinz@ reported the first partial synthesis of the correct enantiomer of
peloruside A. Although De Brabander had determined the absolute stereochemistry of
peloruside A, Taylor and Jin previously compated the structural and conformational
features of peloruside A and epothilone B using NMR and computer modelling
techniques. Their modelling results also indicated that the enantiomer opposite to that
initially reported by West and Northcotels was the correct enantiomer of peloruside A.
Taylor and Jin initially focussed on the synthesis of the C-8 to C-24 fragment of
peloruside A, as depicted in scheme 109.
TBS61"/o
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Scheme 109: Taylor and Jin's target C-8 to C-24 fragment of peloruside A
Taylor's synthesis of the C-8 to C-24 fragment of peloruside A commenced in a manner
very similar to that previously reported by Gosh. Thus an asymmetric alkylation reaction
using Evans's oxazolidinone, a Still-Gennari olefination and Brown's asymmetric
allylation, were the key methodologies used during the nine-step synthesis of alcohol
147. Establishment of the 1,3-syn relationship between C-13 and C-15 was achieved by
an elegant regioselective, iodine-induced, carbonate cyclization to give carbonate 14E in
excellent yield, scheme 110. Exposure of l4E to basic methanol solution and protection
efficiently produced the syn-epoxy ether 149. Ether L49 was then subjected to
nucleophilic attack by the lithium anion of dithiane, methylated in situ, and the dithiane
moiety hydrolysed to give aldehyde 150.
AP
*ru
"Bn
146
9 steps
35%
1) Boc-ON,91%
2) NrS, CH3CH, 92%
1) l Sdithiane, rBuLi
HMPA (CH30)2SO2,8s%
2) Mel, CH3CNYHaO, 90%
Scheme 110: Synthesis of key intermediate aldehyde 150.
1) K2CO3, MeOH
86o/o
2) TBSCI, imid
9?!/"
149
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The final requirement in Taylor's synthesis of the C-8 to C-24 ftagment of peloruside A
involved a Mukaiyama aldol reaction of the B-methoxy aldehyde 150 with the TMS silyl
enol ether 151, scheme 111. It is interesting to note that even though an achiral lewis acid
was used, good 1,3 anti diastereoselectivity was nevertheless observed in this reaction.
\o*'| lsl
BF3OEtz, CH}C\I
-78"C.91o/o
145 anti:svn (8:1\
Scheme 111: Synthesis of the C-8 to C-24 fragment of peloruside A
The final strategy towards the synthesis of peloruside A to be discussed in this
thesis is the recently published partial synthesis of Pagenkopf, Engers and Bassindale.2ro
This strategy has similar disconnects to those proposed by Stocker, Teesdale-Spittle and
Hoberg.te3 These key disconnects are depicted in scheme 112-
OH
- 
-?"p fi f .t ?"i*f
Scheme 112: Pagenkopf, Engers and Bassindale's retrosynthesis of peloruside A
The unique difference between Pagenkopf's strategy, and the other strategies reported for
the synthesis of peloruside A however, is Pagenkopf's use of the commercially available
triacetal n-glucal for providing the chiral backbone for the pyranose segment of
peloruside A. This strategy results in an elegant approach towards the synthesis of
peloruside A.
g[4e
1$l1e151
- 188-
Thus, triacetal u-glucal 154 was converted in five steps to the known pyranose 155,
scheme l13. This transformation involved formation of a methoxy acetal, following
treatment of glucal 154 with l0 mol 7o PhrP.I{Br and methanol, acetate cleavage,
benzylidine acetal formation, methylation, and selective cleavage of the primary
benzylidine acetal under Hanessian-Hullar radial bromination conditions. Allylation of
155, followed by dihydroxylation and NaIOo oxidative cleavage of the resulting diol gave
the desired C-1 to C-7 fragment 156. Indeed, this eight-step synthesis has been performed
on the 50 g scale, with a respectable overall yield of 467o.
.OAc
=
Paao*V'"on"
1s4
+ o-aoBt
-"eoU""oMe
5 steps ..8,: 3 steps
-
..Br
a
FfB'- ,\ /\A/ "." a*
159
1) SrCl2.fizO, Nal
OBn
158
2) Swern
69%
157
Scheme 114: Synthesis of the C-8 to C-12 fragment
Perhaps the most challenging step in Pakenkopf's strategy was in achieving the desired
1,Z-anti relationship between C-7 and C-8 during the coupling of 156 and 159. Thus a
range of Lewis acids were explored during the coupling of 156 and the TMS enolate
159a, with BFr.OEt giving the best, but still modest, diastereoselectivity, scheme 115.
Le4_
155 156
Scheme 113: Pagenkopf's synthesis of the C-l to C-7 fragment of peloruside A
An equivalent of the central C-8 to C-12 piece was synthesised in 69Vo overall yield by
the S"2' addition of an allylic stannane generated in situ from Barbier-type reaction of
157 with SnClr.2Hr0 and benzyloxy acetaldehyde 158, scheme 114. A Swern oxidation
then completed the synthesis of 159.
-189-
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Scheme 11.5: Establishment of the C-7 to C-8 anti relationship
Diastereomer 160a was then methylated and subjected to a suspension of zinc and copper
in ethanol which resulted in Vasella ring cleavage by spontaneous B-elimination of the
alkyl zinc generated in situ by reduction of the alkyl bromide with the zinc-copper
couple, scheme I16. For ease of characterisation, it was then anticipated that conditions
could be established such that equilibration would favour the hemiacetal 162.
Unfortunately though, reliably obtaining 162 proved elusive, indicating that the pyranose
fragment of peloruside may first need to be deprotected for cyclisation to occur.
?M"
Bz 1) MqOBF4, 90% MeOFUH*
",oMe 2)ZnlOu,8?/o
160a tfi t6a
Scheme 116: Attempted cyclisation of the C-l to C-12 fragment of peloruside A
Finally, a series of basic functional group manipulations involving an ozonolysis,
oxidation, and esterification of the resulting carboxylic acid gave the complete C-l to C-
12 carbon framework, scheme ll7. By comparison to the previous synthesises of
peloruside A, establishment of the correct stereochemistry in the C-5 to C-10 region
appears to be the most challenging aspect of the synthesis. Thus the strategy adopted by
Pakenkopf, Engers and Bassindale represents an elegant solution to this problem.
..Br
:
?r"
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1) q, PfuP
2) NaClOz, NaH2POa
3) TMSCHN2
(45% three steps)
Scheme 117: Pagenkopf's synthesis of the C-l to C-12 fragment of peloruside A
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